
<html lang="en"     class="pb-page"  data-request-id="20769445-4e5b-44e7-9dc9-6430605df5d2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2013.56.issue-14;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm400467w;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity" /></meta><meta name="dc.Creator" content="Berkley E.  Gryder" /></meta><meta name="dc.Creator" content="Michael K.  Rood" /></meta><meta name="dc.Creator" content="Kenyetta A.  Johnson" /></meta><meta name="dc.Creator" content="Vishal  Patil" /></meta><meta name="dc.Creator" content="Eric D.  Raftery" /></meta><meta name="dc.Creator" content="Li-Pan D.  Yao" /></meta><meta name="dc.Creator" content="Marcie  Rice" /></meta><meta name="dc.Creator" content="Bahareh  Azizi" /></meta><meta name="dc.Creator" content="Donald F.  Doyle" /></meta><meta name="dc.Creator" content="Adegboyega K.  Oyelere" /></meta><meta name="dc.Description" content="We describe a set of novel histone deacetylase inhibitors (HDACi) equipped with either an antagonist or an agonist of the estrogen receptor (ER) to confer selective activity against breast cancers...." /></meta><meta name="Description" content="We describe a set of novel histone deacetylase inhibitors (HDACi) equipped with either an antagonist or an agonist of the estrogen receptor (ER) to confer selective activity against breast cancers...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 3, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400467w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400467w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400467w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400467w" /></link>
        
    
    

<title>Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400467w" /></meta><meta property="og:title" content="Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0012.jpeg" /></meta><meta property="og:description" content="We describe a set of novel histone deacetylase inhibitors (HDACi) equipped with either an antagonist or an agonist of the estrogen receptor (ER) to confer selective activity against breast cancers. These bifunctional compounds potently inhibit HDAC at nanomolar concentrations and either agonize or antagonize ERα and ERβ. The ER antagonist activities of tamoxifen–HDACi conjugates (Tam-HDACi) are nearly identical to those of tamoxifen. Conversely, ethynyl-estradiol–HDACi conjugates (EED-HDACi) have attenuated ER agonist activities relative to the parent ethynyl-estradiol. In silico docking analysis provides structural basis for the trends of ER agonism/antagonism and ER subtype selectivity. Excitingly, lead Tam-HDACi conjugates show anticancer activity that is selectively more potent against MCF-7 (ERα positive breast cancer) compared to MDA-MB-231 (triple negative breast cancer), DU145 (prostate cancer), or Vero (noncancerous cell line). This dual-targeting approach illustrates the utility of designing small molecules with an emphasis on cell-type selectivity, not merely improved potency, working toward a higher therapeutic index at the earliest stages of drug development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400467w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400467w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400467w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400467w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400467w&amp;href=/doi/10.1021/jm400467w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5782-5796</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400418p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400722d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Berkley+E.++Gryder">Berkley E. Gryder</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+K.++Rood">Michael K. Rood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenyetta+A.++Johnson">Kenyetta A. Johnson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vishal++Patil">Vishal Patil</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+D.++Raftery">Eric D. Raftery</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Pan+D.++Yao">Li-Pan D. Yao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcie++Rice">Marcie Rice</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bahareh++Azizi">Bahareh Azizi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+F.++Doyle">Donald F. Doyle</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adegboyega+K.++Oyelere">Adegboyega K. Oyelere</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">School of Chemistry and Biochemistry, Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia, 30332-0400, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 404-894-4047. Fax: 404-894-2291. E-mail: <a href="/cdn-cgi/l/email-protection#3c5d53455950594e597c5b5d48595f5412595849"><span class="__cf_email__" data-cfemail="41202e38242d243324012620352422296f242534">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400467w&amp;href=/doi/10.1021%2Fjm400467w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5782–5796</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 20, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 March 2013</li><li><span class="item_label"><b>Published</b> online</span>3 July 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 July 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400467w" title="DOI URL">https://doi.org/10.1021/jm400467w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5782%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBerkley%2BE.%2BGryder%252C%2BMichael%2BK.%2BRood%252C%2BKenyetta%2BA.%2BJohnson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D14%26contentID%3Djm400467w%26title%3DHistone%2BDeacetylase%2BInhibitors%2BEquipped%2Bwith%2BEstrogen%2BReceptor%2BModulation%2BActivity%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5796%26publicationDate%3DJuly%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400467w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2470</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">57</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400467w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Berkley&quot;,&quot;last_name&quot;:&quot;E. Gryder&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;K. Rood&quot;},{&quot;first_name&quot;:&quot;Kenyetta&quot;,&quot;last_name&quot;:&quot;A. Johnson&quot;},{&quot;first_name&quot;:&quot;Vishal&quot;,&quot;last_name&quot;:&quot;Patil&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;D. Raftery&quot;},{&quot;first_name&quot;:&quot;Li-Pan&quot;,&quot;last_name&quot;:&quot;D. Yao&quot;},{&quot;first_name&quot;:&quot;Marcie&quot;,&quot;last_name&quot;:&quot;Rice&quot;},{&quot;first_name&quot;:&quot;Bahareh&quot;,&quot;last_name&quot;:&quot;Azizi&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;F. Doyle&quot;},{&quot;first_name&quot;:&quot;Adegboyega&quot;,&quot;last_name&quot;:&quot;K. Oyelere&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;5782-5796&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400467w&quot;},&quot;abstract&quot;:&quot;We describe a set of novel histone deacetylase inhibitors (HDACi) equipped with either an antagonist or an agonist of the estrogen receptor (ER) to confer selective activity against breast cancers. These bifunctional compounds potently inhibit HDAC at nanomolar concentrations and either agonize or antagonize ERα and ERβ. The ER antagonist activities of tamoxifen–HDACi conjugates (Tam-HDACi) are nearly identical to those of tamoxifen. Conversely, ethynyl-estradiol–HDACi conjugates (EED-HDACi) have attenuated ER agonist activities relative to the parent ethynyl-estradiol. In silico docking analysis provides structural basis for the trends of ER agonism/antagonism and ER subtype selectivity. Excitingly, lead Tam-HDACi conjugates show anticancer activity that is selectively more potent against MCF-7 (ERα positive breast cancer) compared to MDA-MB-231 (triple negative breast cancer), DU145 (prostate cancer), or Vero (noncancerous cell line). This dual-targeting approach illustrates the utility of designing small m&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400467w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400467w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400467w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400467w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400467w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400467w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400467w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400467w&amp;href=/doi/10.1021/jm400467w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400467w" /></input><a href="/doi/pdf/10.1021/jm400467w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400467w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400467w%26sid%3Dliteratum%253Aachs%26pmid%3D23786452%26genre%3Darticle%26aulast%3DGryder%26date%3D2013%26atitle%3DHistone%2BDeacetylase%2BInhibitors%2BEquipped%2Bwith%2BEstrogen%2BReceptor%2BModulation%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D14%26spage%3D5782%26epage%3D5796%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jmcmar.2013.56.issue-14/production/jmcmar.2013.56.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We describe a set of novel histone deacetylase inhibitors (HDACi) equipped with either an antagonist or an agonist of the estrogen receptor (ER) to confer selective activity against breast cancers. These bifunctional compounds potently inhibit HDAC at nanomolar concentrations and either agonize or antagonize ERα and ERβ. The ER antagonist activities of tamoxifen–HDACi conjugates (Tam-HDACi) are nearly identical to those of tamoxifen. Conversely, ethynyl-estradiol–HDACi conjugates (EED-HDACi) have attenuated ER agonist activities relative to the parent ethynyl-estradiol. In silico docking analysis provides structural basis for the trends of ER agonism/antagonism and ER subtype selectivity. Excitingly, lead Tam-HDACi conjugates show anticancer activity that is selectively more potent against MCF-7 (ERα positive breast cancer) compared to MDA-MB-231 (triple negative breast cancer), DU145 (prostate cancer), or Vero (noncancerous cell line). This dual-targeting approach illustrates the utility of designing small molecules with an emphasis on cell-type selectivity, not merely improved potency, working toward a higher therapeutic index at the earliest stages of drug development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Histone deacetylases (HDAC) catalyze the removal of acetyl groups from histone and nonhistone proteins for transcriptional regulation, cell cycle progression, and apoptosis. There are 18 human HDAC isoforms subdivided into four different classes (I–IV). Classes I, II, and IV (HDAC-1 through -11) require Zn<sup>2+</sup> for enzymatic activity. The seven members of class III, called sirtuin (SIRT1 through 7), require NAD<sup>+</sup> for activity and do not have histones as their primary targets.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Class I HDACs are ubiquitously expressed and play essential roles in proliferation, whereas classes II and IV have tissue-specific functions.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The maintenance of equilibrium between acetylation and deacetylation of histones and nonhistone substrates is essential for normal cell growth. Aberrant HDAC activity can result in epigenetic imbalance<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and has been linked to cell proliferation in many cancers.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> In particular, overexpression of HDAC1, HDAC6, and HDAC8 has been linked to breast tumors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> As a result, the use of HDAC inhibitors (HDACi) as cancer therapeutics is an area of active investigation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Several HDACi are in various stages of clinical trials, with approximately 500 clinical trials initiated over the past decade,<a onclick="showRef(event, 'cit2b'); return false;" href="javascript:void(0);" class="ref cit2b">(2b)</a> thus far resulting in the FDA approval of SAHA (vorinostat)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and FK228 (romidepsin).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Nevertheless, a lack of solid tumor penetration and broad tissue distribution has resulted in clinical ineffectiveness<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and off-target side effects such as myelosuppression, fatigue, and cardiac toxicity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Selectively delivering HDACi into cells of interest could potentially decrease such unanticipated side effects and increase the potencies and efficacies of these drugs.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The use of HDACi in combination with other anticancer agents has been found to increase the efficiencies of these agents.<a onclick="showRef(event, 'cit2c ref10'); return false;" href="javascript:void(0);" class="ref cit2c ref10">(2c, 10)</a> HDACi are more effective when used in combination with hormone therapy, as they potentiate the effects of tamoxifen in ERα positive cell lines.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Thus, an area of increasing interest is to combine hormone therapies with HDACi to target various stages of the cancer cell cycle and thus broadly inhibit tumor proliferation.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Indeed, a recent phase II study has shown that a combination of SAHA and tamoxifen is well tolerated, with a 40% clinical benefit that positively correlates with histone hyperacetylation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Furthermore, combining HDACi with estrogen modulators could target estrogen modulator resistant cancers. Many breast tumors which were once sensitive to estrogen modulators, such as tamoxifen and fulvestrant, acquire resistance over time.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The exact mechanisms of estrogen modulator acquired resistance are not completely understood. It is, however, clear that resistant tumors still maintained ER expression, either in the form of ERα (in more than 60% of the cases)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> or by up regulation of the expression of ERβ,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> a closely related ER subtype. In other cases, resistance is acquired via epigenetic silencing of ER subtypes and HDACi restores tamoxifen sensitivity in such ER-negative breast cancers by inducing re-expression of ERα.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">ERs are initially bound to heat shock proteins in the cytoplasm and translocate to the cell nucleus upon hormone binding. Small subsets of the population of both ERs, 5–10% for ERα, exist associated with the plasma membrane of target cells. These membrane receptors have been implicated in the rapid nongenomic signaling associated with estrogen modulating cell survival, motility, and proliferation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> We hypothesized that cytoplasmic and nuclear ER could increase retention of ER targeted compounds, while surface expressed ER is anticipated to facilitate their tumor selective uptake.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Regardless of mechanism, these bifunctional compounds could achieve higher concentrations in cells expressing ER.</div><div class="NLM_p last">In this study, we investigate the conjugation of a HDAC inhibition moiety to two estrogen modulator ligands, as an approach to selectively enhance HDACi concentration in hormone positive breast tumors. We investigated the biological effect of both agonist and antagonist scaffolds. Specifically, we have covalently linked aryl- and azido-hydroxamate HDACi to tamoxifen (an antagonist and selective ER modulator, or SERM) and 17α-ethinylestradiol (an ER agonist), respectively. We anticipate that the interaction between the ERα and ER ligand-like portions of these conjugates will selectively sequester them into ER positive cells. Our results reveal that these dual acting molecules retain independent anti-HDAC and estrogen receptor binding activities. Tam-HDACi conjugates are generally less potent inhibitors of HDAC than EED-HDACi compounds but exhibit greater anticancer activity across all cell lines. Particularly, the Tam-HDACi conjugates are selectively potent for MCF-7, less effective in MDA-MB-231 (ERα negative breast cancer cells), DU145 (prostate cancer cells), and VERO (healthy cells). These results suggest that conjugation of estrogen modulators to the HDACi moiety could facilitate a selective enrichment of HDACi in hormone positive tumors and possibly broaden the scope of ER ligand clinical use to ligand resistant breast tumors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of Estrogen Modulator–HDACi Conjugates</h3><div class="NLM_p">With the goal of creating novel HDACi that exhibit a therapeutic effect selectively more potent toward breast cancers, we designed HDACi that are covalently linked to either the ER agonist (17α-ethinylestradiol, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) or the selective ER modulator (SERM, tamoxifen, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B), named EED-HDACi and Tam-HDACi, respectively. To appropriately design the molecular connectivity in such a way that binding is retained to both the ER and HDAC, the crystal structures of each were analyzed. Crystal structures of several hydroxamic acid-derived HDACi (such as SAHA, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) bound to various HDAC isoforms show a remarkable conservation of positioning, which has led to the recognition of a three-part pharmacophore consisting of (1) a cap group that recognizes the surface outside the binding pocket, (2) a linker that traverses the tunnel leading to the active site, and (3) a zinc binding group (ZBG) for chelation to the Zn ion buried at the heart of the active site. In previous SAR studies, we learned that the cap group preference is extremely flexible,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> as should be expected when considering the large number of structurally divergent protein substrates the HDAC enzymes act upon. Cap group variation also allows for selectivity among HDAC isoforms,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Therefore, the ER modulators tamoxifen and EED were designed to function as cap groups in the HDACi pharmacophore to be placed at the end of the linker distal to the ZBG. The size and shape of the linker and ZBG are consistently similar to their acetylated lysine substrate, explaining their more limited diversity as compared to the cap group. We designed all HDACi compounds with the same hydroxamic ZBG and varied alkyl linker lengths. We incorporated the triazole functionality at the junction between the ER targeting cap group and the alkyl linker, based on our previous observations that the triazole ring not only enhanced the HDACi activity of SAHA-like hydroxamates but also facilitated the investigation of the linker length dependence of their activity.<a onclick="showRef(event, 'cit17d ref19'); return false;" href="javascript:void(0);" class="ref cit17d ref19">(17d, 19)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of dual-acting ER ligand–HDACi conjugates. (A) Crystal structures of antagonist tamoxifen (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT">3ERT</a>, blue) and agonist TFMPV-E2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>, teal) bound to ERα, and molecular determinants of agonism or antagonism for E2 and tamoxifen scaffolds. (B) EED/Tamoxifen–HDACi conjugates, with SAHA bound to HDAC (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZZ1">1ZZ1</a>, gold) showing the solvent exposed cap group for chemical modification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For targeting ER, there are many examples of dual-function conjugates modified at various positions of the parent ER modulator.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We aimed here to explore the effect of both agonistic and antagonistic conjugates. Beginning with the steroidal agonist EED, the 17α position was chosen as the point of tethering for compounds <b>1a</b>–<b>e</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). Added bulk at this location often results in a loss of binding affinity,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> but this is the only position where modification allows for retention of agonist activity (as seen in TFMPV-E2, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). E2 derivatives with bulky modifications on the B/C rings have antagonistic activity, as the bulky group is able to extend toward and displace helix 12 in the same manner as tamoxifen (as seen in ICI164,384 and RU 39411, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>). As we envisioned the use of the ER as a route to enhanced nuclear localization, attenuation of binding affinity is a potential benefit, as the ER would be required to release the drug before its secondary activity (HDACi) would take effect. Furthermore, the linker length was varied to probe for optimal HDACi and ER activity.</div><div class="NLM_p">To determine the amenable point of chemical tethering for the tamoxifen cap group, we examined the cocrystal of 4-hydroxy tamoxifen (the active metabolite of tamoxifen) bound to the ligand binding domain of ERα (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT">3ERT</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). Helix-12 (H12, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) is displaced by tamoxifen’s dimethylamino group, an extension of steric bulk from the triphenylethylene core, which if removed results in a switch to estrogenic activity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Analysis revealed that the methyl groups of the dimethylamino moiety are solvent exposed, allowing for modification without disruption of binding affinity. This structural information has been used to conjugate tamoxifen to cytotoxic agents in studies aimed at developing targeted breast cancer therapeutics.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We designed two Tam-HDACi conjugates using the dimethylamino moiety of tamoxifen as the conjugation locale (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B), with either a 1,2,3-triazole ring (compound <b>2</b>) or simple amide-bond linkage (compound <b>3</b>). The choice of the methylene linker length of compound <b>2</b> is based on our prior observation which suggests that five methylene groups, separating the triazole from the hydroximate moiety, are optimal for HDAC inhibition of aryltriazolylhydroxamates.<a onclick="showRef(event, 'ref17 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref19">(17, 19)</a> Compound <b>3</b>, on the other hand, is a direct Tam-SAHA conjugate. We envisioned that this design approach would enable a facile unmasking of the minimal structural attributes for simultaneous HDAC inhibition and estrogen modulation within a single molecular template.</div><div class="NLM_p">All designed compounds were synthesized as outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Starting with alkyne containing EED and trityl-alkyl-azides <b>4a</b>–<b>e</b>, Cu (I) catalyzed azide–alkyne cycloaddition reaction (“click” chemistry) was employed to obtain protected precursors <b>5a</b>–<b>e</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Trifluoroacetic acid (TFA) facilitated removal of the trityl protecting groups furnished EED-HDACi conjugates (<b>1a</b>–<b>e</b>) of various linker lengths.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of EED Based Conjugates (<b>1a</b>–<b>e</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, DIPEA, DMSO, argon, rt, 18 h; (b) TFA, TIPS, DCM, rt, 15 min.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Tam-HDACi (<b>3</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TMSCl, pyridine, DMAP; (b) MsCl, DCM, TEA; (c) DIPEA, DMSO; (d) aq NH<sub>2</sub>OH, KCN, THF, MeOH.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Triazole Containing Tam-HDACi (<b>2</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIPEA, DMSO, 80 °C; (b) CuI, DIPEA, THF; (c) aq NH<sub>2</sub>OH, KCN, THF, MeOH.</p></p></figure><div class="NLM_p last">Tamoxifen conjugates <b>2</b> and <b>3</b> were derived from <i>N</i>-desmethyl tamoxifen <b>10</b>, obtained via demethylation of tamoxifen according to literature protocols.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Alkylation of <b>10</b> with mesylated compound <b>9</b>,<a onclick="showRef(event, 'cit17a'); return false;" href="javascript:void(0);" class="ref cit17a">(17a)</a> followed by KCN catalyzed reaction with NH<sub>2</sub>OH, gave the hydroxamic acid final compound <b>3</b>. The triazole containing conjugate was synthesized by first alkylating <b>10</b> with mesylated alkyne <b>12</b> to obtain tamoxifen alkyne <b>13</b>. Cu(I) catalyzed cycloaddition reaction between azide <b>9</b> and alkyne <b>13</b> was utilized to obtain triazole ester <b>15</b>. Treatment of <b>15</b> with NH<sub>2</sub>OH and catalytic KCN gave the desired hydroxamate <b>2</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> ER Ligand–HDACi Conjugates Exhibit ERα Agonist or Antagonist Activity</h3><div class="NLM_p">To evaluate whether our designed ER ligand–HDACi conjugates would retain their estrogenic or antiestrogenic activity, we tested all conjugates for modulation of ER transcriptional activity in mammalian cell culture. Agonist assays test the ability of the conjugates to bind the ER ligand-binding domain and activate transcription of a luciferase reporter gene in HEK 293T cells. Antagonist assays test the ability of the conjugates to antagonize the transcriptional activation of 300 pM E2 acting on the ER ligand binding domain.</div><div class="NLM_p">Both EED-HDACi and Tam-HDACi conjugates retain the ERα agonist or antagonist activity of their parent drugs EED and tamoxifen, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). All EED-HDACi conjugates have attenuated ER agonist activities relative to the parent ethinylestradiol. Of these EED-HDACi conjugates, <b>1b</b> and <b>1d</b> showed the most significant ERα agonist effect. As expected, Tam-HDACi conjugates have no detectable ERα agonist activity. Tamoxifen derived conjugates have significant ERα antagonist activity, with IC<sub>50</sub> values in the nanomolar range, but like tamoxifen they should also undergo transformation to much more potent hydroxylated metabolites in vivo.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HDACi conjugates exhibit either ERα agonist or antagonist activity. Agonist activity (fold activation, relative to control no drug) was measured at 10 μM. Antagonist activity was measured by competition with 300 pM estradiol. Dose response curves for antagonist effect are shown for Tam-HDACi only, as EED-HDACi showed no antagonist activity at any concentration. All cells were grown in charcoal stripped serum. Antagonist dose response inset is a representative single experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Estrogen Receptor Docking Analysis</h3><div class="NLM_p">In an attempt to understand the structural basis for the observed ERα agonist and antagonist effects of EED-HDACi (<b>1a</b>–<b>e</b>) and Tam-HDACi (<b>2</b>, <b>3</b>), in silico docking analysis was performed using Autodock Vina. This generates low-energy binding poses by evaluating the combined energetic contributions of torsion, steric repulsion, hydrogen bonding, and hydrophobic interaction between the ligand and the protein binding pocket. SAR insights are greatly aided by molecular docking analysis but must be taken as putative due to the rigid modeling of the protein target and the potential for conformational bias.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The wealth of crystal structures for various ER agonist and antagonist scaffolds increases reliability of in silico results. Although direct comparisons are speculative, our docking outputs agree with the agonist and antagonist effects exhibited by all analogues of EED-HDACi and Tam-HDACi (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures agonist bound ERα <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> (A), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT">2YAT</a> (B), and antagonist bound <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT">3ERT</a> (C) were used in docking analysis of dual ER modulator/HDACi compounds. Their original ligands are shown in dark blue–purple, and helix-12 in red. (D) Binding affinities (BA) calculated for <b>1a</b>–<b>e</b> (EED-HDACi, cyan), <b>2</b>, <b>3</b> (Tam-HDACi, orange), and their hydroxylated metabolites (<b>2</b>-<b>OH</b> and <b>3</b>-<b>OH</b>). Only the highest ranked poses with strongest BA were selected. Poses where the EED or tamoxifen moiety is in the ligand binding domain are shown as thicker molecules, and poses where they are outside the pocket are shown as thin lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using the crystal structures of ERα obtained in complex with weak agonists 17α modified EED analogues TFMPV-E2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A)<a onclick="showRef(event, 'cit21a'); return false;" href="javascript:void(0);" class="ref cit21a">(21a)</a> and EEu (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT">2YAT</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> we observed that EED-HDACi compounds adopt docked poses in which their EED moieties are invariant from the EED moieties of the original ligands. These structures show unusual bulging of the ER ligand binding domain (distal from helix-12 rather than through the helix-12 opening) caused by addition of bulk to the 17α position of EED. Because similar modification is known to result in weak ER agonists,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> these docked structures may reflect the most probable mode of binding. This conclusion is also supported by our observation with EED-HDACi conjugates in ER-luciferase reporter assays.</div><div class="NLM_p">Conversely, Tam-HDACi conjugates did not dock into the binding pockets of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT">2YAT</a>, which may explain their inability to agonize ER. This is reflected in an average decrease in calculated binding affinity (BA, kcal/mol) of for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT">2YAT</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D). Docking analysis on the 4-hydroxy metabolites of Tam-HDACi produced results very similar to those of the unmodified Tam-HDACi.</div><div class="NLM_p">The opposite trend is seen when all conjugates are docked against the crystal structure of ERα complex with 4-hydroxy tamoxifen (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT">3ERT</a>). In this structure, tamoxifen prevents helix 12 from closing properly upon the binding pocket of the LBD (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C, helix 12 colored red). None of the EED-HDACi conjugates docked with the EED moiety in the binding pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C, thin cyan sticks). Their bulky 17α modification cannot go through the pocket opening while also allowing the EED moiety the crucial hydrogen bonding interactions with Arg-394/Glu-353 in the base. Tam-HDACi conjugates, however, like their parent antagonist, are able to fill the hydrophobic space, latch onto Arg-394/Glu-353 (for the hydroxylated derivatives), and extend their alkyl hydroxamate moieties through the opening left by the displaced helix-12 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C). These structural factors result in superior in silico binding affinities for all Tam-HDACi relative to their EED-HDACi congeners (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D). A closer inspection of the docked structures of the EED derivatives <b>1a</b>–<b>e</b> reveals additional key interactions that may be responsible for their varying ERα agonist effect. All conjugates maintain the critical H-bonding interactions between the steroid’s A-ring phenolic hydroxyl with Arg-394/Glu-353 and the D-ring 17α alcohol with His-524.</div><div class="NLM_p">Each of the EED-HDACi compounds of various linker lengths has two major binding modes: one with the HDACi moiety coils up inside the binding pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A), and a second where the alkyl chain extends outward toward residues 414–417 of H7 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). In the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> crystal structure, a small tunnel opposite helix-12 is opened by the bulkiness of the 17α substituent on the TFMPV-E2 ligand used. Because the amino acid residues lining this induced-tunnel (Met-342, Met-343, Phe-425, Met-421, and Leu-410) are hydrophobic, they are amenable to the greasy alkyl chain linker of the EED-HDACi conjugates. In the docking conformations where the alkyl hydroxamate moiety extends through this tunnel toward the exterior, the hydroxamic acid group is within hydrogen bonding distance to the side chains of Cys-417 and Gln-414 and the amide backbone of Gln-414 and Gly-415 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Potential correlations between in vitro ER agonist activity and in silico binding affinities, as well as an overlay of all compounds in both binding modes, can be seen in <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S2">Supporting Information Figure S2</a>.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In silico docking results of coiled (A, magenta) and extended (B, pink) conformations of the HDACi alkyl chain, inside the ligand binding pocket of ERα (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>). Critical hydrogen bonding residues are labeled. Helix-12 (H12) is highlighted in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> ERα and ERβ Are Differentially Agonized by EED-HDACi</h3><div class="NLM_p">Selectivity for ERα or ERβ is important for drugs targeting the estrogenic signaling axis, as the two subtypes play significantly divergent roles in disease progression<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and can determine response to treatments.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> All of the EED-HDACi compounds with estrogenic activity, except <b>1b</b>, exhibited a binding preference shift from ERα to ERβ (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The ERβ preference of some EED-HDACi conjugates is a reverse of the binding preference of the initial EED steroid scaffold. The ligand binding pockets are almost identical between the two ER subtypes. None of the critical hydrogen bonding amino acids differ, and only two amino acids are changed (Met-421→Ile-373 and Leu-384→Met-336) without significantly altering the overall pocket hydrophobicity. These amino acids occupy equivalent positions in the 3D structure of the ER subtypes. ER selectivity has therefore been attributed to changes in hydrophobic space-filling.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> None of the conjugates is capable of fitting into the LBD of available ERβ crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OLS">3OLS</a>, see <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S3">Supporting Information Figure S3</a>) in the agonist conformation, so a homology model of the ERβ subtype was constructed by mapping ERβ AA sequence onto the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> scaffold (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Molecular docking analysis of <b>1a</b>–<b>e</b> with both ERα (crystal structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>) and a homology model of ERβ resulted in nearly identical positioning for the steroidal portion of all EED-HDACi compounds in both ER subtypes, with differences only in alkyl chain coiling. Of the two AA changes, the Met-421→Ile-373 substitution offers greater potential for subtype selectivity, as these amino acids line the tight hydrophobic space occupied by the coiled-up alkyl chain of the EED-HDACi conjugates (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). Unless there is a structural reorganization to accommodate the bound ligand, the Met-421 of ERα may clash with the alkyl chains of some of the EED-HDACi conjugates due to distances as short as 3.0 Å between them (see <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S4">Supporting Information Figure S4</a>). Ile-373 affords ERβ an increased volume at this critical position, which we speculate to be responsible for the ability of longer linker chains <b>1c</b> and <b>1d</b> to preferentially bind ERβ. Docking preference for ER subtype in silico (<a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S5">Supporting Information Figure S5</a>) closely matches the experimentally observed preference for <b>1b</b>, <b>1c</b>, and <b>1d</b> (<b>1a</b> and <b>1e</b> are too weak in vitro to have an obvious preference). Tamoxifen and its Tam-HDACi derivatives show very little preference for either ER subtype (<a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S6">Supporting Information Figure S6</a>), owing to their alternative mode of binding that does not induce the same hydrophobic cavity (<a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S7">Supporting Information Figure S7</a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ERα and ERβ agonist activity measured in HEK-luciferase assay. (A) EED-HDACi, E2 (estradiol), and EED (ethinylestradiol) show varying degrees of agonist activity. Gray dotted line indicates basal level threshold. Doses are 10 μM. (B) The ratio of ERα to ERβ agonist activity. (C) Compound <b>1c</b> docked into both ERα (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>, purple) and ERβ (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> derived homology model, blue), with arrows indicating Met-421 (ERα) substitution with Ile-373 (ERβ) and the resulting expansion of hydrophobic space.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Dual-Acting Compounds Exhibit Potent HDAC Inhibition Activity</h3><div class="NLM_p">We tested all of the dual-acting ER ligand–HDACi conjugates for HDAC inhibition against three isoforms important in breast cancer progression, including HDAC1 (nuclear HDAC, responsible for silencing of genes encoding p21, ERα, via histone deacetylation and chromatin condensation), HDAC6 (cytoplasmic HDAC, controlling ERα stability by regulating the acetylation state of its chaperone HSP-90), and HDAC8 (both nuclear and cytoplasmic HDAC, responsible for transcriptional repression of tumor suppressor genes).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Recently, all three isoforms have been found to be critical in the invasion and migration of both ER positive (MCF-7) and negative (MDA-MB-231) cell lines.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Experiments measuring the inhibition of these three HDAC isoforms reveal that attachment of ER targeting moieties, as the surface recognition cap group of a prototypical HDACi does not abolish HDAC inhibition activity (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). In general, these conjugates strongly inhibit HDAC1 and HDAC6 and weakly inhibit the deacetylase activity of HDAC8. Almost across the board, the EED-HDACi conjugates have superior HDAC inhibition activity relative to the Tam-HDACi conjugates. Of the EED-HDACi, <b>1a</b>–<b>d</b> inhibit HDAC1 and HDAC6 with nanomolar range IC<sub>50</sub>s. Conjugates <b>1a</b> and <b>1d</b> have better activity than the clinical HDACi SAHA, suggesting flexibility in the range of optimal linker-lengths that support HDAC inhibition activities of EED-HDACi. However, Tam-HDACi conjugates exclusively inhibit HDAC1 and HDAC6. Interestingly, conjugate <b>3</b> is selective for HDAC6 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. EED-HDACi, Tam-HDACi, and SAHA tested for inhibition of HDAC isoforms 1, 6, and 8. ND, not determinable, up to maximum concentrations tested (100 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Dual-Acting Compounds Have Cell-Type Selective Anticancer Activity</h3><div class="NLM_p">The majority of HDACi tested clinically exhibit unselective cytotoxicity, off-target effects, and on-target ineffectiveness.<a onclick="showRef(event, 'cit2b'); return false;" href="javascript:void(0);" class="ref cit2b">(2b)</a> Cell-type selective delivery of HDACi into targeted cancer cells could potentially increase potencies and decrease unanticipated side effects, thereby improving drug therapeutic indices. In addition, this approach could lead to a new class of chemotherapy for targeted cancer therapy applications.</div><div class="NLM_p">To evaluate cell-type selectivity and anticancer activity, all compounds were screened against two breast cancer cell-types, MCF-7 and MDA-MB-231, as well as two control lines, prostate cancer (DU145) and healthy kidney epithelial cells (VERO). MCF-7 is a commonly used representative of the almost 75% of breast cancer that express ERα, the majority of which initially respond to endocrine therapies such as tamoxifen.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> MDA-MB-231 represents the nearly 25% of breast cancers do not respond to endocrine therapy because ERα is epigenetically silenced by hyper-methylation and/or histone lysine hypo-acetylation.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In this context, HDAC inhibition causes re-expression of ERα in these breast cancers by increasing acetylation of the chromatin scaffolding around the <i>ER</i>α gene,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and the cancers are thereby sensitized to drugs that target ERα (both in vitro and in vivo).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Overall, the Tam-HDACi are much more potent than EED-HDACi at reducing cancer cell proliferation (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A), despite the fact that Tam-HDACi are less potent HDACi (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This observation suggests that targeting the ER goes beyond merely enabling improved cellular uptake/retention of the conjugates and that antagonist/agonist activities more directly impact the antiproliferative activities of these compounds.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cell-type selective antiproliferative activity of ER ligand–HDACi. (A) Whole cell antiproliferative activity (IC<sub>50</sub>, μM) measured 72 h after drug dosing, across ERα+/β+ (MCF-7) and ERα–/β– (MDA-MB-231) breast cancer, metastatic prostate cancer (DU-145), and healthy kidney epithelial cells (VERO). (B) Dose response curves for antiproliferative activity of SAHA and Tam-HDACi compound <b>3</b> against ER+ (MCF-7) and ER– (MDA-MB-231) breast cancer cells. (C) In vitro therapeutic index of EED-HDACi <b>1a</b>, Tam-HDACi <b>2</b> and <b>3</b>, SAHA, and tamoxifen. IC<sub>50</sub> values are an average of at least two independent experiments, ± standard deviation. <sup><i>a</i></sup>Not determinable, IC<sub>50</sub> greater than 40 μM or <sup><i>b</i></sup>greater than 20 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The antiproliferative activities of some EED-HDACi conjugates (<b>1a</b> against MCF-7/MDA-MB-231 and <b>1c</b>–<b>d</b> against MDA-MB-231/DU145) are comparable to those of the other clinically approved endocrine receptor targeting drugs for breast cancer (tamoxifen, 15–20 μM) and prostate cancer (bicalutamide, 18–33 μM).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The three EED-HDACi compounds, <b>1a</b>, <b>1c</b>, and <b>1d</b>, which inhibit the growth of MDA-MB-231, are also the most potent HDACi. Compound <b>1d</b> stands out among these EED-HDACi because it shows both an order of magnitude greater HDAC8 inhibition and also the best antiproliferative activity against MDA-MB-231. Recent studies reveal HDAC8 expression in MDA-MB-231 is much greater than in MCF-7 and is responsible for its significantly increased invasiveness.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This may explain our observed enhanced cytotoxicity of <b>1d</b> against MDA-MB-231. Another interesting aspect of this data is that compounds <b>1c</b> and <b>1d</b>, the only analogues exhibiting both nM HDACi potency and significant ERβ activation, are also the only EED-HDACi that show any evidence of DU145 cell growth inhibition. DU145 is a metastatic prostate cancer line that only expresses ERβ.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Our result suggests that compounds with similar attributes as <b>1c</b> and <b>1d</b> may have potential benefit against ERβ dependent cancers. Compound <b>1e</b> shows the least antiproliferative activity against all cell lines studied, an observation which agrees with its poor HDAC inhibition profile. It is important to note here that EED, the starting scaffold of EED-HDACi, is devoid of antiproliferative activity. Additionally, all EED-HDACi are nontoxic to the healthy VERO cell line (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A).</div><div class="NLM_p">The Tam-HDACi conjugates, which inhibit HDAC and antagonize ER, have even more promising antiproliferative activities. Conjugates <b>2</b> and <b>3</b> show enhanced potency against ER expressing (MCF-7) verses ER negative (MDA-MB-231) breast cancer cells (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), unlike SAHA, which shows a similar dose response curve for both (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B). Specifically, <b>3</b> is equipotent to SAHA and 4-fold more potent than tamoxifen, while <b>2</b> is about 1.7-fold less potent than SAHA and 2-fold more potent than tamoxifen, against MCF-7. Interestingly, the trend of cytotoxicity to MCF-7 follows the ERα antagonist activity of these compounds. The enhancement of antiproliferative activity relative to tamoxifen supports the contribution of the HDAC inhibition to the tumor cell growth inhibition activity of these conjugates. The MDA-MB-231 cell growth inhibition activity of Tam-HDACi could be due to HDAC inhibition, which may lead to a reactivation of epigenetically silenced ER pathways which HDACi are known to induce.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> There is, however, no clear evidence for ER related trend in the sensitivity of DU145 to these conjugates. This suggests that the antiproliferative activity of Tam-HDACi against DU145 derives mainly from HDAC inhibition.</div><div class="NLM_p last">All ER ligand–HDACi conjugates and the control compounds have different effects on the viability of the nontransformed VERO cells. Comparing their effects on VERO and MCF-7 cells, SAHA, the control HDACi, has the smallest in vitro therapeutic index<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (IVTI), while ER ligand-HDACi such as <b>1a</b>, <b>2</b>, and <b>3</b> have greater IVTI (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>C). Using these metrics as surrogate for clinical therapeutic index, <b>2</b> is a promising lead among these ER ligand–HDACi compounds.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Interaction between ERα and estrogen plays a central role in pro-growth/pro-survival signaling pathways in breast tumors and could stimulate tumorigenesis by inducing expression of genes involved in cell proliferation.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> ERα modulators such as tamoxifen inhibit these processes by acting as estrogen antagonists in a tissue dependent manner and effectively inhibit ERα positive breast cancers through cell cycle arrest at the G0 and G1 phases.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Similarly, HDACi’s promote antiproliferation in cancer cells by arresting both G1/S,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> as well as G2/M cell cycle phase progression<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and by disrupting mitosis.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> A cooperative activity has been seen with tamoxifen and HDACi combination in ERα positive breast cancer cells.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a></div><div class="NLM_p">Combination therapy is a proven approach for overcoming drug induced resistance in many human diseases including breast cancer. However, a common liability of multiple drug therapies is the inherent pharmacokinetic disadvantage of two separate drugs. Other disadvantages of multiple drug combination include increase risk of drug–drug interactions and additive toxicities. Clinical trials of combination therapy of some FDA approved anticancer drugs have been halted due to unacceptable toxicities which were not presented when the drugs were administered individually.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> We demonstrate herein that conjugation of a HDACi moiety to representative ER ligands is a viable approach to generate dual acting agents which retain independent anti-HDAC and estrogen receptor binding activities and have an improved in vitro therapeutic index.</div><div class="NLM_p">Two types of ER ligands with divergent effects on ER activity, EED (ER agonist) and tamoxifen (ER antagonist), are used in our design. Relative to the corresponding ER ligand, the EED-derived conjugates have attenuated ER agonist activity while the antagonist activity of the tamoxifen-derived conjugates remains essentially unchanged. A subset of these conjugates possesses tumor cell-type selective toxicity, potentially driven by their interaction with ER. Docking analyses provide insights on the molecular basis of the ER binding affinity and the ER subtype preferences of these ER ligand–HDACi compounds.</div><div class="NLM_p last">Although several of these compounds possess attributes that confer favorable pharmacokinetic profiles (log <i>P</i> < 5, total polar surface area (TPSA) < 140, molecular weight (MW) < 500, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Table 1">Supporting Information Table 1</a>),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> we anticipate that their bioactivity will be significantly influenced by active cell uptake. It is conceivable that the ER ligand-like portions of these conjugates selectively sequester them into (or enhance their retention in) ER positive cells. In fact, we have previously observed that gold nanoparticle conjugated tamoxifen is capable of selective uptake into MCF-7 cells in a mechanism that has all the signatures of cell surface receptor mediated endocytosis.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Making use of this phenomenon may prove beneficial as membrane ER has been found to be exclusively expressed in the tumor mass and not in surrounding healthy cells.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Agents that possess “combination chemotherapy” potential within a single molecule, such as the conjugates described herein, could ameliorate many of the shortcomings of the traditional combination therapy approach.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tamoxifen, 17α-ethynylestradiol, 4-ethynylbenzyl alcohol, (4-aminophenyl) methanol, methyl 8-chloro-8-oxooctanoate, ethyl 6-bromohexanoate, and ethyl 7-bromoheptanoate were purchased from Sigma Aldrich. 17β-Estradiol was purchased from MP Biomedicals, (Salon, OH). Anhydrous solvents and other reagents were purchased and used without further purification. Analtech silica gel plates (60 F<sub>254</sub>) were used for analytical TLC, and Analtech preparative TLC plates (UV 254, 2000 μm) were used for purification. UV light was used to examine the spots. Silica gel (200–400 mesh) was used in column chromatography. NMR spectra were recorded on a Varian-Gemini 400 magnetic resonance spectrometer. <sup>1</sup>H NMR spectra are recorded in parts per million (ppm) relative to the peak of CDCl<sub>3</sub>, (7.24 ppm), CD<sub>3</sub>OD (3.31 ppm), or DMSO-<i>d</i><sub>6</sub> (2.49 ppm). <sup>13</sup>C spectra were recorded relative to the central peak of the CDCl<sub>3</sub> triplet (77.0 ppm), CD<sub>3</sub>OD (49.0 ppm), or the DMSO-<i>d</i><sub>6</sub> septet (39.7 ppm) and were recorded with complete heterodecoupling. Multiplicities are described using the abbreviations: s, singlet; d, doublet, t, triplet; q, quartet; m, multiplet; app, apparent. All biologically evaluated compounds were established to be >95% pure using HPLC. These HPLC analyses were done on a Beckman Coulter instrument with a Phenomenex RP C-18 column (250 mm × 4.6 mm), using 0.1% TFA in water (solvent A) and 0.1% TFA in acetonitrile (solvent B), starting with 5% B for 4 min, then a gradient increase of 5–100% of B over 25 min. The flow rate was 1.0 mL/min and detection was at 254 nm. High-resolution mass spectra were recorded at the Georgia Institute of Technology mass spectrometry facility in Atlanta. 4-Ethynyl-benzyl methylsulfonate <b>12</b>, methyl 8-(4-(hydroxylmethyl)phenylamino)-8-oxo-octanoate <b>8</b> and its mesylated analogue <b>9</b>, and azidoalkyl esters were synthesized by adapting literature protocols.<a onclick="showRef(event, 'cit17a ref19'); return false;" href="javascript:void(0);" class="ref cit17a ref19">(17a, 19)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 4-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(trityloxy)butanamide (<b>5a</b>)</h3><div class="NLM_p last">17α-Ethynylestradiol (280 mg, 0.95 mmol) was combined with 4-azido-<i>O</i>-trityl amide <b>4a</b> (352 mg, 0.95 mmol) and placed under argon. Dimethylsulfoxide (6.6 mL) was added, and the solution was stirred. Argon was bubbled through the solution for 10 min. Diisopropylethylamine DIPEA (0.33 mL) was added via syringe. Copper iodide (90 mg, 0.47 mmol) was added, and argon was bubbled through the solution from a cylinder for about 10 min. Argon line was replaced with an argon balloon, and the reaction was allowed to proceed overnight. The solution was transferred to a separatory funnel using 2:1 EtOAc/Et<sub>2</sub>O (100 mL), and 4:1 saturated NH<sub>4</sub>Cl/NH<sub>4</sub>OH was added (100 mL). The two layers were separated, the organic layer washed three times with 4:1 saturated NH<sub>4</sub>Cl/NH<sub>4</sub>OH (100 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvent was evaporated in vacuo to give a white solid. The solid was triturated with hexane, filtered off, and dried under vacuum at ∼50 °C for several hours to obtain product <b>5a</b> (479 mg, 74.2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85 (s, 1H), 7.78–7.05 (m, 15H), 7.00 (s, 1H), 6.56 (d, <i>J</i> = 12.8 Hz, 2H), 4.08 (t, <i>J</i> = 17.0 Hz, 2H), 2.76 (s, 2H), 2.32 (d, <i>J</i> = 14.0 Hz, 1H), 2.42–1.95 (m, 3H), 2.13–1.65 (m, 6H), 1.69–1.19 (m, 10H), 1.03 (s, 3H), 0.61 (t, 1H). HRMS (ESI) calcd for [C<sub>43</sub>H<sub>46</sub>N<sub>4</sub>O<sub>4</sub> + H]<sup>+</sup> 683.3592, found 683.3590.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 5-(4-((13<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(trityloxy)pentanamide (<b>5b</b>)</h3><div class="NLM_p last">The reaction of 17α-ethynylestradiol (270 mg, 0.92 mmol), 5-azido-<i>O</i>-trityl amide <b>4b</b> (367 mg, 0.92 mmol), dimethylsulfoxide (6.4 mL), DIPEA (0.32 mL), and copper iodide (87 mg, 0.46 mmol) using the same procedure described for the synthesis of <b>5a</b> gave <b>5b</b> (580 mg, 90.8%) as white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.84 (s, 1H), 7.52–6.89 (m, 15H), 7.01 (d, <i>J</i> = 8.3 Hz, 1H), 6.76–6.40 (m, 2H), 4.17 (t, <i>J</i> = 12.5 Hz, 2H), 3.13–2.59 (m, 2H), 2.55–2.26 (m, 1H), 2.10 (d, <i>J</i> = 14.2 Hz, 2H), 1.91 (dd, <i>J</i> = 16.0, 5.3 Hz, 4H), 1.75–1.14 (m, 14H), 1.03 (s, 3H), 0.64 (t, <i>J</i> = 11.1 Hz, 1H). <i>m</i>/<i>z</i>: expected, 697.3; found, 697.3</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 6-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(trityloxy)hexanamide (<b>5c</b>)</h3><div class="NLM_p last">The reaction of 17α-ethynylestradiol (170 mg, 0.57 mmol), 6-azido-<i>O</i>-trityl amide <b>4c</b> (237.71 mg, 0.57 mmol), dimethylsulfoxide (4.0 mL), DIPEA (0.19 mL), and copper iodide (55 mg, 0.46 mmol) using the same procedure described for the synthesis of <b>5a</b> gave <b>5c</b> (422 mg, quantitative) as white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (s, 1H), 7.66–7.11 (m, 15H), 7.01 (d, <i>J</i> = 8.6 Hz, 1H), 6.71–6.31 (m, 2H), 4.25 (t, <i>J</i> = 5.3 Hz, 2H), 2.78 (d, <i>J</i> = 17.1 Hz, 2H), 2.38 (d, <i>J</i> = 9.9 Hz, 1H), 2.24–1.99 (m, 2H), 2.00–1.79 (m, 5H), 1.75 (s, 3H), 1.69–1.18 (m, 12H), 1.03 (s, 3H), 0.65 (t, <i>J</i> = 13.4 Hz, 1H). <i>m</i>/<i>z</i>: expected, 711.4; found, 711.4</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 7-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(trityloxy)heptanamide (<b>5d</b>)</h3><div class="NLM_p last">The reaction of 17α-ethynylestradiol (255.9 mg, 0.8633 mmol), 7-azido-<i>O</i>-trityl amide <b>4d</b> (365 mg, 0.86 mmol), dimethylsulfoxide (6.0 mL), DIPEA (0.3 mL), and copper iodide (82 mg, 0.43 mmol) using the same procedure described for the synthesis of <b>5a</b> gave <b>5d</b> (517 mg, 82.6%) as white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (s, 1H), 7.57–7.26 (m, 15H), 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 6.61–6.51 (m, 2H), 4.28 (t, <i>J</i> = 6.9 Hz, 2H), 2.89–2.64 (m, 2H), 2.49–2.27 (m, 1H), 2.15–2.03 (m, 2H), 1.97–1.74 (m, 6H), 1.69–1.11 (m, 12H), 1.03 (s, 3H), 0.65 (td, <i>J</i> = 12.7, 3.9 Hz, 1H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 8-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(trityloxy)octanamide (<b>5e</b>)</h3><div class="NLM_p last">The reaction of 17α-ethynylestradiol (250 mg, 0.84 mmol), 8-azido-<i>O</i>-trityl amide <b>4e</b> (372 mg, 0.84 mmol), dimethylsulfoxide (6.0 mL), DIPEA (0.29 mL), and copper iodide (80 mg, 0.42 mmol) using the same procedure described for the synthesis of <b>5a</b> gave <b>5d</b> (549 mg, 88.3%) as white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71 (s, 1H), 7.29 (d, <i>J</i> = 28.0 Hz, 17H), 7.04 (d, <i>J</i> = 8.3 Hz, 1H), 6.65–6.47 (m, 2H), 4.32 (t, <i>J</i> = 7.2 Hz, 2H), 2.80 (s, 2H), 2.39 (s, 1H), 2.11 (s, 2H), 1.90 (d, <i>J</i> = 13.0 Hz, 5H), 1.67–1.13 (m, 13H), 1.04 (s, 4H), 0.66 (t, <i>J</i> = 10.6 Hz, 1H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 4-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-hydroxybutanamide (<b>1a</b>)</h3><div class="NLM_p last">EED-triazolyl-<i>O</i>-trityl <b>5a</b> (200 mg, 0.29 mmol) was dissolved in dichloromethane (7 mL),  triisopropylsilane (TIPS) (0.35 mL) was added via syringe, and the resulting mixture was stirred at room temperature for 10 min. Trifluoroacetic acid (0.35 mL) was added dropwise, and the reaction was allowed to proceed for 10 min. The product was precipitated out of solution using hexane:petroleum ether:diethylether 10:10:1 (50 mL). The solid was filtered off and dried under vacuum at ∼45 °C to obtain <b>1a</b> (78 mg, 60.4%) as a white solid. HPLC retention time 16.12 min. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.84 (s, 1H), 6.97 (d, <i>J</i> = 8.4 Hz, 1H), 6.62–6.34 (m, 2H), 4.45 (t, <i>J</i> = 6.6 Hz, 2H), 2.74 (s, 2H), 2.55–2.35 (m, 1H), 2.32–2.02 (m, 6H), 2.01–1.79 (m, 3H), 1.75–1.21 (m, 7H), 1.03 (s, 3H), 0.68 (t, <i>J</i> = 11.2 Hz, 1H). HRMS (ESI) calcd for [C<sub>24</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub> + H]<sup>+</sup> 441.2496, found 441.2494.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 5-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-hydroxypentanamide (<b>1b</b>)</h3><div class="NLM_p last">The reaction of EED-triazolyl-<i>O</i>-trityl <b>5b</b> (102 mg, 0.147 mmol), TIPS (0.35 mL), and TFA (0.35 mL) in dichloromethane (7 mL), as described for the synthesis of <b>1a</b>, gave <b>1b</b> (35.5 mg, 53.4%) as white solid. HPLC retention time 16.32 min. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.82 (s, 1H), 6.97 (d, <i>J</i> = 8.2 Hz, 1H), 6.69–6.32 (m, 2H), 4.41 (t, <i>J</i> = 6.2 Hz, 2H), 2.73 (s, 2H), 2.44 (s, 1H), 2.31–2.01 (m, 4H), 1.88 (d, <i>J</i> = 37.9 Hz, 6H), 1.61 (d, <i>J</i> = 7.7 Hz, 6H), 1.48–1.16 (m, 3H), 1.02 (s, 3H), 0.66 (t, <i>J</i> = 11.1 Hz, 1H). HRMS (ESI) calcd for [C<sub>25</sub>H<sub>34</sub>N<sub>4</sub>O<sub>4</sub> + H]<sup>+</sup> 455.2653, found 455.2649.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 6-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-hydroxyhexanamide (<b>1c</b>)</h3><div class="NLM_p last">The reaction of EED-triazolyl-<i>O</i>-trityl <b>5c</b> (118 mg, 0.167 mmol), TIPS (0.25 mL), and TFA (0.25 mL) in dichloromethane (5 mL), as described for the synthesis of <b>1a</b>, gave <b>1c</b> (50.9 mg, 65%) as white solid. HPLC retention time 16.68 min. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.82 (s, 1H), 6.98 (d, <i>J</i> = 8.4 Hz, 1H), 6.69–6.27 (m, 2H), 4.40 (t, <i>J</i> = 7.0 Hz, 2H), 2.75 (s, 2H), 2.57–2.30 (m, 2H), 2.32–2.01 (m, 4H), 1.92 (dt, <i>J</i> = 31.0, 11.7 Hz, 5H), 1.81–1.48 (m, 5H), 1.52–1.18 (m, 5H), 1.03 (s, 3H), 0.66 (t, <i>J</i> = 10.9 Hz, 1H). HRMS (ESI) calcd for [C<sub>26</sub>H<sub>36</sub>N<sub>4</sub>O<sub>4</sub> + H]<sup>+</sup> 469.2809, found 469.2805.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 7-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-hydroxyheptanamide (<b>1d</b>)</h3><div class="NLM_p last">The reaction of EED-triazolyl-<i>O</i>-trityl <b>5d</b> (160 mg, 0.22 mmol), TIPS (0.30 mL), and TFA (0.30 mL) in dichloromethane (6 mL), as described for the synthesis of <b>1a</b>, gave <b>1d</b> (84.6 mg, 79.2%) as yellow-tinted white solid. HPLC retention time 17.12 min. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.79 (s, 1H), 6.98 (d, <i>J</i> = 8.4 Hz, 1H), 6.58–6.37 (m, 2H), 4.39 (t, <i>J</i> = 7.0 Hz, 2H), 2.93–2.67 (m, 2H), 2.45 (ddd, <i>J</i> = 14.6, 9.5, 5.3 Hz, 1H), 2.27–2.02 (m, 4H), 2.00–1.80 (m, 6H), 1.72–1.47 (m, 5H), 1.46–1.21 (m, 7H), 1.03 (s, 3H), 0.67 (t, <i>J</i> = 10.7 Hz, 1H). HRMS (ESI) calcd for [C<sub>27</sub>H<sub>38</sub>N<sub>4</sub>O<sub>4</sub> + H]<sup>+</sup> 483.2966, found 483.2956.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 8-(4-((8<i>R</i>,9<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl)-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-hydroxyoctannamide (<b>1e</b>)</h3><div class="NLM_p last">The reaction of EED-triazolyl-<i>O</i>-trityl <b>5e</b> (124 mg, 0.16 mmol), TIPS (0.25 mL), and TFA (0.25 mL) in dichloromethane (5 mL), as described for the synthesis of <b>1a</b>, gave <b>1e</b> (64.4 mg, 79.6%) as white solid. HPLC retention time 17.68 min. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.82 (s, 1H), 6.97 (d, <i>J</i> = 8.4 Hz, 1H), 6.56–6.42 (m, 2H), 4.38 (t, <i>J</i> = 6.9 Hz, 2H), 2.88–2.62 (m, 2H), 2.45 (td, <i>J</i> = 9.8, 5.1 Hz, 1H), 2.20–1.76 (m, 10H), 1.67–1.49 (m, 5H), 1.46–1.20 (m, 10H), 1.06 (s, 3H), 0.66 (t, <i>J</i> = 10.9 Hz, 1H). HRMS (ESI) calcd for [C<sub>28</sub>H<sub>40</sub>N<sub>4</sub>O<sub>4</sub> + H]<sup>+</sup> 497.3122, found 497.3113.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-Desmethyltamoxifen (<b>10</b>)</h3><div class="NLM_p last">The synthetic procedure was adapted from Olofson et al (S1).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Briefly, to a solution of tamoxifen (860 mg, 2.32 mmol) in 1,2-dichloroethane (15 mL) at 0 °C was added 1-chloroethyl chloroformate (332 mg, 2.32 mmol). Stirring continued at 0 °C for 15 min, followed by heating under reflux for 24 h. TLC revealed a near quantitative conversion to a higher <i>R</i><sub>f</sub> intermediate. Solvent was evaporated off and the oily residue was dissolved in methanol and the mixture was refluxed for 3 h, during which a reconversion to a lower <i>R</i><sub>f</sub> product was seen. Solvent was evaporated off to give 753 mg (91%) of white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.89 (3H, t, <i>J</i> = 7.2 Hz), 2.43 (2H, q, <i>J</i> = 14.8, 7.6 Hz), 2.56 (3H, s), 3.12 (2H, t, <i>J</i> = 4.0 Hz), 4.08 (2H, t, <i>J</i> = 4.8 Hz), 6.57 (2H, d, <i>J</i> = 8.8 Hz), 6.76 (2H, d, <i>J</i> = 8.8 Hz), 7.03–7.31 (10H, m), 9.56 (1H, s). HRMS (FAB, mnba) calcd for [C<sub>25</sub>H<sub>27</sub>NO + H]<sup>+</sup> 358.2171, found 358.2198.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Tamoxifen–SAHA Conjugate (<b>3</b>)</h3><div class="NLM_p">To a stirring mixture of <i>N</i>-desmethyltamoxifen <b>10</b> (230 mg, 0.58 mmol) and mesylated compound <b>9</b> (296 mg, 0.80 mmol) in DMSO (7 mL) was added Hunig’s base (0.7 mL, 7.31 mmol). After 4 h of stirring at 80 °C, reaction mixture was cooled down to room temperature and partitioned between EtOAc (40 mL) and saturated NaHCO<sub>3</sub> (35 mL). Organic layer was washed successively with NaHCO<sub>3</sub> (35 mL) and brine (30 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvent was evaporated, and the residue was purified by prep-TLC eluting with 12:1:0.1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>Cl to give 158 mg (43%) of ester <b>11</b> as a colorless oil. HRMS (FAB,mnba) calcd for [C<sub>41</sub>H<sub>49</sub>N<sub>2</sub>O<sub>4</sub> + H]<sup>+</sup> 633.3692, found 633.3724.</div><div class="NLM_p last">To a solution of ester <b>11</b> (98 mg, 0.11 mmol) in 1:1 THF (5 mL) and methanol (5 mL) was added 50% aqueous hydroxylamine (0.1 mL, 1.51 mmol) and KCN (4 mg, 0.06 mmol), and stirring continued for 2 days. The reaction was diluted with 10% methanol in EtOAc (30 mL) and washed with saturated NaHCO<sub>3</sub> (2 × 30 mL) and saturated brine (30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give 65 mg (66%) of tamoxifen–SAHA conjugate <b>3</b> as a white solid. HPLC retention time 22.88 min. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 0.86–0.92 (3H, m) 1.26–1.36 (6H, m), 1.54–1.67 (4H, m), 2.27–2.34 (5H, m) 2.42 (2H, q, <i>J</i> = 7.2 Hz), 2.81–2.84 (2H, m), 3.61–3.66 (2H, m), 3.94–3.97 (2H, m), 6.52 (2H, d, <i>J</i> = 8.8 Hz), 6.74 (2H, d, <i>J</i> = 8.8 Hz), 7.05–7.13 (5H, m), 7.17–7.32 (7H, m), 7.52–7.54 (2H, m). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 400 MHz) δ 14.0, 26.5, 26.7, 29.9, 30.8, 37.8, 42.4, 54.7, 56.1, 62.3, 65.9, 114.2, 120.8, 126.9, 127.4, 128.9, 130.2, 130.6, 131.2, 131.3, 132.5, 132.7, 136.8, 139.3, 139.5, 142.3, 143.3, 144.7, 157.6, 174.2. HRMS (FAB, mnba) calcd for [C<sub>40</sub>H<sub>48</sub>N<sub>3</sub>O<sub>4</sub> + H]<sup>+</sup> 634.3645, found 634.3676.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-(4-Ethynylbenzyl)–Tamoxifen (<b>13</b>)</h3><div class="NLM_p last">To a stirring solution of <i>N</i>-desmethyltamoxifen <b>10</b> (358 mg, 0.9 mmol) and 4-ethynylbenzyl methanesulfonate <b>12</b> (250 mg, 1.2 mmol) in DMSO (5 mL) was added Hunig’s base (0.5 mL, 2.78 mmol). The reaction mixture was heated at 80 °C for 2 h and partitioned between ethyl acetate (40 mL) and saturated NaHCO<sub>3</sub> (30 mL). The two layers were separated, and the organic layer was washed with saturated brine (1 × 30 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvent was evaporated off, and crude was purified by prep-TLC, eluting with 4:1:0.1 hexanes/EtOAc/Et<sub>3</sub>N to yield 329 mg (78%) of <b>13</b> as a white–brown solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.98 (3H, t, <i>J</i> = 7.2 Hz), 2.28 (3H, s), 2.51 (2H, q, <i>J</i> = 7.2 Hz), 2.75 (2H, t, <i>J</i> = 5.6 Hz), 3.06 (1H, s), 3.57 (2H, s), 3.96 (2H, t, <i>J</i> = 6), 6.57 (2H, d, <i>J</i> = 8.8 Hz), 6.83 (2H, d, <i>J</i> = 8.4 Hz), 7.10–7.22 (6H, m), 7.27–7.30 (4H, m), 7.35–7.39 (2H, m), 7.45 (2H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 400 MHz) δ 11.4, 28.9, 42.7, 55.6, 62.1, 65.7, 76.9, 83.4, 113.0, 120.4, 125.7, 126.2, 127.6, 127.8, 128.5, 129.1, 129.3, 131.5, 131.7, 135.1, 137.9, 139.5, 140.9, 142.0, 143.4, 156.3. HRMS (ESI) calcd for [C<sub>34</sub>H<sub>33</sub>NO + H]<sup>+</sup> 472.2640, found 472.2566</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Triazolyl Ethyl Ester (<b>15</b>)</h3><div class="NLM_p last">Ethyl 6-azidohexanoate <b>14</b> (129 mg, 0.70 mmol) and 4-(4-ethynylbenzyl)-tamoxifen <b>13</b> (126 mg, 0.27 mmol) were dissolved in anhydrous THF (10 mL) and stirred under argon at room temperature. Copper iodide (11 mg, 0.07 mmol) and DIPEA (0.1 mL, 0.57 mmol) were then added to the reaction mixture, and stirring continued for 4 h. The reaction mixture was diluted with dichloromethane (20 mL) and washed with 1:4 NH<sub>4</sub>OH/saturated NH<sub>4</sub>Cl (3 × 30 mL) and saturated NH<sub>4</sub>Cl (30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude product was purified by prep-TLC, eluting with 10:1:0.1 hexanes/acetone/Et<sub>3</sub>N to give 127 mg (71%) of <b>15</b> as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.89–0.93 (3H, t, <i>J =</i> 7.2 Hz), 1.32–1.35 (3H, m), 1.57–1.62 (2H, m), 1.90–1.94 (2H, m), 2.27–2.30 (3H, m), 2.44 (2H, q, <i>J =</i> 7.6 Hz), 2.76 (2H, t, <i>J =</i> 5.6 Hz), 3.59–3.63 (5H, m), 3.95 (2H, t, <i>J =</i> 5.6 Hz), 4.35 (2H, t, <i>J =</i> 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 400 MHz) δ 13.6, 14.2, 24.1, 25.8, 28.9, 29.9, 33.8, 42.7, 49.8, 55.6, 60.1, 62.1, 65.7, 113.0, 119.1, 125.2, 125.7, 126.2, 127.5, 127.7, 129.1, 129.2, 129.3, 131.5, 135.1, 137.8, 138.4, 140.8, 142.0, 143.4, 147.2, 156.3, 172.9. HRMS (FAB, thioglycerol) calcd for [C<sub>42</sub>H<sub>48</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup> 657.3805, found 657.3804.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Tamoxifen–Triazolylhydroxamic Acid (<b>2</b>)</h3><div class="NLM_p last">To a solution of <b>15</b> (83 mg, 0.11 mmol) in 1:1 THF (1.5 mL) and methanol (1.5 mL) was added 50% aqueous hydroxylamine (0.1 mL, 1.51 mmol) and KCN (4 mg, 0.06 mmol), and the stirring continued for 2 days. The reaction was diluted with 10% methanol in EtOAc (30 mL) and washed with saturated NaHCO<sub>3</sub> (2 × 30 mL) and saturated brine (30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give 72 mg (quantitative) of <b>2</b> as a white solid. HPLC retention time 22.68 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.89 (3H, t, <i>J =</i> 7.2 Hz), 1.14–1.1.31 (8H, m), 1.53–1.59 (2H, m), 1.77–1.86 (2H, m), 2.05 (1H, t, <i>J =</i> 6.8 Hz), 2.21 (1H, s), 2.39–2.45 (5H, m), 2.90 (2H, t, <i>J =</i> 5.2 Hz), 3.64 (2H, s), 3.92 (2H, t, <i>J =</i> 5.2 Hz), 4.24–4.30 (2H, m), 6.43 (2H, d, <i>J =</i> 8.8 Hz), 6.74 (2H, d, <i>J =</i> 8.4 Hz), 7.06–7.14 (5H, m), 7.19–7.24 (3H, m), 7.28–7.32 (3H, m), 7.65 (2H, d, <i>J =</i> 7.6 Hz), 7.82 (1H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 400 MHz) δ 13.3, 24.4, 25.5, 25.7, 28.8, 29.2, 29.5, 29.6, 29.7, 32.2, 41.7, 49.9, 50.0, 54.9, 61.3, 64.6, 112.9, 120.0, 125.3, 125.6, 126.1, 127.4, 127.7, 129.0, 129.2, 129.4, 129.9, 131.5, 135.5, 137.7, 141.0, 141.9, 143.2, 146.9, 155.8, 170.3, 180.1. HRMS (ESI) calcd for [C<sub>40</sub>H<sub>45</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup> 644.3595, found 644.3647.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> HDAC Activity Assay</h3><div class="NLM_p last">In vitro HDAC inhibition was assayed through a contract agreement with BPS Bioscience (San Diego, USA; <a href="http://www.bpsbioscience.com" class="extLink">www.bpsbioscience.com</a>). All of the compounds were dissolved in DMSO. A series of dilutions of the compounds were prepared with 10% DMSO in HDAC assay buffer, and 5 μL of the dilution was added to a 50 μL reaction so that the final concentration of DMSO is 1% in all of reactions. The enzymatic reactions were conducted in duplicate at 37 °C for 30 min in a 50 μL mixture containing HDAC assay buffer, 5 μg of BSA, HDAC substrate, HDAC enzyme (human recombinant HDAC1, HDAC6 or HDAC8), and various concentrations of each compound. After enzymatic reactions, 50 μL of 2× HDAC Developer was added to each well and the plate was incubated at room temperature for an additional 15 min. Fluorescence intensity was measured at an excitation of 360 nm and an emission of 460 nm using a Biotek Synergy microplate reader.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> HDAC Activity Data Analysis</h3><div class="NLM_p last">The fluorescent intensity data were analyzed using the computer software, Graphpad Prism. In the absence of the compound, the fluorescent intensity (<i>F</i><sub>t</sub>) in each data set was defined as 100% activity. In the absence of HDAC, the fluorescent intensity (<i>F</i><sub>b</sub>) in each data set was defined as 0% activity. The percent activity in the presence of each compound was calculated according to the following equation: %activity = (<i>F</i> – <i>F</i><sub>b</sub>)/(<i>F</i><sub>t</sub> – <i>F</i><sub>b</sub>), where <i>F</i> = the fluorescent intensity in the presence of the compound. The values of % activity versus a series of compound concentrations were then plotted using nonlinear regression analysis of Sigmoidal dose–response curve generated with the equation <i>Y</i> = <i>B</i> + (<i>T</i> – <i>B</i>)/1 + 10<sup>((LogEC50-X)×Hill Slope)</sup>, where <i>Y</i> = percent activity, <i>B</i> = minimum percent activity, <i>T</i> = maximum percent activity, <i>X</i> = logarithm of compound, and Hill Slope = slope factor or Hill coefficient. The IC<sub>50</sub> value was determined by the concentration causing a half-maximal percent activity.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Luciferase Assay Cell Lines and Plasmids</h3><div class="NLM_p last">The human embryonic kidney cell line, HEK 293T, was purchased from ATCC (Manassas, VA) and routinely cultured in DMEM with 10% fetal bovine serum (FBS). The pCMXGBDhERα vector was previously constructed in the lab and contains a CMV promoter expressing the yeast Gal4 DNA binding domain fused to the human ERα ligand binding domain (GBD:hERαLBD). To construct the pCMXGBDhERβ plasmid, the human ERβ LBD was first amplified from pReciever-M01 ESR2 (GeneCopoeia, Rackville, MD) with primers having a BmtI site (5′-aagctagcctgagccccgagcag-3′) and a SpeI site (5′-aaactagttcactgagactgtgggttc-3′). The amplified gene was first cloned into the pGBD plasmid creating the GBD:hERβLBD fusion. The resulting fusion was amplified with primers having the SacII site (5′-tccccgcggatgaagctactgtcttctatcgaacaag-3′) and the NotI site (5′-aagcggccgctcactgagactgtgggttc-3′) and subsequently cloned into pCMX. The p17*4TATALuc vector, containing firefly luciferase downstream of Gal4 response elements, was used as a reporter. pCMXβGal was used to express β-galactosidase as an internal control and to assess transfection efficiency.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Transfection and Luciferase Assay for ERα and ERβ Activity</h3><div class="NLM_p">Cells were cultured in phenol red-free DMEM (MediaTech, Manassas, VA) with 10% charcoal stripped FBS to an approximate confluence of 60–70% in 48-well plates. Cells were then transiently transfected as previously described.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Briefly, for each well, 20 ng of ER expression vector (expressing residues 301–595 of ERα or residues 263–530 of ERβ fused to the Gal4 DNA binding domain), 40 ng of p17*4TATALuc reporter vector, and 40 ng of pCMXβGal vector (used as an internal standard) were mixed with 0.3 μL of Lipofectamine 2000 in 40 μL of Opti-MEM (Invitrogen, Grand Island, NY). After 45 min incubation at room temperature, the mixture was diluted with 160 μL of Opti-MEM. Growth media was aspirated, and transfection mixture was added to the cells. After incubation for 8 h at 37 °C, transfection mixture was aspirated and cells were dosed with phenol red-free DMEM with 10% charcoal stripped FBS medium with varied ligand concentrations. For antagonism assays, 300 pM E2 was added to all wells in addition to antagonist ligand. After 40 h (20 h for antagonists), cells were lysed and assayed for both luciferase and β-galactosidase activities.</div><div class="NLM_p last">Luciferase assays were performed on a Dynex MLX microtiter luminometer by addition of 100 μL of firefly luciferin (0.311 g/mL in 0.1 M potassium phosphate pH = 7.8) to a mixture of 100 μL of luciferase assay buffer (0.1 M potassium phosphate pH = 7.8, 21.5 mM MgCl<sub>2</sub>, 3.7 mM ATP) and 20 μL of cell lysate. β-Galactosidase activity was determined by addition of 125 μL of β-gal assay buffer (80 mM sodium phosphate pH = 7.4, 8.0 mM KCl, 0.8 mM MgCl<sub>2</sub>, 40 mM mercaptoethanol, 0.4 mg/mL <i>ortho</i>-nitrophenyl-β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside, and 5 mM PIPES) to 40 μL of cell lysate. Mixture was incubated at 37 °C for 2 to 3 min and 50 μL of stop buffer (1 M sodium carbonate, 0.8 μL/mL Antifoam A concentrate) was added and absorbance readings were taken at 405 nm with a Dynex OpsysMR plate reader. Data reported represent the average of three sets luciferase assays normalized to β-galactosidase activity.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Molecular Docking Analysis</h3><div class="NLM_p last">In silico docking was performed using Autodock Vina<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> run through PyRx to manage the workflow and PyMol to visualize the results. Ligands were prepared by first generating an energy minimized 3D structure in ChemBioDraw3D, followed by processing with Autodock Tools 1.5.4 to assign Gasteiger charges, merging nonpolar hydrogens, and set torsional bonds. Initial docking runs were performed within a 25–30 Å cubic search space surrounding the binding pocket, with solutions found using an exhaustiveness of 8, with output modes ranked according to binding affinity (BA). For detailed comparisons, multiple runs with reduced search space were run with an increased exhaustiveness of 16 and 32. Autodock Vina finds ligand poses with the best fit and strongest BA (global minimums) by a stochastic algorithm to explore surfaces/pockets of the rigid macromolecule, through an iterative series of local optimizations evaluating both intermolecular (hydrophobic interactions, repulsions, hydrogen bonding, etc.) and intramolecular (torsion, rotational torque) factors.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Crystal Structures</h3><div class="NLM_p">For ERα, bulky agonist crystal structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> (bound to trifluoromethyl-substituted phenylvinyl estradiol, TFMPV-E2), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT">2YAT</a> (bound to estradiol-pyridine tetra acetate europium, EEu), and antagonist structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT">3ERT</a> (bound to 4-hydroxy tamoxifen) were employed. These structures are of the ERα ligand binding domain (LBD) only. They were prepared for molecular docking analysis in Autodock Tools 1.5.4 by removing the ligand from the binding pocket, merging nonpolar hydrogens, adding polar hydrogens, and rendering Gasteiger charges to each atom. In the base of the binding pocket, ER ligands are held in place by hydrogen bonding with Arg-394, Glu-353, and a critical water molecule. Routine docking analysis ignores water molecules by removing them from the rigid macromolecular structure, so we selectively kept the critical water molecule. The WHAT-CHECK web-based modeling program was used to add polar hydrogens to the crystal structure prior to processing and kept for docking analysis.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div id="sec4_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Homology Models of ERβ</h4><div class="NLM_p last">There are no available crystal structures of ERβ solved with a bulky 17α modified EED agonist. None of the conjugates fit into the ERβ structure solved with estradiol (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OLS">3OLS</a>, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S3">Supporting Information Figure S3</a>). Therefore, we generated a homology model using the SWISS-MODEL server running in automated mode.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The protein sequence of the human ERβ (accession: AAC05985.1) was submitted with the ERα <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> structure as the template. Models of both the A and B chains from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> were generated in this manner. The LBD of ERβ has 60% sequence homology with the LBD of ERα.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Residues 262–500 of ERβ were built into the model for chain A and residues 262–501 for chain B.</div></div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Cell Culture and Cell Viability Assay</h3><div class="NLM_p last">The human breast cancer cell line MCF-7 was a generous gift from Dr. Al Merrill’s laboratory (Georgia Institute of Technology, GA). MDA-MB-231, DU145, and Vero cells were obtained from ATCC (Manassas, VA). Cells were routinely cultured in EMEM (Invitrogen, Grand Island, NY) with 10% fetal bovine serum (FBS) (Hycone, Logan, UT) with and without antibiotics. All cell cultures were incubated at 37 °C under a 5% CO<sub>2</sub> atmosphere. For all experiments, cells were grown in 96-well cell culture treated microtiter plates (Techno Plastic Products AG, Trasadingen, Switzerland) with the appropriate ligand in duplicate for 72 h. MTS and MTT colorimetric tests (CellTiter 96 Aqueous One Solution and CellTiter 96 Non-Radioactive Cell Proliferation Assays, Promega, Madison, WI) were employed to determine cell viability per manufacturer instructions. Logit plot analysis was used to determine the IC<sub>50</sub> values for each compound.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/jm400467w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectral information, general methods, predicted pharmacokinetic properties, and molecular modeling outputs.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400467w/suppl_file/jm400467w_si_001.pdf">jm400467w_si_001.pdf (5.56 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400467w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adegboyega K. Oyelere</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ea8b85938f868f988faa8d8b9e8f8982c48f8e9f"><span class="__cf_email__" data-cfemail="b0d1dfc9d5dcd5c2d5f0d7d1c4d5d3d89ed5d4c5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Berkley E. Gryder</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael K. Rood</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenyetta A. Johnson</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vishal Patil</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric D. Raftery</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Pan D. Yao</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcie Rice</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bahareh Azizi</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald F. Doyle</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry and Biochemistry, Parker H. Petit
Institute for Bioengineering and Biosciences, Georgia
Institute of Technology, Atlanta, Georgia, 30332-0400,
United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>These authors contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2402-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was financially supported by NIH grants R01CA131217 (A.K.O.) and R01AI064817 (D.F.D.). B.E.G. and M.K.R. are thankful recipients of the GAANN predoctoral fellowship from the Georgia Tech Center for Drug Design, Development, and Delivery.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used</h2><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">SERM</td><td class="NLM_def"><p class="first last">selective estrogen receptor modulators</p></td></tr><tr><td class="NLM_term">HDACi</td><td class="NLM_def"><p class="first last">histone deacetylase inhibitor</p></td></tr><tr><td class="NLM_term">E</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">ERα</td><td class="NLM_def"><p class="first last">estrogen receptor alpha</p></td></tr><tr><td class="NLM_term">E2</td><td class="NLM_def"><p class="first last">estradiol</p></td></tr><tr><td class="NLM_term">EED</td><td class="NLM_def"><p class="first last">ethynyl-estradiol</p></td></tr><tr><td class="NLM_term">EED-HDACi</td><td class="NLM_def"><p class="first last">ethynyl-estradiol–HDACi conjugates</p></td></tr><tr><td class="NLM_term">Tam-HDACi</td><td class="NLM_def"><p class="first last">tamoxifen–HDACi conjugates</p></td></tr><tr><td class="NLM_term">SAHA</td><td class="NLM_def"><p class="first last">suberoylanilide hydroxamic acid</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc binding group</p></td></tr><tr><td class="NLM_term">H12</td><td class="NLM_def"><p class="first last">helix-12</p></td></tr><tr><td class="NLM_term">BA</td><td class="NLM_def"><p class="first last">binding affinity</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand binding domain</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lehrmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel-Bellan, A.</span><span> </span><span class="NLM_article-title">Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=41-65&author=H.+Lehrmannauthor=L.+L.+Pritchardauthor=A.+Harel-Bellan&title=Histone+acetyltransferases+and+deacetylases+in+the+control+of+cell+proliferation+and+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehrmann%26aufirst%3DH.%26aulast%3DPritchard%26aufirst%3DL.%2BL.%26aulast%3DHarel-Bellan%26aufirst%3DA.%26atitle%3DHistone%2520acetyltransferases%2520and%2520deacetylases%2520in%2520the%2520control%2520of%2520cell%2520proliferation%2520and%2520differentiation%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2002%26volume%3D86%26spage%3D41%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer: causes and therapies</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1038%2F35106079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=11902574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=194-202&issue=3&author=P.+Marksauthor=R.+A.+Rifkindauthor=V.+M.+Richonauthor=R.+Breslowauthor=T.+Millerauthor=W.+K.+Kelly&title=Histone+deacetylases+and+cancer%3A+causes+and+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer: causes and therapies</span></div><div class="casAuthors">Marks, Paul A.; Rifkind, Richard A.; Richon, Victoria M.; Breslow, Ronald; Miller, Thomas; Kelly, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Together, histone acetyltransferases and histone deacetylases (HDACs) det. the acetylation status of histones.  This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumors cells by altering the transcription of a small no. of genes.  HDAC inhibitors are proving to be an exciting therapeutic approach to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNXyL8yvd0OrVg90H21EOLACvtfcHk0ljk7v-1bKI_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D&md5=ea50a1a72a6df9ea3a0e1a6a0d5cda5e</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2F35106079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106079%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%253A%2520causes%2520and%2520therapies%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26issue%3D3%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bolden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Anticancer activities of histone deacetylase inhibitors</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=769-784&issue=9&author=J.+E.+Boldenauthor=M.+J.+Peartauthor=R.+W.+Johnstone&title=Anticancer+activities+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolden%26aufirst%3DJ.%2BE.%26aulast%3DPeart%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DAnticancer%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D9%26spage%3D769%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gryder, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodji, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.4155%2Ffmc.12.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22416777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=505-524&issue=4&author=B.+E.+Gryderauthor=Q.+H.+Sodjiauthor=A.+K.+Oyelere&title=Targeted+cancer+therapy%3A+giving+histone+deacetylase+inhibitors+all+they+need+to+succeed"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span></div><div class="casAuthors">Gryder, Berkley E.; Sodji, Quaovi H.; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-524</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of small-mol. therapeutics acting through the regulation of the acetylation states of histone proteins (a form of epigenetic modulation) and other non-histone protein targets.  Over 490 clin. trials have been initiated in the last 10 years, culminating in the approval of two structurally distinct HDACis-SAHA (vorinostat, Zolinza) and FK228 (romidepsin, Istodax).  However, the current HDACis have serious limitations, including ineffectively low concns. in solid tumors and cardiac toxicity, which is hindering their progress in the clinic.  Herein, we review the primary paradigms being pursued to overcome these hindrances, including HDAC isoform selectivity, localized administration, and targeting cap groups to achieve selective tissue and cell type distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwrW1IVCIULVg90H21EOLACvtfcHk0lhB9Qgr-8NeBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D&md5=234080d1b0862680a68062a03afee20c</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.3%26sid%3Dliteratum%253Aachs%26aulast%3DGryder%26aufirst%3DB.%2BE.%26aulast%3DSodji%26aufirst%3DQ.%2BH.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DTargeted%2520cancer%2520therapy%253A%2520giving%2520histone%2520deacetylase%2520inhibitors%2520all%2520they%2520need%2520to%2520succeed%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26issue%3D4%26spage%3D505%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. S.</span><span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors: Potential in Cancer Therapy</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2009&pages=600-608&issue=4&author=P.+A.+Marksauthor=W.+S.+Xu&title=Histone+Deacetylase+Inhibitors%3A+Potential+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DXu%26aufirst%3DW.%2BS.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%253A%2520Potential%2520in%2520Cancer%2520Therapy%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2009%26volume%3D107%26issue%3D4%26spage%3D600%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gryder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span> </span><span class="NLM_article-title">Biosemiotic Entropy of the Genome: Mutations and Epigenetic Imbalances Resulting in Cancer</span> <span class="citation_source-journal">Entropy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=234-261&issue=1&author=B.+Gryderauthor=C.+Nelsonauthor=S.+Shepard&title=Biosemiotic+Entropy+of+the+Genome%3A+Mutations+and+Epigenetic+Imbalances+Resulting+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGryder%26aufirst%3DB.%26aulast%3DNelson%26aufirst%3DC.%26aulast%3DShepard%26aufirst%3DS.%26atitle%3DBiosemiotic%2520Entropy%2520of%2520the%2520Genome%253A%2520Mutations%2520and%2520Epigenetic%2520Imbalances%2520Resulting%2520in%2520Cancer%26jtitle%3DEntropy%26date%3D2013%26volume%3D15%26issue%3D1%26spage%3D234%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span> </span><span class="NLM_article-title">Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=21455583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVWhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1677-1681&issue=6&author=S.+Y.+Parkauthor=J.+A.+Junauthor=K.+T.+Jeongauthor=H.+J.+Heoauthor=J.+S.+Sohnauthor=H.+Y.+Leeauthor=C.+G.+Parkauthor=J.+Kang&title=Histone+deacetylases+1%2C+6+and+8+are+critical+for+invasion+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer</span></div><div class="casAuthors">Park, Soon Young; Jun, Ji Ae; Jeong, Kang Jin; Heo, Hoi Jeong; Sohn, Jang Sihn; Lee, Hoi Young; Park, Chang Gyo; Kang, Jaeku</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1677-1681</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are assocd. with the development and progression of cancer, but it is not known which of the HDAC isoforms play important roles in breast cancer metastasis.  This study identified the specific HDAC isoforms that are necessary for invasion and/or migration in human breast cancer cell lines.  MDA-MB-231 cells were significantly more invasive and expressed higher levels of matrix metalloproteinase-9 (MMP-9) compared to MCF-7 cells.  We compared the expression of HDAC isoforms between MCF-7 and MDA-MB-231 cells and found greater expression of HDAC4, 6 and 8 in MDA-MB-231 cells by RT-PCR and Western blot analyses.  In addn., apicidin, a histone deacetylase inhibitor, was shown to attenuate the invasion, migration and MMP-9 expression in MDA-MB-231 cells.  Using specific siRNAs directed against HDAC1, 4, 6 and 8, we show that inhibition of HDAC1,6 and 8, but not HDAC4, are responsible for invasion and MMP-9 expression in MDA-MB-231 cells.  We analyzed the invasiveness of MCF-7 cells overexpressing HDAC1, 4, 6 or 8 and found that overexpression of HDAC1, 6 or 8 increased invasion and MMP-9 expression.  By developing HDAC isoforms as potential biomarkers for breast cancer metastasis, the present study can be extended to developing therapies for breast cancer invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFSJ-L_l4YjLVg90H21EOLACvtfcHk0licZ-wXLW4TzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVWhtLs%253D&md5=ad1df87a667af5e0c4bb325c6c94a9e5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DJun%26aufirst%3DJ.%2BA.%26aulast%3DJeong%26aufirst%3DK.%2BT.%26aulast%3DHeo%26aufirst%3DH.%2BJ.%26aulast%3DSohn%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DC.%2BG.%26aulast%3DKang%26aufirst%3DJ.%26atitle%3DHistone%2520deacetylases%25201%252C%25206%2520and%25208%2520are%2520critical%2520for%2520invasion%2520in%2520breast%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2011%26volume%3D25%26issue%3D6%26spage%3D1677%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Discovery and development of SAHA as an anticancer agent</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1351-1356&issue=9&author=P.+A.+Marks&title=Discovery+and+development+of+SAHA+as+an+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520and%2520development%2520of%2520SAHA%2520as%2520an%2520anticancer%2520agent%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26issue%3D9%26spage%3D1351%26epage%3D1356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Grant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piekarz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batest, S. E.</span><span> </span><span class="NLM_article-title">Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1586%2Fera.10.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=20645688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=997-1008&issue=7&author=C.+Grantauthor=F.+Rahmanauthor=R.+Piekarzauthor=C.+Peerauthor=R.+Fryeauthor=R.+W.+Robeyauthor=E.+R.+Gardnerauthor=W.+D.+Figgauthor=S.+E.+Batest&title=Romidepsin%3A+a+new+therapy+for+cutaneous+T-cell+lymphoma+and+a+potential+therapy+for+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span></div><div class="casAuthors">Grant, Cliona; Rahman, Fahd; Piekarz, Richard; Peer, Cody; Frye, Robin; Robey, Robert W.; Gardner, Erin R.; Figg, William D.; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">997-1008</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Romidepsin is a histone deacetylase inhibitor (HDI), approved by the US FDA for the treatment of cutaneous T-cell lymphoma (CTCL).  Although various mechanisms have been proposed for the activity of HDIs, including induction of genes controlling cell cycle, acetylation of cytoplasmic proteins and direct induction of apoptosis, the mechanism underlying activity of romidepsin and other HDIs in CTCL is not known.  Romidepsin induces long-lasting responses.  The side-effect profile is similar to that of other HDIs, causing fatigue, nausea and thrombocytopenia.  Management of the CTCL population requires vigilence to prevent infection with skin contaminants, and monitoring of potassium and magnesium, electrolytes found to be low in a large proportion of patients.  Electrocardiog. (ECG) changes are common but are not assocd. with myocardial damage.  When mol. end points were evaluated in 61 patients enrolled on a Phase II trial with romidepsin, response was assocd. with persistence of acetylated histone H3, suggesting that drug exposure is important in effective therapy with romidepsin.  Future studies will endeavor to identify combination strategies to increase the efficacy both in resistant CTCL and in solid tumors and to identify biomarkers of response that will allow selection of patients most likely to benefit from the therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhGXcIbdqpk7Vg90H21EOLACvtfcHk0likkqEsteGAVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D&md5=b28fd17c77991e4662f7c0e08d6d7297</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1586%2Fera.10.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.10.88%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DC.%26aulast%3DRahman%26aufirst%3DF.%26aulast%3DPiekarz%26aufirst%3DR.%26aulast%3DPeer%26aufirst%3DC.%26aulast%3DFrye%26aufirst%3DR.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DGardner%26aufirst%3DE.%2BR.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DBatest%26aufirst%3DS.%2BE.%26atitle%3DRomidepsin%253A%2520a%2520new%2520therapy%2520for%2520cutaneous%2520T-cell%2520lymphoma%2520and%2520a%2520potential%2520therapy%2520for%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2010%26volume%3D10%26issue%3D7%26spage%3D997%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Schneider, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalemkerian, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daignault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, M.</span><span> </span><span class="NLM_article-title">Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=249-257&issue=1&author=B.+J.+Schneiderauthor=G.+P.+Kalemkerianauthor=D.+Bradleyauthor=D.+C.+Smithauthor=M.+J.+Egorinauthor=S.+Daignaultauthor=R.+Dunnauthor=M.+Hussain&title=Phase+I+study+of+vorinostat+%28suberoylanilide+hydroxamic+acid%2C+NSC+701852%29+in+combination+with+docetaxel+in+patients+with+advanced+and+relapsed+solid+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DB.%2BJ.%26aulast%3DKalemkerian%26aufirst%3DG.%2BP.%26aulast%3DBradley%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DDaignault%26aufirst%3DS.%26aulast%3DDunn%26aufirst%3DR.%26aulast%3DHussain%26aufirst%3DM.%26atitle%3DPhase%2520I%2520study%2520of%2520vorinostat%2520%2528suberoylanilide%2520hydroxamic%2520acid%252C%2520NSC%2520701852%2529%2520in%2520combination%2520with%2520docetaxel%2520in%2520patients%2520with%2520advanced%2520and%2520relapsed%2520solid%2520malignancies%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26issue%3D1%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Shah, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbogast, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collamore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farra, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3997</span><span class="NLM_x">–</span> <span class="NLM_lpage">4003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1158%2F1078-0432.CCR-05-2689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=16818698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsValurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3997-4003&issue=13&author=M.+H.+Shahauthor=P.+Binkleyauthor=K.+Chanauthor=J.+Xiaoauthor=D.+Arbogastauthor=M.+Collamoreauthor=Y.+Farraauthor=D.+Youngauthor=M.+Grever&title=Cardiotoxicity+of+Histone+Deacetylase+Inhibitor+Depsipeptide+in+Patients+with+Metastatic+Neuroendocrine+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors</span></div><div class="casAuthors">Shah, Manisha H.; Binkley, Philip; Chan, Kenneth; Xiao, Jim; Arbogast, Daria; Collamore, Minden; Farra, Yasser; Young, Donn; Grever, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3997-4003</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: This phase II study was undertaken to assess objective response and toxicity of histone deacetylase inhibitor depsipeptide in patients with neuroendocrine tumors.  Exptl. Design: A total of 15 patients with metastatic neuroendocrine tumors received a 4-h i.v. infusion of depsipeptide at 14 mg/m2 on days 1, 8, and 15 every 28 days.  Tumor response was assessed at 8-wk intervals using Response Evaluation Criteria in Solid Tumors.  Most patients were chemo-naive (n = 12) but receiving long-acting octreotide for carcinoid syndrome (n = 11).  All patients had Eastern Cooperative Oncol. Group performance status of 0 to 1.  Results: The study was terminated prematurely due to an unexpected high no. of serious cardiac adverse events so the objective response rate could not be detd.  A total of 77 doses of depsipeptide with a median of four doses (range, 2-13) per patient were administered.  The most common adverse events included nausea (86%), anorexia (73%), vomiting (66%), and fatigue (73%).  A sudden death attributed to possible fatal ventricular arrhythmia occurred within 24 h after the fifth dose of depsipeptide.  Furthermore, asymptomatic grade 2 ventricular tachycardia (n = 2) and prolonged QTc (n = 3) probably related to depsipeptide were obsd.  Plasma depsipeptide levels measured in a subset of patients failed to reveal differences among patients with or without cardiac adverse events.  Conclusions: Depsipeptide was assocd. with a high no. of potentially serious cardiac adverse events in patients with metastatic neuroendocrine tumor.  As sudden death possibly assocd. with depsipeptide was obsd. in this trial, the risks for potentially life-threatening arrhythmia assocd. with this agent need to be comprehensively evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr29P_uZcrVv7Vg90H21EOLACvtfcHk0lhHqXUmUS_VKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsValurw%253D&md5=af1cd4cd67eb3f134a7cc3efe2206fb2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-2689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-2689%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%2BH.%26aulast%3DBinkley%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DArbogast%26aufirst%3DD.%26aulast%3DCollamore%26aufirst%3DM.%26aulast%3DFarra%26aufirst%3DY.%26aulast%3DYoung%26aufirst%3DD.%26aulast%3DGrever%26aufirst%3DM.%26atitle%3DCardiotoxicity%2520of%2520Histone%2520Deacetylase%2520Inhibitor%2520Depsipeptide%2520in%2520Patients%2520with%2520Metastatic%2520Neuroendocrine%2520Tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26issue%3D13%26spage%3D3997%26epage%3D4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.2174%2F092986712798918842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22204328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=475-487&issue=4&author=T.+Aiauthor=H.+Cuiauthor=L.+Chen&title=Multi-Targeted+Histone+Deacetylase+Inhibitors+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-targeted histone deacetylase inhibitors in cancer therapy</span></div><div class="casAuthors">Ai, T.; Cui, H.; Chen, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">475-487</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The heterogeneous nature of cancer requires a comprehensive approach for attacking the multiple mechanisms underlying the initiation and progression of cancers.  Histone deacetylase inhibitors (HDACi) have emerged as a new class of anticancer agents, targeting the biol. processes including cell cycle, apoptosis and differentiation.  Studies have revealed that HDACi are synergistic with diverse classes of anticancer therapies including targeted therapeutics and conventional anticancer agents.  Extensive medicinal chem. efforts have yielded a wide range of chem. structures, indicative of the structural flexibility of HDACi.  These findings have supported a strategy to generate multi-targeted HDACi by combining structural features from HDACi and other anticancer agents.  HDACi can also be connected to a motif that allows for a selective delivery.  Highlighting current examples, this brief review focuses on the rational design of multi-targeted inhibitors based on the examn. and manipulation of chem. structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtZJdxdSYVbVg90H21EOLACvtfcHk0lhHqXUmUS_VKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqt74%253D&md5=c550eb21bc4849713ae2f816736f175a</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.2174%2F092986712798918842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712798918842%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DMulti-Targeted%2520Histone%2520Deacetylase%2520Inhibitors%2520in%2520Cancer%2520Therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26issue%3D4%26spage%3D475%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Seo, S. Y.</span><span> </span><span class="NLM_article-title">Multi-Targeted Hybrids Based on HDAC Inhibitors for Anti-Cancer Drug Discovery</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1007%2Fs12272-012-0221-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22370774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XivFyns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=197-200&issue=2&author=S.+Y.+Seo&title=Multi-Targeted+Hybrids+Based+on+HDAC+Inhibitors+for+Anti-Cancer+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery</span></div><div class="casAuthors">Seo, Seung-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-200</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Multi-targeted hybrids combine two drugs in a single mol. to have greater medicinal effects than its individual components.  Recently, a no. of anti-cancer drug candidates such as CUDC-101 (Curis) have been designed based on linking properly two selected pharmacophores endowed with activity against different therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSulm2ApOOprVg90H21EOLACvtfcHk0lhHqXUmUS_VKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivFyns7o%253D&md5=3285f75262c7a19e05822ad48624fc05</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0221-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0221-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DS.%2BY.%26atitle%3DMulti-Targeted%2520Hybrids%2520Based%2520on%2520HDAC%2520Inhibitors%2520for%2520Anti-Cancer%2520Drug%2520Discovery%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2012%26volume%3D35%26issue%3D2%26spage%3D197%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balusu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudunuru, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkannagari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembruff, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K. N.</span><span> </span><span class="NLM_article-title">Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1158%2F1535-7163.MCT-11-0979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22367781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=973-983&issue=4&author=R.+Raoauthor=R.+Balusuauthor=W.+Fiskusauthor=U.+Mudunuruauthor=S.+Venkannagariauthor=L.+Chauhanauthor=J.+E.+Smithauthor=S.+L.+Hembruffauthor=K.+Haauthor=P.+Atadjaauthor=K.+N.+Bhalla&title=Combination+of+Pan-Histone+Deacetylase+Inhibitor+and+Autophagy+Inhibitor+Exerts+Superior+Efficacy+against+Triple-Negative+Human+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells</span></div><div class="casAuthors">Rao, Rekha; Balusu, Ramesh; Fiskus, Warren; Mudunuru, Uma; Venkannagari, Sreedhar; Chauhan, Lata; Smith, Jacqueline E.; Hembruff, Stacey L.; Ha, Kyungsoo; Atadja, Peter; Bhalla, Kapil N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">973-983</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors (HDI) induce endoplasmic reticulum (ER) stress and apoptosis, while promoting autophagy, which promotes cancer cell survival when apoptosis is compromised.  Here, we detd. the in vitro and in vivo activity of the combination of the pan-HDI panobinostat and the autophagy inhibitor chloroquine against human estrogen/progesterone receptor and HER2 (triple)-neg. breast cancer (TNBC) cells.  Treatment of MB-231 and SUM159PT cells with panobinostat disrupted the hsp90/histone deacetylase 6/HSF1/p97 complex, resulting in the upregulation of hsp.  This was accompanied by the induction of enhanced autophagic flux as evidenced by increased expression of LC3B-II and the degrdn. of the autophagic substrate p62.  Treatment with panobinostat also induced the accumulation and colocalization of p62 with LC3B-II in cytosolic foci as evidenced by immunofluorescent confocal microscopy.  Inhibition of panobinostat-induced autophagic flux by chloroquine markedly induced the accumulation of polyubiquitylated proteins and p62, caused synergistic cell death of MB-231 and SUM159PT cells, and inhibited mammosphere formation in MB-231 cells, compared with treatment with each agent alone.  Finally, in mouse mammary fat pad xenografts of MB-231 cells, a tumor size-dependent induction of heat shock response, ER stress and autophagy were obsd.  Cotreatment with panobinostat and chloroquine resulted in reduced tumor burden and increased the survival of MB-231 breast cancer xenografts.  Collectively,these findings show that cotreatment with an autophagy inhibitor and pan-HDI, for example, chloroquine and panobinostat results in accumulation of toxic polyubiquitylated proteins, exerts superior inhibitory effects on TNBC cell growth, and increases the survival of TNBC xenografts.  Mol Cancer Ther; 11(4); 973-83.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_T3FzhT-9LVg90H21EOLACvtfcHk0ljeT2eUUOHExA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2nuro%253D&md5=3eff7850dd1b33306b5314a7814beaf5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0979%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%26aulast%3DBalusu%26aufirst%3DR.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DMudunuru%26aufirst%3DU.%26aulast%3DVenkannagari%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DJ.%2BE.%26aulast%3DHembruff%26aufirst%3DS.%2BL.%26aulast%3DHa%26aufirst%3DK.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DCombination%2520of%2520Pan-Histone%2520Deacetylase%2520Inhibitor%2520and%2520Autophagy%2520Inhibitor%2520Exerts%2520Superior%2520Efficacy%2520against%2520Triple-Negative%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26issue%3D4%26spage%3D973%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Munster, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacevic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail-Khan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melisko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minton, S. E.</span><span> </span><span class="NLM_article-title">Clinical Phase II Study of Vorinostat, a Hydroxamic Type Histone Deacetylase Inhibitor, in Combination with Tamoxifen To Reverse Acquired Hormone Resistance in Breast Cancer Patients Who Progressed on Hormone Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">856S</span><span class="NLM_x">–</span> <span class="NLM_lpage">856S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=856S-856S&issue=24&author=P.+N.+Munsterauthor=M.+Lacevicauthor=S.+Thomasauthor=R.+Ismail-Khanauthor=H.+Rugoauthor=M.+Meliskoauthor=S.+E.+Minton&title=Clinical+Phase+II+Study+of+Vorinostat%2C+a+Hydroxamic+Type+Histone+Deacetylase+Inhibitor%2C+in+Combination+with+Tamoxifen+To+Reverse+Acquired+Hormone+Resistance+in+Breast+Cancer+Patients+Who+Progressed+on+Hormone+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunster%26aufirst%3DP.%2BN.%26aulast%3DLacevic%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DIsmail-Khan%26aufirst%3DR.%26aulast%3DRugo%26aufirst%3DH.%26aulast%3DMelisko%26aufirst%3DM.%26aulast%3DMinton%26aufirst%3DS.%2BE.%26atitle%3DClinical%2520Phase%2520II%2520Study%2520of%2520Vorinostat%252C%2520a%2520Hydroxamic%2520Type%2520Histone%2520Deacetylase%2520Inhibitor%252C%2520in%2520Combination%2520with%2520Tamoxifen%2520To%2520Reverse%2520Acquired%2520Hormone%2520Resistance%2520in%2520Breast%2520Cancer%2520Patients%2520Who%2520Progressed%2520on%2520Hormone%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D24%26spage%3D856S%26epage%3D856S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ring, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">Mechanisms of tamoxifen resistance</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=643-658&issue=4&author=A.+Ringauthor=M.+Dowsett&title=Mechanisms+of+tamoxifen+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DA.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520tamoxifen%2520resistance%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2004%26volume%3D11%26issue%3D4%26spage%3D643%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Speirs, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkin, S. L.</span><span> </span><span class="NLM_article-title">Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">5421</span><span class="NLM_x">–</span> <span class="NLM_lpage">5424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5421-5424&issue=21&author=V.+Speirsauthor=C.+Maloneauthor=D.+S.+Waltonauthor=M.+J.+Kerinauthor=S.+L.+Atkin&title=Increased+expression+of+estrogen+receptor+beta+mRNA+in+tamoxifen-resistant+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpeirs%26aufirst%3DV.%26aulast%3DMalone%26aufirst%3DC.%26aulast%3DWalton%26aufirst%3DD.%2BS.%26aulast%3DKerin%26aufirst%3DM.%2BJ.%26aulast%3DAtkin%26aufirst%3DS.%2BL.%26atitle%3DIncreased%2520expression%2520of%2520estrogen%2520receptor%2520beta%2520mRNA%2520in%2520tamoxifen-resistant%2520breast%2520cancer%2520patients%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D21%26spage%3D5421%26epage%3D5424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sharma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vertino, P. M.</span><span> </span><span class="NLM_article-title">Restoration of Tamoxifen Sensitivity in Estrogen Receptor-Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor Complexes</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">6370</span><span class="NLM_x">–</span> <span class="NLM_lpage">6378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=6370-6378&issue=12&author=D.+Sharmaauthor=N.+K.+Saxenaauthor=N.+E.+Davidsonauthor=P.+M.+Vertino&title=Restoration+of+Tamoxifen+Sensitivity+in+Estrogen+Receptor-Negative+Breast+Cancer+Cells%3A+Tamoxifen-Bound+Reactivated+ER+Recruits+Distinctive+Corepressor+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DN.%2BK.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DVertino%26aufirst%3DP.%2BM.%26atitle%3DRestoration%2520of%2520Tamoxifen%2520Sensitivity%2520in%2520Estrogen%2520Receptor-Negative%2520Breast%2520Cancer%2520Cells%253A%2520Tamoxifen-Bound%2520Reactivated%2520ER%2520Recruits%2520Distinctive%2520Corepressor%2520Complexes%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D12%26spage%3D6370%26epage%3D6378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Levin, E. R.</span><span> </span><span class="NLM_article-title">Plasma membrane estrogen receptors</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1016%2Fj.tem.2009.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=19783454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=477-482&issue=10&author=E.+R.+Levin&title=Plasma+membrane+estrogen+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane estrogen receptors</span></div><div class="casAuthors">Levin, Ellis R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It is now firmly established that estrogen and all sex steroid receptors exist in discrete cellular pools outside the nucleus.  Estrogen receptors (ER) have been localized to the plasma membrane where both ERα and ERβ function in a wide variety of cells and organs.  ERs have also been found in discrete cytoplasmic organelles including mitochondria and the endoplasmic reticulum.  In ligand-dependent fashion, each ER pool contributes to the overall, integrated effects of estrogens producing biol. outcomes.  I highlight the recent work establishing new roles and targets of membrane ER signaling.  Such actions include prevention of vascular injury or cardiac hypertrophy, sexual behavior, and pain perception mediated through the central nervous system, osteoblast survival, and fluid resorption in the colon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBkbQK_CyFMbVg90H21EOLACvtfcHk0lhN253sORh77Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrur3P&md5=ec58841eec1d7f1372af471c9cb32f65</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2009.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2009.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BR.%26atitle%3DPlasma%2520membrane%2520estrogen%2520receptors%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26issue%3D10%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cheng, S.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeber, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filardo, E. J.</span><span> </span><span class="NLM_article-title">Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=892-896&issue=9&author=S.-B.+Chengauthor=C.+T.+Graeberauthor=J.+A.+Quinnauthor=E.+J.+Filardo&title=Retrograde+transport+of+the+transmembrane+estrogen+receptor%2C+G-protein-coupled-receptor-30+%28GPR30%2FGPER%29+from+the+plasma+membrane+towards+the+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.-B.%26aulast%3DGraeber%26aufirst%3DC.%2BT.%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DFilardo%26aufirst%3DE.%2BJ.%26atitle%3DRetrograde%2520transport%2520of%2520the%2520transmembrane%2520estrogen%2520receptor%252C%2520G-protein-coupled-receptor-30%2520%2528GPR30%252FGPER%2529%2520from%2520the%2520plasma%2520membrane%2520towards%2520the%2520nucleus%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26issue%3D9%26spage%3D892%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y. H.</span><span> </span><span class="NLM_article-title">Non-Peptide Macrocyclic Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801128g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=456-468&issue=2&author=A.+K.+Oyelereauthor=P.+C.+Chenauthor=W.+Guerrantauthor=S.+C.+Mwakwariauthor=R.+Hoodauthor=Y.+Z.+Zhangauthor=Y.+H.+Fan&title=Non-Peptide+Macrocyclic+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm801128g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801128g%26sid%3Dliteratum%253Aachs%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DHood%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26aulast%3DFan%26aufirst%3DY.%2BH.%26atitle%3DNon-Peptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D456%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canzoneri, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1465</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200799p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1465-1477&issue=4&author=W.+Guerrantauthor=V.+Patilauthor=J.+C.+Canzoneriauthor=A.+K.+Oyelere&title=Dual+Targeting+of+Histone+Deacetylase+and+Topoisomerase+II+with+Novel+Bifunctional+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors</span></div><div class="casAuthors">Guerrant, William; Patil, Vishal; Canzoneri, Joshua C.; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1465-1477</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Strategies to ameliorate the flaws of current chemotherapeutic agents, while maintaining potent anticancer activity, are of particular interest.  Agents which can modulate multiple targets may have superior utility and fewer side effects than current single-target drugs.  To explore the prospect in cancer therapy of a bivalent agent that combines two complementary chemo-active groups within a single mol. architecture, we have synthesized dual-acting histone deacetylase and topoisomerase II inhibitors.  These dual-acting agents are derived from suberoylanilide hydroxamic acid (SAHA) and anthracycline daunorubicin, prototypical histone deacetylase (HDAC) and topoisomerase II (Topo II) inhibitors, resp.  For example, 4-aminobenzyl alc. reacted with suberic anhydride to give 4-HOCH2C6H4NHCO(CH2)6CO2H, which was oxidized to the corresponding benzaldehyde.  This benzaldehyde reacted with H2NOCPh3 to give the terminal O-tritylated amide, which, after addn. to daunorubicin HCl and removal of the trityl group, produced conjugate I.  We report herein that these agents present the signatures of inhibition of HDAC and Topo II in both cell-free and whole-cell assays.  Moreover, these agents potently inhibit the proliferation of representative cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Yf6AQQjHxLVg90H21EOLACvtfcHk0lhN253sORh77Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyhuw%253D%253D&md5=f0d6a8b98bb524de8e9fbbf1680610a1</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm200799p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200799p%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DCanzoneri%26aufirst%3DJ.%2BC.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DDual%2520Targeting%2520of%2520Histone%2520Deacetylase%2520and%2520Topoisomerase%2520II%2520with%2520Novel%2520Bifunctional%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D4%26spage%3D1465%26epage%3D1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurard-Levin, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrksich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Non-Peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">6100</span><span class="NLM_x">–</span> <span class="NLM_lpage">6111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100507q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6100-6111&issue=16&author=S.+C.+Mwakwariauthor=W.+Guerrantauthor=V.+Patilauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=Z.+A.+Gurard-Levinauthor=M.+Mrksichauthor=A.+K.+Oyelere&title=Non-Peptide+Macrocyclic+Histone+Deacetylase+Inhibitors+Derived+from+Tricyclic+Ketolide+Skeleton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm100507q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100507q%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DGurard-Levin%26aufirst%3DZ.%2BA.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DNon-Peptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%2520Derived%2520from%2520Tricyclic%2520Ketolide%2520Skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D16%26spage%3D6100%26epage%3D6111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gryder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benicewicz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=415-425&issue=1&author=V.+Patilauthor=W.+Guerrantauthor=P.+C.+Chenauthor=B.+Gryderauthor=D.+B.+Benicewiczauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=A.+K.+Oyelere&title=Antimalarial+and+antileishmanial+activities+of+histone+deacetylase+inhibitors+with+triazole-linked+cap+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGryder%26aufirst%3DB.%26aulast%3DBenicewicz%26aufirst%3DD.%2BB.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DAntimalarial%2520and%2520antileishmanial%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%2520with%2520triazole-linked%2520cap%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26issue%3D1%26spage%3D415%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guh, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-I.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4042</span><span class="NLM_x">–</span> <span class="NLM_lpage">4049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4042-4049&issue=9&author=W.-J.+Huangauthor=C.-C.+Chenauthor=S.-W.+Chaoauthor=C.-C.+Yuauthor=C.-Y.+Yangauthor=J.-H.+Guhauthor=Y.-C.+Linauthor=C.-I.+Kuoauthor=P.+Yangauthor=C.-I.+Chang&title=Synthesis+and+evaluation+of+aliphatic-chain+hydroxamates+capped+with+osthole+derivatives+as+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.-J.%26aulast%3DChen%26aufirst%3DC.-C.%26aulast%3DChao%26aufirst%3DS.-W.%26aulast%3DYu%26aufirst%3DC.-C.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DGuh%26aufirst%3DJ.-H.%26aulast%3DLin%26aufirst%3DY.-C.%26aulast%3DKuo%26aufirst%3DC.-I.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.-I.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520aliphatic-chain%2520hydroxamates%2520capped%2520with%2520osthole%2520derivatives%2520as%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D4042%26epage%3D4049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Butler, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemical origins of isoform selectivity in histone deacetylase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.2174%2F138161208783885353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=18336297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=505-528&issue=6&author=K.+V.+Butlerauthor=A.+P.+Kozikowski&title=Chemical+origins+of+isoform+selectivity+in+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical origins of isoform selectivity in histone deacetylase inhibitors</span></div><div class="casAuthors">Butler, Kyle V.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">505-528</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histones undergo extensive posttranslational modifications that affect gene expression.  Acetylation is a key histone modification that is primarily regulated by two enzymes, one of which is histone deacetylase (HDAC).  The activity of HDAC causes transcriptional silencing of DNA.  Eleven distinct zinc-dependent histone deacetylase isoforms have been identified in humans.  Each isoform has a unique structure and function, and regulates a unique set of genes.  HDAC is responsible for the regulation of many genes involved in cancer cell proliferation, and it has been implicated in the pathogenesis of many neurol. conditions.  HDAC inhibitors are known to be very effective anti-cancer agents, and research has shown them to be potential treatments for many other conditions.  Histone deacetylase inhibitors modify the expression of many genes, and it is possible that inhibition of one isoform could cause epigenetic changes that are beneficial to treatment of a disease, while inhibition of another isoform could cause contradictory changes.  Selective HDAC inhibitors will be better able to avoid these types of situations than non-specific inhibitors, and may also be less toxic than pan-HDAC inhibitors.  Many potent pan-HDAC inhibitors have already been developed, leaving the development of selective inhibitors at the forefront of HDAC drug development.  Certain structural moieties may be added to HDAC inhibitors to give isoform selectivity, and these will be discussed in this review.  This review will focus on the applications of selective HDAC inhibitors, inhibitors reported to show selectivity, and the relationship between inhibitor structure and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7uBS33WLxbbVg90H21EOLACvtfcHk0lirQCso9HTJrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVGksbw%253D&md5=7cb09f53ee939192450879caec4821bf</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.2174%2F138161208783885353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208783885353%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemical%2520origins%2520of%2520isoform%2520selectivity%2520in%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26issue%3D6%26spage%3D505%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4839</span><span class="NLM_x">–</span> <span class="NLM_lpage">4853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4839-4853&issue=9&author=P.+C.+Chenauthor=V.+Patilauthor=W.+Guerrantauthor=P.+Greenauthor=A.+K.+Oyelere&title=Synthesis+and+structure%E2%80%93activity+relationship+of+histone+deacetylase+%28HDAC%29+inhibitors+with+triazole-linked+cap+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%2520with%2520triazole-linked%2520cap%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D9%26spage%3D4839%26epage%3D4853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cyrus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehenkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span> </span><span class="NLM_article-title">Jostling for Position: Optimizing Linker Location in the Design of Estrogen Receptor-Targeting PROTACs</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=979-985&issue=7&author=K.+Cyrusauthor=M.+Wehenkelauthor=E.+Y.+Choiauthor=H.+Leeauthor=H.+Swansonauthor=K.+B.+Kim&title=Jostling+for+Position%3A+Optimizing+Linker+Location+in+the+Design+of+Estrogen+Receptor-Targeting+PROTACs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCyrus%26aufirst%3DK.%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DE.%2BY.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DSwanson%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BB.%26atitle%3DJostling%2520for%2520Position%253A%2520Optimizing%2520Linker%2520Location%2520in%2520the%2520Design%2520of%2520Estrogen%2520Receptor-Targeting%2520PROTACs%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26issue%3D7%26spage%3D979%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dao, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawant, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torchilin, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Initial Biological Evaluation of a Steroidal Anti-Estrogen-Doxorubicin Bioconjugate for Targeting Estrogen Receptor-Positive Breast Cancer Cells</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc200645n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFehtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=785-795&issue=4&author=K.+L.+Daoauthor=R.+R.+Sawantauthor=J.+A.+Hendricksauthor=V.+Rongaauthor=V.+P.+Torchilinauthor=R.+N.+Hanson&title=Design%2C+Synthesis%2C+and+Initial+Biological+Evaluation+of+a+Steroidal+Anti-Estrogen-Doxorubicin+Bioconjugate+for+Targeting+Estrogen+Receptor-Positive+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Initial Biological Evaluation of a Steroidal Anti-Estrogen-Doxorubicin Bioconjugate for Targeting Estrogen Receptor-Positive Breast Cancer Cells</span></div><div class="casAuthors">Dao, Kinh-Luan; Sawant, Rupa R.; Hendricks, J. Adam; Ronga, Victoria; Torchilin, Vladimir P.; Hanson, Robert N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">785-795</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our program to develop breast cancer specific therapeutic agents, we have synthesized a conjugate agent that is a conjugate of the steroidal anti-estrogen and the potent cytotoxin doxorubicin.  In this effort, we employed a modular assembly approach to prep. a novel 11β-substituted steroidal anti-estrogen functionalized with an azido-tetraethylene glycol moiety, which could be coupled to a complementary doxorubicin benzoyl hydrazone functionalized with a propargyl tetraethylene glycol moiety.  Huisgen [3 + 2] cycloaddn. chem. gave the final hybrid that was evaluated for selective uptake and cytotoxicity in ER(+)-MCF-7 and ER(-)-MDA-MB-231 breast cancer cell lines.  The results demonstrated that the presence of the anti-estrogenic component in the hybrid compd. was crit. for selectivity and cytotoxicity in ER(+)-MCF-7 human breast cancer cells as the hybrid was ∼70-fold more potent than doxorubicin in inhibition of cell proliferation and promoting cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJbOft1UFN2bVg90H21EOLACvtfcHk0lgiNA8vXgsM7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFehtLo%253D&md5=40b61cd9934223ce0e284af7ba9df0be</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fbc200645n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200645n%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DK.%2BL.%26aulast%3DSawant%26aufirst%3DR.%2BR.%26aulast%3DHendricks%26aufirst%3DJ.%2BA.%26aulast%3DRonga%26aufirst%3DV.%26aulast%3DTorchilin%26aufirst%3DV.%2BP.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Initial%2520Biological%2520Evaluation%2520of%2520a%2520Steroidal%2520Anti-Estrogen-Doxorubicin%2520Bioconjugate%2520for%2520Targeting%2520Estrogen%2520Receptor-Positive%2520Breast%2520Cancer%2520Cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26issue%3D4%26spage%3D785%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Peng, K.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijewickrama, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Selective Estrogen Receptor Modulator Delivery of Quinone Warheads to DNA Triggering Apoptosis in Breast Cancer Cells</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb9001848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1039-1049&issue=12&author=K.-w.+Pengauthor=H.+Wangauthor=Z.+Qinauthor=G.+T.+Wijewickramaauthor=M.+Luauthor=Z.+Wangauthor=J.+L.+Boltonauthor=G.+R.+J.+Thatcher&title=Selective+Estrogen+Receptor+Modulator+Delivery+of+Quinone+Warheads+to+DNA+Triggering+Apoptosis+in+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fcb9001848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9001848%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DK.-w.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DWijewickrama%26aufirst%3DG.%2BT.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBolton%26aufirst%3DJ.%2BL.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DSelective%2520Estrogen%2520Receptor%2520Modulator%2520Delivery%2520of%2520Quinone%2520Warheads%2520to%2520DNA%2520Triggering%2520Apoptosis%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26issue%3D12%26spage%3D1039%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nettles, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruning, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSombre, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, G. L.</span><span> </span><span class="NLM_article-title">Structural plasticity in the oestrogen receptor ligand-binding domain</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=563-568&issue=6&author=K.+W.+Nettlesauthor=J.+B.+Bruningauthor=G.+Gilauthor=E.+E.+O%E2%80%99Neillauthor=J.+Nowakauthor=A.+Hughsauthor=Y.+Kimauthor=E.+R.+DeSombreauthor=R.+Dilisauthor=R.+N.+Hansonauthor=A.+Joachimiakauthor=G.+L.+Greene&title=Structural+plasticity+in+the+oestrogen+receptor+ligand-binding+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNettles%26aufirst%3DK.%2BW.%26aulast%3DBruning%26aufirst%3DJ.%2BB.%26aulast%3DGil%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BE.%26aulast%3DNowak%26aufirst%3DJ.%26aulast%3DHughs%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DDeSombre%26aufirst%3DE.%2BR.%26aulast%3DDilis%26aufirst%3DR.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26atitle%3DStructural%2520plasticity%2520in%2520the%2520oestrogen%2520receptor%2520ligand-binding%2520domain%26jtitle%3DEMBO%2520Rep.%26date%3D2007%26volume%3D8%26issue%3D6%26spage%3D563%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olmsted, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tongcharoensirikul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaskill, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandiaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labaree, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochberg, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 17α-<i>E</i>-20-(heteroaryl)norpregn-1,3,5(10),20 tetraene-3,17β-diols [17α-(heteroaryl)vinyl estradiols] as ligands for the estrogen receptor-α ligand binding domain (ERα-LBD)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=977-979&issue=2&author=S.+L.+Olmstedauthor=P.+Tongcharoensirikulauthor=E.+McCaskillauthor=K.+Gandiagaauthor=D.+Labareeauthor=R.+B.+Hochbergauthor=R.+N.+Hanson&title=Synthesis+and+evaluation+of+17%CE%B1-E-20-%28heteroaryl%29norpregn-1%2C3%2C5%2810%29%2C20+tetraene-3%2C17%CE%B2-diols+%5B17%CE%B1-%28heteroaryl%29vinyl+estradiols%5D+as+ligands+for+the+estrogen+receptor-%CE%B1+ligand+binding+domain+%28ER%CE%B1-LBD%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlmsted%26aufirst%3DS.%2BL.%26aulast%3DTongcharoensirikul%26aufirst%3DP.%26aulast%3DMcCaskill%26aufirst%3DE.%26aulast%3DGandiaga%26aufirst%3DK.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DHochberg%26aufirst%3DR.%2BB.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%252017%25CE%25B1-E-20-%2528heteroaryl%2529norpregn-1%252C3%252C5%252810%2529%252C20%2520tetraene-3%252C17%25CE%25B2-diols%2520%255B17%25CE%25B1-%2528heteroaryl%2529vinyl%2520estradiols%255D%2520as%2520ligands%2520for%2520the%2520estrogen%2520receptor-%25CE%25B1%2520ligand%2520binding%2520domain%2520%2528ER%25CE%25B1-LBD%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D977%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Maximov, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curpan, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis-Wambi, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Structure–Function Relationships of Estrogenic Triphenylethylenes Related to Endoxifen and 4-Hydroxytamoxifen</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3273</span><span class="NLM_x">–</span> <span class="NLM_lpage">3283</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901907u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3273-3283&issue=8&author=P.+Y.+Maximovauthor=C.+B.+Myersauthor=R.+F.+Curpanauthor=J.+S.+Lewis-Wambiauthor=V.+C.+Jordan&title=Structure%E2%80%93Function+Relationships+of+Estrogenic+Triphenylethylenes+Related+to+Endoxifen+and+4-Hydroxytamoxifen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm901907u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901907u%26sid%3Dliteratum%253Aachs%26aulast%3DMaximov%26aufirst%3DP.%2BY.%26aulast%3DMyers%26aufirst%3DC.%2BB.%26aulast%3DCurpan%26aufirst%3DR.%2BF.%26aulast%3DLewis-Wambi%26aufirst%3DJ.%2BS.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DStructure%25E2%2580%2593Function%2520Relationships%2520of%2520Estrogenic%2520Triphenylethylenes%2520Related%2520to%2520Endoxifen%2520and%25204-Hydroxytamoxifen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D8%26spage%3D3273%26epage%3D3283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Burke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of doxorubicin–formaldehyde conjugates targeted to breast cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030352r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1193-1206&issue=5&author=P.+J.+Burkeauthor=T.+H.+Koch&title=Design%2C+synthesis%2C+and+biological+evaluation+of+doxorubicin%E2%80%93formaldehyde+conjugates+targeted+to+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm030352r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030352r%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DP.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520doxorubicin%25E2%2580%2593formaldehyde%2520conjugates%2520targeted%2520to%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D5%26spage%3D1193%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2596</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2596-2599&issue=14&author=V.+V.+Rostovtsevauthor=L.+G.+Greenauthor=V.+V.+Fokinauthor=K.+B.+Sharpless&title=A+stepwise+Huisgen+cycloaddition+process%3A+Copper%28I%29-catalyzed+regioselective+%E2%80%9Cligation%E2%80%9D+of+azides+and+terminal+alkynes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520stepwise%2520Huisgen%2520cycloaddition%2520process%253A%2520Copper%2528I%2529-catalyzed%2520regioselective%2520%25E2%2580%259Cligation%25E2%2580%259D%2520of%2520azides%2520and%2520terminal%2520alkynes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26issue%3D14%26spage%3D2596%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Olofson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piteau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malfroot, T.</span><span> </span><span class="NLM_article-title">A New Reagent For The Selective, High-Yield <i>N</i>-Dealkylation Of Tertiary-Amines—Improved Syntheses Of Naltrexone And Nalbuphine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00185a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=2081-2082&issue=11&author=R.+A.+Olofsonauthor=J.+T.+Martzauthor=J.+P.+Senetauthor=M.+Piteauauthor=T.+Malfroot&title=A+New+Reagent+For+The+Selective%2C+High-Yield+N-Dealkylation+Of+Tertiary-Amines%E2%80%94Improved+Syntheses+Of+Naltrexone+And+Nalbuphine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00185a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00185a072%26sid%3Dliteratum%253Aachs%26aulast%3DOlofson%26aufirst%3DR.%2BA.%26aulast%3DMartz%26aufirst%3DJ.%2BT.%26aulast%3DSenet%26aufirst%3DJ.%2BP.%26aulast%3DPiteau%26aufirst%3DM.%26aulast%3DMalfroot%26aufirst%3DT.%26atitle%3DA%2520New%2520Reagent%2520For%2520The%2520Selective%252C%2520High-Yield%2520N-Dealkylation%2520Of%2520Tertiary-Amines%25E2%2580%2594Improved%2520Syntheses%2520Of%2520Naltrexone%2520And%2520Nalbuphine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26issue%3D11%26spage%3D2081%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A Medicinal Chemist’s Guide to Molecular Interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&issue=14&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+Medicinal+Chemist%E2%80%99s+Guide+to+Molecular+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520Medicinal%2520Chemist%25E2%2580%2599s%2520Guide%2520to%2520Molecular%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D14%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Li, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dym, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albeck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pais, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunanathan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Structure of Estradiol Metal Chelate and Estrogen Receptor Complex: The Basis for Designing a New Class of Selective Estrogen Receptor Modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3575</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200192y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3575-3580&issue=10&author=M.-J.+Liauthor=H.+M.+Greenblattauthor=O.+Dymauthor=S.+Albeckauthor=A.+Paisauthor=C.+Gunanathanauthor=D.+Milsteinauthor=H.+Deganiauthor=J.+L.+Sussman&title=Structure+of+Estradiol+Metal+Chelate+and+Estrogen+Receptor+Complex%3A+The+Basis+for+Designing+a+New+Class+of+Selective+Estrogen+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm200192y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200192y%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.-J.%26aulast%3DGreenblatt%26aufirst%3DH.%2BM.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DAlbeck%26aufirst%3DS.%26aulast%3DPais%26aufirst%3DA.%26aulast%3DGunanathan%26aufirst%3DC.%26aulast%3DMilstein%26aufirst%3DD.%26aulast%3DDegani%26aufirst%3DH.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520Estradiol%2520Metal%2520Chelate%2520and%2520Estrogen%2520Receptor%2520Complex%253A%2520The%2520Basis%2520for%2520Designing%2520a%2520New%2520Class%2520of%2520Selective%2520Estrogen%2520Receptor%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D10%26spage%3D3575%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Thomas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, J. A.</span><span> </span><span class="NLM_article-title">The different roles of ER subtypes in cancer biology and therapy</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1038%2Fnrc3093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=21779010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1aqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=597-608&issue=8&author=C.+Thomasauthor=J.+A.+Gustafsson&title=The+different+roles+of+ER+subtypes+in+cancer+biology+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The different roles of ER subtypes in cancer biology and therapy</span></div><div class="casAuthors">Thomas, Christoforos; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  By eliciting distinct transcriptional responses, the estrogen receptors (ERs) ERα and ERβ exert opposite effects on cellular processes that include proliferation, apoptosis and migration and that differentially influence the development and the progression of cancer.  Perturbation of ER subtype-specific expression has been detected in various types of cancer, and the differences in the expression of ERs are correlated with the clin. outcome.  The changes in the bioavailability of ERs in tumors, together with their specific biol. functions, promote the selective restoration of their activity as one of the major therapeutic approaches for hormone-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQgsx59rM16LVg90H21EOLACvtfcHk0lif6wE2Pqdq0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1aqt7g%253D&md5=97cdcb21bff3447afbccac915ec6af77</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrc3093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3093%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520different%2520roles%2520of%2520ER%2520subtypes%2520in%2520cancer%2520biology%2520and%2520therapy%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D8%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fox, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shupnik, M. A.</span><span> </span><span class="NLM_article-title">ER beta in breast cancer—onlooker, passive player, or active protector?</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1039-1051&issue=11&author=E.+M.+Foxauthor=R.+J.+Davisauthor=M.+A.+Shupnik&title=ER+beta+in+breast+cancer%E2%80%94onlooker%2C+passive+player%2C+or+active+protector%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DShupnik%26aufirst%3DM.%2BA.%26atitle%3DER%2520beta%2520in%2520breast%2520cancer%25E2%2580%2594onlooker%252C%2520passive%2520player%252C%2520or%2520active%2520protector%253F%26jtitle%3DSteroids%26date%3D2008%26volume%3D73%26issue%3D11%26spage%3D1039%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. H.</span><span> </span><span class="NLM_article-title">In Silico Prediction of Estrogen Receptor Subtype Binding Affinity and Selectivity Using Statistical Methods and Molecular Docking with 2-Arylnaphthalenes and 2-Arylquinolines</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3434</span><span class="NLM_x">–</span> <span class="NLM_lpage">3458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.3390%2Fijms11093434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Oiur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=3434-3458&issue=9&author=Z.+Z.+Wangauthor=Y.+Liauthor=C.+Z.+Aiauthor=Y.+H.+Wang&title=In+Silico+Prediction+of+Estrogen+Receptor+Subtype+Binding+Affinity+and+Selectivity+Using+Statistical+Methods+and+Molecular+Docking+with+2-Arylnaphthalenes+and+2-Arylquinolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines</span></div><div class="casAuthors">Wang, Zhizhong; Li, Yan; Ai, Chunzhi; Wang, Yonghua</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3434-3458</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">Over the years development of selective estrogen receptor (ER) ligands has been of great concern to researchers involved in the chem. and pharmacol. of anticancer drugs, resulting in numerous synthesized selective ER subtype inhibitors.  A data set of 82 ER ligands with ERα and ERβ inhibitory activities was built, and quant. structure-activity relationship (QSAR) methods based on the two linear (multiple linear regression, MLR, partial least squares regression, PLSR) and a nonlinear statistical method (Bayesian regularized neural network, BRNN) were applied to investigate the potential relationship of mol. structural features related to the activity and selectivity of these ligands.  For ERα and ERβ, the performances of the MLR and PLSR models are superior to the BRNN model, giving more reasonable statistical properties (ERα: for MLR, RtR2 = 0.72, QtE2 = 0.63; for PLSR, RtR2 = 0.92, QtE2 = 0.84; ERβ: for MLR, RtR2 = 0.75, QtE2 = 0.75; for PLSR, RtR2 = 0.98, QtE2 = 0.80).  The MLR method is also more powerful than other two methods for generating the subtype selectivity models, resulting in RtR2 = 0.74 and QtE2 = 0.80.  In addn., the mol. docking method was also used to explore the possible binding modes of the ligands and a relationship between the 3D-binding modes and the 2D-mol. structural features of ligands was further explored.  The results show that the binding affinity strength for both ERα and ERβ is more correlated with the atom fragment type, polarity, electronegativities and hydrophobicity.  The substituent in position 8 of the naphthalene or the quinoline plane and the space orientation of these two planes contribute the most to the subtype selectivity on the basis of similar hydrogen bond interactions between binding ligands and both ER subtypes.  The QSAR models built together with the docking procedure should be of great advantage for screening and designing ER ligands with improved affinity and subtype selectivity property.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU767KgAYF07Vg90H21EOLACvtfcHk0lif6wE2Pqdq0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Oiur3L&md5=61af2ca611e645bba3ceb5ca50556714</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fijms11093434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms11093434%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DC.%2BZ.%26aulast%3DWang%26aufirst%3DY.%2BH.%26atitle%3DIn%2520Silico%2520Prediction%2520of%2520Estrogen%2520Receptor%2520Subtype%2520Binding%2520Affinity%2520and%2520Selectivity%2520Using%2520Statistical%2520Methods%2520and%2520Molecular%2520Docking%2520with%25202-Arylnaphthalenes%2520and%25202-Arylquinolines%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2010%26volume%3D11%26issue%3D9%26spage%3D3434%26epage%3D3458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Allred, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, D.</span><span> </span><span class="NLM_article-title">The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1186%2Fbcr938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=15535853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1ajtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=240-245&issue=6&author=D.+C.+Allredauthor=P.+Brownauthor=D.+Medina&title=The+origins+of+estrogen+receptor+alpha-positive+and+estrogen+receptor+alpha-negative+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer</span></div><div class="casAuthors">Allred, D. Craig; Brown, Powel; Medina, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">240-245</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Current hormonal therapies have benefited millions of patients with breast cancer.  Their success, however, is often temporary and limited to a subset of patients whose tumors express estrogen receptor alpha (ER).  The therapies are entirely ineffective in ER-neg. disease.  Recent studies suggest that there are many biol. pathways and alterations involved in detg. whether ER is expressed and how it is regulated during breast cancer evolution.  Improving hormonal therapies, in addn. to perfecting current strategies, will also target these newly discovered pathways and alterations, and others yet to be found.  The present commentary will briefly highlight a few important observations and unanswered questions regarding ER status and growth regulation during breast cancer evolution, which hopefully will help to stimulate new thinking and progress in this important area of medial research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZgdKpwipVZrVg90H21EOLACvtfcHk0ljkjJZfmqdueA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1ajtr8%253D&md5=ccc5537f91918096dc45c3c4e62cfe91</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1186%2Fbcr938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr938%26sid%3Dliteratum%253Aachs%26aulast%3DAllred%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DMedina%26aufirst%3DD.%26atitle%3DThe%2520origins%2520of%2520estrogen%2520receptor%2520alpha-positive%2520and%2520estrogen%2520receptor%2520alpha-negative%2520human%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2004%26volume%3D6%26issue%3D6%26spage%3D240%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sabnis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goloubeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumsri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A. M. H.</span><span> </span><span class="NLM_article-title">Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1893-1903&issue=5&author=G.+J.+Sabnisauthor=O.+Goloubevaauthor=S.+Chumsriauthor=N.+Nguyenauthor=S.+Sukumarauthor=A.+M.+H.+Brodie&title=Functional+Activation+of+the+Estrogen+Receptor-%CE%B1+and+Aromatase+by+the+HDAC+Inhibitor+Entinostat+Sensitizes+ER-Negative+Tumors+to+Letrozole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabnis%26aufirst%3DG.%2BJ.%26aulast%3DGoloubeva%26aufirst%3DO.%26aulast%3DChumsri%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DSukumar%26aufirst%3DS.%26aulast%3DBrodie%26aufirst%3DA.%2BM.%2BH.%26atitle%3DFunctional%2520Activation%2520of%2520the%2520Estrogen%2520Receptor-%25CE%25B1%2520and%2520Aromatase%2520by%2520the%2520HDAC%2520Inhibitor%2520Entinostat%2520Sensitizes%2520ER-Negative%2520Tumors%2520to%2520Letrozole%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D5%26spage%3D1893%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nass, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butash, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span> </span><span class="NLM_article-title">Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6890</span><span class="NLM_x">–</span> <span class="NLM_lpage">6894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6890-6894&issue=24&author=X.+Yangauthor=A.+T.+Fergusonauthor=S.+J.+Nassauthor=D.+L.+Phillipsauthor=K.+A.+Butashauthor=S.+M.+Wangauthor=J.+G.+Hermanauthor=N.+E.+Davidson&title=Transcriptional+activation+of+estrogen+receptor+alpha+in+human+breast+cancer+cells+by+histone+deacetylase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DFerguson%26aufirst%3DA.%2BT.%26aulast%3DNass%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DD.%2BL.%26aulast%3DButash%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DHerman%26aufirst%3DJ.%2BG.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26atitle%3DTranscriptional%2520activation%2520of%2520estrogen%2520receptor%2520alpha%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520histone%2520deacetylase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26issue%3D24%26spage%3D6890%26epage%3D6894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kreis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budman, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabro, A.</span><span> </span><span class="NLM_article-title">A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1007%2Fs002800000191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=11221966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVWmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2001&pages=78-82&issue=1&author=W.+Kreisauthor=D.+R.+Budmanauthor=A.+Calabro&title=A+reexamination+of+PSC+833+%28Valspodar%29+as+a+cytotoxic+agent+and+in+combination+with+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents</span></div><div class="casAuthors">Kreis, Willi; Budman, Daniel R.; Calabro, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-82</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The cytotoxicity of cyclosporins was examd. in defined cell lines, both as single agents and in combination with agents which may be of value in human malignant disease.  Cells were grown to confluence, and growth patterns and death were detd. by an MTT assay.  Median effect anal. was used to look for synergy, additive effects, or antagonism between the cyclosporins and drugs with antitumor effects in humans.  Cyclosporin A and PSC 833 had cytotoxic activity at clin. achievable concns. in breast, leukemia, and prostate cell lines.  Synergistic or additive effects were demonstrated in all three prostate cell lines when PSC 833 was combined with estramustine, etoposide, ketoconazole, suramin, or vinorelbine.  Cell line-selective additive effects or synergism were also identified with bicalutamide, carboplatin, cisplatin, cis-retinoic acid, dexamethasone, 5-fluorouracil, liarozole, and trans-retinoic acid.  Thus, PSC 833 or cyclosporin alone or in combination with other agents may have an anticancer effect independently of their modulatory action on multidrug resistance.  Several of the synergistic combinations which are not mediated by the multidrug resistance pump need to be tested in vivo for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOi043NQPYG7Vg90H21EOLACvtfcHk0lhZxDqmhGs5yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVWmsQ%253D%253D&md5=b9d8fcd448a36ad966a4262bd80d282a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs002800000191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800000191%26sid%3Dliteratum%253Aachs%26aulast%3DKreis%26aufirst%3DW.%26aulast%3DBudman%26aufirst%3DD.%2BR.%26aulast%3DCalabro%26aufirst%3DA.%26atitle%3DA%2520reexamination%2520of%2520PSC%2520833%2520%2528Valspodar%2529%2520as%2520a%2520cytotoxic%2520agent%2520and%2520in%2520combination%2520with%2520anticancer%2520agents%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2001%26volume%3D47%26issue%3D1%26spage%3D78%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Lau, K.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaSpina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S.-M.</span><span> </span><span class="NLM_article-title">Expression of Estrogen Receptor (ER)-α and ER-β in Normal and Malignant Prostatic Epithelial Cells: Regulation by Methylation and Involvement in Growth Regulation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=3175-3182&issue=12&author=K.-M.+Lauauthor=M.+LaSpinaauthor=J.+Longauthor=S.-M.+Ho&title=Expression+of+Estrogen+Receptor+%28ER%29-%CE%B1+and+ER-%CE%B2+in+Normal+and+Malignant+Prostatic+Epithelial+Cells%3A+Regulation+by+Methylation+and+Involvement+in+Growth+Regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DK.-M.%26aulast%3DLaSpina%26aufirst%3DM.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DS.-M.%26atitle%3DExpression%2520of%2520Estrogen%2520Receptor%2520%2528ER%2529-%25CE%25B1%2520and%2520ER-%25CE%25B2%2520in%2520Normal%2520and%2520Malignant%2520Prostatic%2520Epithelial%2520Cells%253A%2520Regulation%2520by%2520Methylation%2520and%2520Involvement%2520in%2520Growth%2520Regulation%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26issue%3D12%26spage%3D3175%26epage%3D3182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Muller, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, M. N.</span><span> </span><span class="NLM_article-title">The determination and interpretation of the therapeutic index in drug development</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=751-761&issue=10&author=P.+Y.+Mullerauthor=M.+N.+Milton&title=The+determination+and+interpretation+of+the+therapeutic+index+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DP.%2BY.%26aulast%3DMilton%26aufirst%3DM.%2BN.%26atitle%3DThe%2520determination%2520and%2520interpretation%2520of%2520the%2520therapeutic%2520index%2520in%2520drug%2520development%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D10%26spage%3D751%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Owens, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Young, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyse, K. J.</span><span> </span><span class="NLM_article-title">Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1993&pages=467-473&issue=2&author=P.+C.+Owensauthor=P.+G.+Gillauthor=N.+J.+De+Youngauthor=M.+A.+Wegerauthor=S.+E.+Knowlesauthor=K.+J.+Moyse&title=Estrogen+and+progesterone+regulate+secretion+of+insulin-like+growth+factor+binding+proteins+by+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DP.%2BC.%26aulast%3DGill%26aufirst%3DP.%2BG.%26aulast%3DDe%2BYoung%26aufirst%3DN.%2BJ.%26aulast%3DWeger%26aufirst%3DM.%2BA.%26aulast%3DKnowles%26aufirst%3DS.%2BE.%26aulast%3DMoyse%26aufirst%3DK.%2BJ.%26atitle%3DEstrogen%2520and%2520progesterone%2520regulate%2520secretion%2520of%2520insulin-like%2520growth%2520factor%2520binding%2520proteins%2520by%2520human%2520breast%2520cancer%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1993%26volume%3D193%26issue%3D2%26spage%3D467%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sutherland, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddel, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I. W.</span><span> </span><span class="NLM_article-title">Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle</span> <span class="citation_source-journal">Eur. J. Cancer Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1016%2F0277-5379%2883%2990177-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=6683633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADyaL3sXktlart74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1983&pages=615-621&issue=5&author=R.+L.+Sutherlandauthor=M.+D.+Greenauthor=R.+E.+Hallauthor=R.+R.+Reddelauthor=I.+W.+Taylor&title=Tamoxifen+induces+accumulation+of+MCF+7+human+mammary+carcinoma+cells+in+the+G0%2FG1+phase+of+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle</span></div><div class="casAuthors">Sutherland, Robert L.; Green, Michael D.; Hall, Rosemary E.; Reddel, Roger R.; Taylor, Ian W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer & Clinical Oncology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">615-21</span>CODEN:
                <span class="NLM_cas:coden">EJCODS</span>;
        ISSN:<span class="NLM_cas:issn">0277-5379</span>.
    </div><div class="casAbstract">When MCF 7 human mammary carcinoma cells in exponential growth phase were treated with tamoxifen (I)  [10540-29-1], a dose-dependent inhibition of cell growth was obsd.  This inhibition was accompanied by a dose-dependent decrease in the percentage of S phase cells and a concomitant increase in the percentage of cells in the G0/G1 phase of the cell cycle.  Simultaneous treatment of cultures with a 10-fold lower concn. of estradiol  [50-28-2] completely reversed the growth inhibitory and cell cycle effects of tamoxifen at doses < 5 μM but only partially reversed the effects of higher doses of this drug.  Thus, tamoxifen is a cell cycle phase-specific growth inhibitory agent.  In addn. to having effects on cell proliferation that are reversed by estrogens and are likely to be estrogen receptor-mediated, tamoxifen has antitumor activity in vitro that involves biochem. mechanisms independent of the estrogen receptor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcY6107cWVU7Vg90H21EOLACvtfcHk0ljzLElsniJBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXktlart74%253D&md5=c3165258377ee45cd0eb2ac0e36fc3aa</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0277-5379%2883%2990177-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0277-5379%252883%252990177-3%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DGreen%26aufirst%3DM.%2BD.%26aulast%3DHall%26aufirst%3DR.%2BE.%26aulast%3DReddel%26aufirst%3DR.%2BR.%26aulast%3DTaylor%26aufirst%3DI.%2BW.%26atitle%3DTamoxifen%2520induces%2520accumulation%2520of%2520MCF%25207%2520human%2520mammary%2520carcinoma%2520cells%2520in%2520the%2520G0%252FG1%2520phase%2520of%2520the%2520cell%2520cycle%26jtitle%3DEur.%2520J.%2520Cancer%2520Clin.%2520Oncol.%26date%3D1983%26volume%3D19%26issue%3D5%26spage%3D615%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, B. G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2069</span><span class="NLM_x">–</span> <span class="NLM_lpage">2083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1091%2Fmbc.11.6.2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=10848630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=2069-2083&issue=6&author=L.+Qiuauthor=A.+Burgessauthor=D.+P.+Fairlieauthor=H.+Leonardauthor=P.+G.+Parsonsauthor=B.+G.+Gabrielli&title=Histone+deacetylase+inhibitors+trigger+a+G2+checkpoint+in+normal+cells+that+is+defective+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells</span></div><div class="casAuthors">Qiu, Ling; Burgess, Andrew; Fairlie, David P.; Leonard, Helen; Parsons, Peter G.; Gabrielli, Brian G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2069-2083</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Important aspects of cell cycle regulation are the checkpoints, which respond to a variety of cellular stresses to inhibit cell cycle progression and act as protective mechanisms to ensure genomic integrity.  An increasing no. of tumor suppressors are being demonstrated to have roles in checkpoint mechanisms, implying that checkpoint dysfunction is likely to be a common feature of cancers.  Here we report that histone deacetylase inhibitors, in particular azelaic bishydroxamic acid, triggers a G2 phase cell cycle checkpoint response in normal human cells, and this checkpoint is defective in a range of tumor cell lines.  Loss of this G2 checkpoint results in the tumor cells undergoing an aberrant mitosis resulting in fractured multinuclei and micronuclei and eventually cell death.  This histone deacetylase inhibitor-sensitive checkpoint appears to be distinct from G2/M checkpoints activated by genotoxins and microtubule poisons and may be the human homolog of a yeast G2 checkpoint, which responds to aberrant histone acetylation states.  Azelaic bishydroxamic acid may represent a new class of anticancer drugs with selective toxicity based on its ability to target a dysfunctional checkpoint mechanism in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnlqZq6d7QILVg90H21EOLACvtfcHk0ljzLElsniJBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1Sisbc%253D&md5=b53ae6e6752acfd61069314aeebe7850</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1091%2Fmbc.11.6.2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.11.6.2069%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DBurgess%26aufirst%3DA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DP.%2BG.%26aulast%3DGabrielli%26aufirst%3DB.%2BG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520trigger%2520a%2520G2%2520checkpoint%2520in%2520normal%2520cells%2520that%2520is%2520defective%2520in%2520tumor%2520cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2000%26volume%3D11%26issue%3D6%26spage%3D2069%26epage%3D2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span> </span><span class="NLM_article-title">p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">49</span><span class="NLM_x">) </span> <span class="NLM_fpage">7762</span><span class="NLM_x">–</span> <span class="NLM_lpage">7773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7762-7773&issue=49&author=T.+Hiroseauthor=Y.+Sowaauthor=S.+Takahashiauthor=S.+Saitoauthor=C.+Yasudaauthor=N.+Shindoauthor=K.+Furuichiauthor=T.+Sakai&title=p53-independent+induction+of+Gadd45+by+histone+deacetylase+inhibitor%3A+coordinate+regulation+by+transcription+factors+Oct-1+and+NF-Y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DSowa%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DYasuda%26aufirst%3DC.%26aulast%3DShindo%26aufirst%3DN.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3Dp53-independent%2520induction%2520of%2520Gadd45%2520by%2520histone%2520deacetylase%2520inhibitor%253A%2520coordinate%2520regulation%2520by%2520transcription%2520factors%2520Oct-1%2520and%2520NF-Y%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26issue%3D49%26spage%3D7762%26epage%3D7773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Warrener, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beamish, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, B.</span><span> </span><span class="NLM_article-title">Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=1550-1552&issue=11&author=R.+Warrenerauthor=H.+Beamishauthor=A.+Burgessauthor=N.+J.+Waterhouseauthor=N.+Gilesauthor=D.+Fairlieauthor=B.+Gabrielli&title=Tumor+cell-selective+cytotoxicity+by+targeting+cell+cycle+checkpoints"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWarrener%26aufirst%3DR.%26aulast%3DBeamish%26aufirst%3DH.%26aulast%3DBurgess%26aufirst%3DA.%26aulast%3DWaterhouse%26aufirst%3DN.%2BJ.%26aulast%3DGiles%26aufirst%3DN.%26aulast%3DFairlie%26aufirst%3DD.%26aulast%3DGabrielli%26aufirst%3DB.%26atitle%3DTumor%2520cell-selective%2520cytotoxicity%2520by%2520targeting%2520cell%2520cycle%2520checkpoints%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26issue%3D11%26spage%3D1550%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Pujol, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Pawel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hearn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G.</span><span> </span><span class="NLM_article-title">Preliminary results of combined therapy with topotecan and carboplatin in advanced non-small-cell lung cancer</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=47-54&issue=Suppl+1&author=J.+L.+Pujolauthor=J.+von+Pawelauthor=S.+Tumoloauthor=A.+Martoniauthor=S.+Hearnauthor=S.+Z.+Fieldsauthor=G.+Ross&title=Preliminary+results+of+combined+therapy+with+topotecan+and+carboplatin+in+advanced+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPujol%26aufirst%3DJ.%2BL.%26aulast%3Dvon%2BPawel%26aufirst%3DJ.%26aulast%3DTumolo%26aufirst%3DS.%26aulast%3DMartoni%26aufirst%3DA.%26aulast%3DHearn%26aufirst%3DS.%26aulast%3DFields%26aufirst%3DS.%2BZ.%26aulast%3DRoss%26aufirst%3DG.%26atitle%3DPreliminary%2520results%2520of%2520combined%2520therapy%2520with%2520topotecan%2520and%2520carboplatin%2520in%2520advanced%2520non-small-cell%2520lung%2520cancer%26jtitle%3DOncology%26date%3D2001%26volume%3D61%26issue%3DSuppl%25201%26spage%3D47%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&issue=1%E2%80%933&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0liyMuxX9lK4ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26issue%3D1%25E2%2580%25933%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Dreaden, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodji, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Sayed, M. A.</span><span> </span><span class="NLM_article-title">Tamoxifen–Poly(ethylene glycol)-thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2253</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9002212" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=2247-2253&issue=12&author=E.+C.+Dreadenauthor=S.+C.+Mwakwariauthor=Q.+H.+Sodjiauthor=A.+K.+Oyelereauthor=M.+A.+El-Sayed&title=Tamoxifen%E2%80%93Poly%28ethylene+glycol%29-thiol+Gold+Nanoparticle+Conjugates%3A+Enhanced+Potency+and+Selective+Delivery+for+Breast+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tamoxifen-Poly(ethylene glycol)-Thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment</span></div><div class="casAuthors">Dreaden, Erik C.; Mwakwari, Sandra C.; Sodji, Quaovi H.; Oyelere, Adegboyega K.; El-Sayed, Mostafa A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2253</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The breast cancer treatment drug tamoxifen has been widely administered for more than three decades.  This small mol. competes with 17β-estradiol for binding to estrogen receptor, a hormone receptor upregulated in a majority of breast cancers, subsequently initiating programmed cell death.  We have synthesized a thiol-PEGylated tamoxifen deriv. that can be used to selectively target and deliver plasmonic gold nanoparticles to estrogen receptor pos. breast cancer cells with up to 2.7-fold enhanced drug potency in vitro.  Optical microscopy/spectroscopy, time-dependent dose-response data, and estrogen competition studies indicate that augmented activity is due to increased rates of intracellular tamoxifen transport by nanoparticle endocytosis, rather than by passive diffusion of the free drug.  Both ligand- and receptor-dependent intracellular delivery of gold nanoparticles suggest that plasma membrane localized estrogen receptor alpha may facilitate selective uptake and retention of this and other therapeutic nanoparticle conjugates.  Combined targeting selectivity and enhanced potency provides opportunities for both multimodal endocrine treatment strategies and adjunctive laser photothermal therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Zs2_AAkoO7Vg90H21EOLACvtfcHk0liyMuxX9lK4ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtLfL&md5=a280ed117ce356f75d4de231a6e04ad6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fbc9002212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9002212%26sid%3Dliteratum%253Aachs%26aulast%3DDreaden%26aufirst%3DE.%2BC.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DSodji%26aufirst%3DQ.%2BH.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26aulast%3DEl-Sayed%26aufirst%3DM.%2BA.%26atitle%3DTamoxifen%25E2%2580%2593Poly%2528ethylene%2520glycol%2529-thiol%2520Gold%2520Nanoparticle%2520Conjugates%253A%2520Enhanced%2520Potency%2520and%2520Selective%2520Delivery%2520for%2520Breast%2520Cancer%2520Treatment%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26issue%3D12%26spage%3D2247%26epage%3D2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Pelekanou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kafousi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dambaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darivianaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrekoussis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanidas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiftsis, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathopoulos, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanas, E.</span><span> </span><span class="NLM_article-title">Erythropoietin and Its Receptor in Breast Cancer: Correlation with Steroid Receptors and Outcome</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2016</span><span class="NLM_x">–</span> <span class="NLM_lpage">2023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=2016-2023&issue=10&author=V.+Pelekanouauthor=M.+Kampaauthor=M.+Kafousiauthor=K.+Dambakiauthor=K.+Darivianakiauthor=T.+Vrekoussisauthor=E.+Sanidasauthor=D.+D.+Tsiftsisauthor=E.+N.+Stathopoulosauthor=E.+Castanas&title=Erythropoietin+and+Its+Receptor+in+Breast+Cancer%3A+Correlation+with+Steroid+Receptors+and+Outcome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPelekanou%26aufirst%3DV.%26aulast%3DKampa%26aufirst%3DM.%26aulast%3DKafousi%26aufirst%3DM.%26aulast%3DDambaki%26aufirst%3DK.%26aulast%3DDarivianaki%26aufirst%3DK.%26aulast%3DVrekoussis%26aufirst%3DT.%26aulast%3DSanidas%26aufirst%3DE.%26aulast%3DTsiftsis%26aufirst%3DD.%2BD.%26aulast%3DStathopoulos%26aufirst%3DE.%2BN.%26aulast%3DCastanas%26aufirst%3DE.%26atitle%3DErythropoietin%2520and%2520Its%2520Receptor%2520in%2520Breast%2520Cancer%253A%2520Correlation%2520with%2520Steroid%2520Receptors%2520and%2520Outcome%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2007%26volume%3D16%26issue%3D10%26spage%3D2016%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohatgi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azizi, B.</span><span> </span><span class="NLM_article-title">Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule</span> <span class="citation_source-journal">BMC Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1186%2F1472-6750-10-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=20167077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ltFOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=15&issue=1&author=J.+Taylorauthor=P.+Rohatgiauthor=H.+T.+Spencerauthor=D.+Doyleauthor=B.+Azizi&title=Characterization+of+a+molecular+switch+system+that+regulates+gene+expression+in+mammalian+cells+through+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule</span></div><div class="casAuthors">Taylor Jennifer L; Rohatgi Priyanka; Spencer H Trent; Doyle Donald F; Azizi Bahareh</div><div class="citationInfo"><span class="NLM_cas:title">BMC biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Molecular switch systems that activate gene expression by a small molecule are effective technologies that are widely used in applied biological research.  Nuclear receptors are valuable candidates for these regulation systems due to their functional role as ligand activated transcription factors.  Previously, our group engineered a variant of the retinoid x receptor to be responsive to the synthetic compound, LG335, but not responsive to its natural ligand, 9-cis-retinoic acid.  RESULTS:  This work focuses on characterizing a molecular switch system that quantitatively controls transgene expression.  This system is composed of an orthogonal ligand/nuclear receptor pair, LG335 and GRQCIMFI, along with an artificial promoter controlling expression of a target transgene.  GRQCIMFI is composed of the fusion of the DNA binding domain of the yeast transcription factor, Gal4, and a retinoid x receptor variant.  The variant consists of the following mutations: Q275C, I310M, and F313I in the ligand binding domain.  When introduced into mammalian cell culture, the switch shows luciferase activity at concentrations as low as 100 nM of LG335 with a 6.3 +/- 1.7-fold induction ratio.  The developed one-component system activates transgene expression when introduced transiently or virally.  CONCLUSIONS:  We have successfully shown that this system can induce tightly controlled transgene expression and can be used for transient transfections or retroviral transductions in mammalian cell culture.  Further characterization is needed for gene therapy applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFv_UyM0JWlnp3bfzSLaX5fW6udTcc2eZmnfRTr7P9d7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ltFOmuw%253D%253D&md5=e2b1df9993ab616edb6191813b138440</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1186%2F1472-6750-10-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6750-10-15%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DRohatgi%26aufirst%3DP.%26aulast%3DSpencer%26aufirst%3DH.%2BT.%26aulast%3DDoyle%26aufirst%3DD.%26aulast%3DAzizi%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520a%2520molecular%2520switch%2520system%2520that%2520regulates%2520gene%2520expression%2520in%2520mammalian%2520cells%2520through%2520a%2520small%2520molecule%26jtitle%3DBMC%2520Biotechnol.%26date%3D2010%26volume%3D10%26issue%3D1%26spage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&issue=2&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0ljPHc4NLepA5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26issue%3D2%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Hooft, R. W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vriend, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abola, E. E.</span><span> </span><span class="NLM_article-title">Errors in protein structures</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">381</span><span class="NLM_x"> (</span><span class="NLM_issue">6580</span><span class="NLM_x">) </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=272-272&issue=6580&author=R.+W.+W.+Hooftauthor=G.+Vriendauthor=C.+Sanderauthor=E.+E.+Abola&title=Errors+in+protein+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHooft%26aufirst%3DR.%2BW.%2BW.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DAbola%26aufirst%3DE.%2BE.%26atitle%3DErrors%2520in%2520protein%2520structures%26jtitle%3DNature%26date%3D1996%26volume%3D381%26issue%3D6580%26spage%3D272%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Arnold, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwede, T.</span><span> </span><span class="NLM_article-title">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=195-201&issue=2&author=K.+Arnoldauthor=L.+Bordoliauthor=J.+Koppauthor=T.+Schwede&title=The+SWISS-MODEL+workspace%3A+a+web-based+environment+for+protein+structure+homology+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520workspace%253A%2520a%2520web-based%2520environment%2520for%2520protein%2520structure%2520homology%2520modelling%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26issue%3D2%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kuiper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchenthaler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, J. A.</span><span> </span><span class="NLM_article-title">The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems</span> <span class="citation_source-journal">Front. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1006%2Ffrne.1998.0170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=9799586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADyaK1cXntl2iur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=253-286&issue=4&author=G.+Kuiperauthor=P.+J.+Shughrueauthor=I.+Merchenthalerauthor=J.+A.+Gustafsson&title=The+estrogen+receptor+beta+subtype%3A+a+novel+mediator+of+estrogen+action+in+neuroendocrine+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The estrogen receptor β subtype: a novel mediator of estrogen action in neuroendocrine systems</span></div><div class="casAuthors">Kuiper, George G. J. M.; Shughrue, Paul J.; Merchenthaler, Istvan; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Neuroendocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-286</span>CODEN:
                <span class="NLM_cas:coden">FNEDA7</span>;
        ISSN:<span class="NLM_cas:issn">0091-3022</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 170 refs.  The recent discovery that an addnl. estrogen receptor (ERβ) subtype is present in many rat, mouse, and human tissues has advanced the authors' understanding of the mechanisms underlying estrogen signaling.  Ligand-binding expts. have shown specific binding of 17β-estradiol by ERβ with an affinity similar to that of ERα.  The rat tissue distribution and/or the relative level of ERα and ERβ expression seems to be quite different, i.e., moderate to high expression in uterus, testis, pituitary, ovary, kidney, epididymis, and adrenal for ERα and prostate, ovary, lung, bladder, brain, bone, uterus, and testis for ERβ.  Within the same organ it often appears that the ER subtypes are expressed in different cell types, supporting the hypothesis that the ER's may have different biol. functions.  The cell type-specific expression of ERα and ERβ in rat prostate, testis, uterus, ovary, and brain and the distribution of ERβ mRNA in the ERα knock-out mouse brain are discussed.  The discovery of ERβ suggests the existence of two previously unrecognized pathways of estrogen signaling; via the ERβ subtype in tissues exclusively expressing this subtype and via the formation of heterodimers in tissues expressing both ER subtypes.  The existence of two ER subtypes, their differential expression pattern, and different actions on certain response elements could provide explanations for the striking species-, cell-, and promoter-specific actions of estrogens and antiestrogens.  The challenge for the future is to unravel the detailed physiol. role of each subtype and to use this knowledge to develop the next generation of ER-targeted drugs with improved therapeutic profiles in the treatment or prevention of osteoporosis, cardiovascular system disorders, Alzheimer's disease, breast cancer, and disorders of the urogenital tract.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF_BbY8aCugrVg90H21EOLACvtfcHk0lintrzinrEj9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntl2iur8%253D&md5=5778675c3ad5cd44092f361d7d895706</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1006%2Ffrne.1998.0170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ffrne.1998.0170%26sid%3Dliteratum%253Aachs%26aulast%3DKuiper%26aufirst%3DG.%26aulast%3DShughrue%26aufirst%3DP.%2BJ.%26aulast%3DMerchenthaler%26aufirst%3DI.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520estrogen%2520receptor%2520beta%2520subtype%253A%2520a%2520novel%2520mediator%2520of%2520estrogen%2520action%2520in%2520neuroendocrine%2520systems%26jtitle%3DFront.%2520Neuroendocrinol.%26date%3D1998%26volume%3D19%26issue%3D4%26spage%3D253%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c','cit17d'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20a','cit20b','cit20c'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 57 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yepeng Luan, Jerry Li, Jean A. Bernatchez, <span class="NLM_string-name hlFld-ContribAuthor">Rongshi Li</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3171-3183. <a href="https://doi.org/10.1021/acs.jmedchem.8b00189" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00189%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252Band%252BHistone%252BDeacetylase%252BHybrid%252BInhibitors%252Bfor%252BCancer%252BTherapy%26aulast%3DLuan%26aufirst%3DYepeng%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05022018%26date%3D16112018%26date%3D12112018%26volume%3D62%26issue%3D7%26spage%3D3171%26epage%3D3183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chu Tang, Yang Du, Qian Liang, Zhen Cheng, <span class="NLM_string-name hlFld-ContribAuthor">Jie Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Novel Ferrocenyl Histone Deacetylase Inhibitor for Triple-Negative Breast Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2018,</strong> <em>37 </em>
                                    (14)
                                     , 2368-2375. <a href="https://doi.org/10.1021/acs.organomet.8b00354" title="DOI URL">https://doi.org/10.1021/acs.organomet.8b00354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.8b00354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.8b00354%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DDevelopment%252Bof%252Ba%252BNovel%252BFerrocenyl%252BHistone%252BDeacetylase%252BInhibitor%252Bfor%252BTriple-Negative%252BBreast%252BCancer%252BTherapy%26aulast%3DTang%26aufirst%3DChu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25052018%26date%3D12072018%26volume%3D37%26issue%3D14%26spage%3D2368%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Changhao  Li</span>, <span class="hlFld-ContribAuthor ">Silong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, and <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4550-4572. <a href="https://doi.org/10.1021/acs.jmedchem.5b00099" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00099%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BBioactive%252BHybrid%252BCompound%252BDual%252BTargeting%252BEstrogen%252BReceptor%252Band%252BHistone%252BDeacetylase%252Bfor%252Bthe%252BTreatment%252Bof%252BBreast%252BCancer%26aulast%3DTang%26aufirst%3DChu%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D20012015%26date%3D02062015%26date%3D11062015%26date%3D20052015%26volume%3D58%26issue%3D11%26spage%3D4550%26epage%3D4572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feifei  Yang</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Haigang  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Ning  Liu</span>, <span class="hlFld-ContribAuthor ">Ang  Chen</span>, <span class="hlFld-ContribAuthor ">Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Jingjie  Li</span>, <span class="hlFld-ContribAuthor ">Liwen  Qin</span>, <span class="hlFld-ContribAuthor ">Beier  Jiang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiufeng  Pang</span>, <span class="hlFld-ContribAuthor ">Zhengfang  Yi</span>, <span class="hlFld-ContribAuthor ">Mingyao  Liu</span>, and <span class="hlFld-ContribAuthor ">Yihua  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Optimization of Novel Hydroxamate-Based Histone Deacetylase Inhibitors of Bis-Substituted Aromatic Amides Bearing Potent Activities against Tumor Growth and Metastasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (22)
                                     , 9357-9369. <a href="https://doi.org/10.1021/jm5012148" title="DOI URL">https://doi.org/10.1021/jm5012148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5012148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5012148%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BOptimization%252Bof%252BNovel%252BHydroxamate-Based%252BHistone%252BDeacetylase%252BInhibitors%252Bof%252BBis-Substituted%252BAromatic%252BAmides%252BBearing%252BPotent%252BActivities%252Bagainst%252BTumor%252BGrowth%252Band%252BMetastasis%26aulast%3DYang%26aufirst%3DFeifei%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24042014%26date%3D12112014%26date%3D26112014%26date%3D31102014%26volume%3D57%26issue%3D22%26spage%3D9357%26epage%3D9369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Quaovi H.  Sodji</span>, <span class="hlFld-ContribAuthor ">Vishal  Patil</span>, <span class="hlFld-ContribAuthor ">James R.  Kornacki</span>, <span class="hlFld-ContribAuthor ">Milan  Mrksich</span>, and <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationship of 3-Hydroxypyridine-2-thione-Based Histone Deacetylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (24)
                                     , 9969-9981. <a href="https://doi.org/10.1021/jm401225q" title="DOI URL">https://doi.org/10.1021/jm401225q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401225q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401225q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252B3-Hydroxypyridine-2-thione-Based%252BHistone%252BDeacetylase%252BInhibitors%26aulast%3DSodji%26aufirst%3DQuaovi%2BH.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D07082013%26date%3D12122013%26date%3D27122013%26date%3D04122013%26volume%3D56%26issue%3D24%26spage%3D9969%26epage%3D9981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Berkley E.  Gryder</span>, <span class="hlFld-ContribAuthor ">Michelle J.  Akbashev</span>, <span class="hlFld-ContribAuthor ">Michael K.  Rood</span>, <span class="hlFld-ContribAuthor ">Eric D.  Raftery</span>, <span class="hlFld-ContribAuthor ">Warren M.  Meyers</span>, <span class="hlFld-ContribAuthor ">Paulette  Dillard</span>, <span class="hlFld-ContribAuthor ">Shafiq  Khan</span>, and <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>  . </span><span class="cited-content_cbyCitation_article-title">Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (11)
                                     , 2550-2560. <a href="https://doi.org/10.1021/cb400542w" title="DOI URL">https://doi.org/10.1021/cb400542w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400542w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400542w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSelectively%252BTargeting%252BProstate%252BCancer%252Bwith%252BAntiandrogen%252BEquipped%252BHistone%252BDeacetylase%252BInhibitors%26aulast%3DGryder%26aufirst%3DBerkley%2BE.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D17072013%26date%3D04092013%26date%3D20092013%26date%3D15112013%26date%3D04092013%26volume%3D8%26issue%3D11%26spage%3D2550%26epage%3D2560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenxi  Zhao</span>, <span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Changhao  Li</span>, <span class="hlFld-ContribAuthor ">Wentao  Ning</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Lilan  Xin</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel hybrid conjugates with dual estrogen receptor α degradation and histone deacetylase inhibitory activities for breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>40 </em>, 116185. <a href="https://doi.org/10.1016/j.bmc.2021.116185" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116185%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bhybrid%252Bconjugates%252Bwith%252Bdual%252Bestrogen%252Breceptor%252B%2525CE%2525B1%252Bdegradation%252Band%252Bhistone%252Bdeacetylase%252Binhibitory%252Bactivities%252Bfor%252Bbreast%252Bcancer%252Btherapy%26aulast%3DZhao%26aufirst%3DChenxi%26date%3D2021%26volume%3D40%26spage%3D116185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurício Temotheo  Tavares</span>, <span class="hlFld-ContribAuthor ">Larissa Costa  de Almeida</span>, <span class="hlFld-ContribAuthor ">Thales  Kronenberger</span>, <span class="hlFld-ContribAuthor ">Glaucio  Monteiro Ferreira</span>, <span class="hlFld-ContribAuthor ">Thainá  Fujii de Divitiis</span>, <span class="hlFld-ContribAuthor ">Mônica  Franco Zannini Junqueira Toledo</span>, <span class="hlFld-ContribAuthor ">Neuza  Mariko Aymoto Hassimotto</span>, <span class="hlFld-ContribAuthor ">João  Agostinho Machado-Neto</span>, <span class="hlFld-ContribAuthor ">Letícia  Veras Costa-Lotufo</span>, <span class="hlFld-ContribAuthor ">Roberto  Parise-Filho</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>35 </em>, 116085. <a href="https://doi.org/10.1016/j.bmc.2021.116085" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116085%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Band%252Bmechanistic%252Bstudies%252Bfor%252Ba%252Bseries%252Bof%252Bcinnamyl%252Bhydroxamate%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DTavares%26aufirst%3DMaur%25C3%25ADcio%2BTemotheo%26date%3D2021%26volume%3D35%26spage%3D116085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Jenke</span>, <span class="hlFld-ContribAuthor ">Nina  Reßing</span>, <span class="hlFld-ContribAuthor ">Finn K.  Hansen</span>, <span class="hlFld-ContribAuthor ">Achim  Aigner</span>, <span class="hlFld-ContribAuthor ">Thomas  Büch</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 634. <a href="https://doi.org/10.3390/cancers13040634" title="DOI URL">https://doi.org/10.3390/cancers13040634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040634%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DAnticancer%252BTherapy%252Bwith%252BHDAC%252BInhibitors%25253A%252BMechanism-Based%252BCombination%252BStrategies%252Band%252BFuture%252BPerspectives%26aulast%3DJenke%26aufirst%3DRobert%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Somnath Dharmaraj  Bhagat</span>, <span class="hlFld-ContribAuthor ">Abhishek  Chanchal</span>, <span class="hlFld-ContribAuthor ">Mansi  Gujrati</span>, <span class="hlFld-ContribAuthor ">Aditi  Banerjee</span>, <span class="hlFld-ContribAuthor ">Ram Kumar  Mishra</span>, <span class="hlFld-ContribAuthor ">Aasheesh  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Implantable HDAC-inhibiting chemotherapeutics derived from hydrophobic amino acids for localized anticancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials Science</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     , 261-271. <a href="https://doi.org/10.1039/D0BM01417F" title="DOI URL">https://doi.org/10.1039/D0BM01417F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0BM01417F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0BM01417F%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%2520Science%26atitle%3DImplantable%252BHDAC-inhibiting%252Bchemotherapeutics%252Bderived%252Bfrom%252Bhydrophobic%252Bamino%252Bacids%252Bfor%252Blocalized%252Banticancer%252Btherapy%26aulast%3DBhagat%26aufirst%3DSomnath%2BDharmaraj%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1%26spage%3D261%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gargi Nikhil  Vaidya</span>, <span class="hlFld-ContribAuthor ">Pooja  Rana</span>, <span class="hlFld-ContribAuthor ">Ashwini  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Deep Rohan  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Darshan  Contractor</span>, <span class="hlFld-ContribAuthor ">Dinesh Parshuram  Satpute</span>, <span class="hlFld-ContribAuthor ">Mithilesh  Nagpure</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Paradigm shift of “classical” HDAC inhibitors to “hybrid” HDAC inhibitors in therapeutic interventions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112844. <a href="https://doi.org/10.1016/j.ejmech.2020.112844" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112844%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DParadigm%252Bshift%252Bof%252B%2525E2%252580%25259Cclassical%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bto%252B%2525E2%252580%25259Chybrid%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bin%252Btherapeutic%252Binterventions%26aulast%3DVaidya%26aufirst%3DGargi%2BNikhil%26date%3D2021%26volume%3D209%26spage%3D112844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amr K.A.  Bass</span>, <span class="hlFld-ContribAuthor ">Mona S.  El-Zoghbi</span>, <span class="hlFld-ContribAuthor ">El-Shimaa M.  Nageeb</span>, <span class="hlFld-ContribAuthor ">Mamdouh F.A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Mohamed  Badr</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112904. <a href="https://doi.org/10.1016/j.ejmech.2020.112904" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112904%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComprehensive%252Breview%252Bfor%252Banticancer%252Bhybridized%252Bmultitargeting%252BHDAC%252Binhibitors%26aulast%3DBass%26aufirst%3DAmr%2BK.A.%26date%3D2021%26volume%3D209%26spage%3D112904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subhasish  Tapadar</span>, <span class="hlFld-ContribAuthor ">Shaghayegh  Fathi</span>, <span class="hlFld-ContribAuthor ">Bocheng  Wu</span>, <span class="hlFld-ContribAuthor ">Carrie Q.  Sun</span>, <span class="hlFld-ContribAuthor ">Idris  Raji</span>, <span class="hlFld-ContribAuthor ">Samuel G.  Moore</span>, <span class="hlFld-ContribAuthor ">Rebecca S.  Arnold</span>, <span class="hlFld-ContribAuthor ">David A.  Gaul</span>, <span class="hlFld-ContribAuthor ">John A.  Petros</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>. </span><span class="cited-content_cbyCitation_article-title">Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (11)
                                     , 3095. <a href="https://doi.org/10.3390/cancers12113095" title="DOI URL">https://doi.org/10.3390/cancers12113095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12113095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12113095%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DLiver-Targeting%252BClass%252BI%252BSelective%252BHistone%252BDeacetylase%252BInhibitors%252BPotently%252BSuppress%252BHepatocellular%252BTumor%252BGrowth%252Bas%252BStandalone%252BAgents%26aulast%3DTapadar%26aufirst%3DSubhasish%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D11%26spage%3D3095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward A.  Wetzel</span>, <span class="hlFld-ContribAuthor ">Alicia M.  Hanson</span>, <span class="hlFld-ContribAuthor ">Callie L.  Troutfetter</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burkett</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Sem</span>, <span class="hlFld-ContribAuthor ">William A.  Donaldson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 17α-triazolyl and 9α-cyano derivatives of estradiol. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (19)
                                     , 115670. <a href="https://doi.org/10.1016/j.bmc.2020.115670" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115670%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B17%2525CE%2525B1-triazolyl%252Band%252B9%2525CE%2525B1-cyano%252Bderivatives%252Bof%252Bestradiol%26aulast%3DWetzel%26aufirst%3DEdward%2BA.%26date%3D2020%26volume%3D28%26issue%3D19%26spage%3D115670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Fröhlich</span>, <span class="hlFld-ContribAuthor ">Christina  Mai</span>, <span class="hlFld-ContribAuthor ">Roman P.  Bogautdinov</span>, <span class="hlFld-ContribAuthor ">Svetlana N.  Morozkina</span>, <span class="hlFld-ContribAuthor ">Alexander G.  Shavva</span>, <span class="hlFld-ContribAuthor ">Oliver  Friedrich</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Svetlana B.  Tsogoeva</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (15)
                                     , 1473-1479. <a href="https://doi.org/10.1002/cmdc.202000174" title="DOI URL">https://doi.org/10.1002/cmdc.202000174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000174%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Bof%252BTamoxifen%2525E2%252580%252590Artemisinin%252Band%252BEstrogen%2525E2%252580%252590Artemisinin%252BHybrids%252BHighly%252BPotent%252BAgainst%252BBreast%252Band%252BProstate%252BCancer%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DTony%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D15%26spage%3D1473%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Yang  Du</span>, <span class="hlFld-ContribAuthor ">Qian  Liang</span>, <span class="hlFld-ContribAuthor ">Zhen  Cheng</span>, <span class="hlFld-ContribAuthor ">Jie  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2020,</strong> <em>22 </em>
                                    (3)
                                     , 476-485. <a href="https://doi.org/10.1007/s11307-019-01389-4" title="DOI URL">https://doi.org/10.1007/s11307-019-01389-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-019-01389-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-019-01389-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DDevelopment%252Bof%252Ba%252BNovel%252BHistone%252BDeacetylase-Targeted%252BNear-Infrared%252BProbe%252Bfor%252BHepatocellular%252BCarcinoma%252BImaging%252Band%252BFluorescence%252BImage-Guided%252BSurgery%26aulast%3DTang%26aufirst%3DChu%26date%3D2020%26date%3D2019%26volume%3D22%26issue%3D3%26spage%3D476%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Caggia</span>, <span class="hlFld-ContribAuthor ">Subhasish  Tapadar</span>, <span class="hlFld-ContribAuthor ">Bocheng  Wu</span>, <span class="hlFld-ContribAuthor ">Smrruthi V.  Venugopal</span>, <span class="hlFld-ContribAuthor ">Autumn S.  Garrett</span>, <span class="hlFld-ContribAuthor ">Aditi  Kumar</span>, <span class="hlFld-ContribAuthor ">Janae S.  Stiffend</span>, <span class="hlFld-ContribAuthor ">John S.  Davis</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>, <span class="hlFld-ContribAuthor ">Shafiq A.  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors Targeting Gαi2 Protein Attenuate Migration of Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1631. <a href="https://doi.org/10.3390/cancers12061631" title="DOI URL">https://doi.org/10.3390/cancers12061631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061631%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DSmall%252BMolecule%252BInhibitors%252BTargeting%252BG%2525CE%2525B1i2%252BProtein%252BAttenuate%252BMigration%252Bof%252BCancer%252BCells%26aulast%3DCaggia%26aufirst%3DSilvia%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vânia  Camilo</span>, <span class="hlFld-ContribAuthor ">Carmen  Jerónimo</span>. </span><span class="cited-content_cbyCitation_article-title">Present and future perspectives for targeting histone modifications in therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 415-457. <a href="https://doi.org/10.1016/B978-0-12-816422-8.00018-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816422-8.00018-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816422-8.00018-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816422-8.00018-0%26sid%3Dliteratum%253Aachs%26atitle%3DPresent%252Band%252Bfuture%252Bperspectives%252Bfor%252Btargeting%252Bhistone%252Bmodifications%252Bin%252Btherapy%26aulast%3DCamilo%26aufirst%3DV%25C3%25A2nia%26date%3D2020%26spage%3D415%26epage%3D457%26pub%3DElsevier%26atitle%3DHistone%252BModifications%252Bin%252BTherapy%26date%3D2020%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Mehndiratta</span>, <span class="hlFld-ContribAuthor ">Mei-Hsiang  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Chun-Han  Chen</span>, <span class="hlFld-ContribAuthor ">Tung-Yun  Wu</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiang  Chuang</span>, <span class="hlFld-ContribAuthor ">Min-Wu  Chao</span>, <span class="hlFld-ContribAuthor ">Yi-Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111725. <a href="https://doi.org/10.1016/j.ejmech.2019.111725" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111725%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-alkyl-hydroxybenzoyl%252Banilide%252Bhydroxamates%252Bas%252Bdual%252Binhibitors%252Bof%252BHDAC%252Band%252BHSP90%25252C%252Bdownregulating%252BIFN-%2525CE%2525B3%252Binduced%252BPD-L1%252Bexpression%26aulast%3DMehndiratta%26aufirst%3DSamir%26date%3D2020%26volume%3D185%26spage%3D111725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baolei  Wang</span>, <span class="hlFld-ContribAuthor ">Xuehong  Chen</span>, <span class="hlFld-ContribAuthor ">Jianjun  Gao</span>, <span class="hlFld-ContribAuthor ">Li  Su</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongwei  Xu</span>, <span class="hlFld-ContribAuthor ">Yepeng  Luan</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2638-2645. <a href="https://doi.org/10.1016/j.bmcl.2019.07.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnti-tumor%252Bactivity%252Bevaluation%252Bof%252Bnovel%252Btubulin%252Band%252BHDAC%252Bdual-targeting%252Binhibitors%26aulast%3DWang%26aufirst%3DBaolei%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2638%26epage%3D2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahmud  Hasan</span>, <span class="hlFld-ContribAuthor ">Mohamed Akmal  Marzouk</span>, <span class="hlFld-ContribAuthor ">Saugat  Adhikari</span>, <span class="hlFld-ContribAuthor ">Thomas D.  Wright</span>, <span class="hlFld-ContribAuthor ">Benton P.  Miller</span>, <span class="hlFld-ContribAuthor ">Margarite D.  Matossian</span>, <span class="hlFld-ContribAuthor ">Steven  Elliott</span>, <span class="hlFld-ContribAuthor ">Maryl  Wright</span>, <span class="hlFld-ContribAuthor ">Madlin  Alzoubi</span>, <span class="hlFld-ContribAuthor ">Bridgette M.  Collins-Burow</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Burow</span>, <span class="hlFld-ContribAuthor ">Ulrike  Holzgrabe</span>, <span class="hlFld-ContribAuthor ">Darius P.  Zlotos</span>, <span class="hlFld-ContribAuthor ">Robert E.  Stratford</span>, <span class="hlFld-ContribAuthor ">Paula A.  Witt-Enderby</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (2)
                                     , 272-296. <a href="https://doi.org/10.1124/mol.119.116202" title="DOI URL">https://doi.org/10.1124/mol.119.116202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.116202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.116202%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DPharmacological%25252C%252BMechanistic%25252C%252Band%252BPharmacokinetic%252BAssessment%252Bof%252BNovel%252BMelatonin-Tamoxifen%252BDrug%252BConjugates%252Bas%252BBreast%252BCancer%252BDrugs%26aulast%3DHasan%26aufirst%3DMahmud%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D2%26spage%3D272%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad A.  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Hydroxamic Acid Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (9)
                                     , 978-993. <a href="https://doi.org/10.2174/1385272823666190424142821" title="DOI URL">https://doi.org/10.2174/1385272823666190424142821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190424142821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190424142821%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DMethods%252Bfor%252BHydroxamic%252BAcid%252BSynthesis%26aulast%3DAlam%26aufirst%3DMohammad%2BA.%26date%3D2019%26volume%3D23%26issue%3D9%26spage%3D978%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Yang  Du</span>, <span class="hlFld-ContribAuthor ">Qian  Liang</span>, <span class="hlFld-ContribAuthor ">Zhen  Cheng</span>, <span class="hlFld-ContribAuthor ">Jie  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">A selenium-containing selective histone deacetylase 6 inhibitor for targeted
              in vivo
              breast tumor imaging and therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2019,</strong> <em>7 </em>
                                    (22)
                                     , 3528-3536. <a href="https://doi.org/10.1039/C9TB00383E" title="DOI URL">https://doi.org/10.1039/C9TB00383E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9TB00383E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9TB00383E%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DA%252Bselenium-containing%252Bselective%252Bhistone%252Bdeacetylase%252B6%252Binhibitor%252Bfor%252Btargeted%252Bin%252Bvivo%252Bbreast%252Btumor%252Bimaging%252Band%252Btherapy%26aulast%3DTang%26aufirst%3DChu%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D22%26spage%3D3528%26epage%3D3536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rekha  Sangwan</span>, <span class="hlFld-ContribAuthor ">Remya  Rajan</span>, <span class="hlFld-ContribAuthor ">Pintu Kumar  Mandal</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 620-706. <a href="https://doi.org/10.1016/j.ejmech.2018.08.073" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.073%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHDAC%252Bas%252Bonco%252Btarget%25253A%252BReviewing%252Bthe%252Bsynthetic%252Bapproaches%252Bwith%252BSAR%252Bstudy%252Bof%252Btheir%252Binhibitors%26aulast%3DSangwan%26aufirst%3DRekha%26date%3D2018%26volume%3D158%26spage%3D620%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba M.  Hesham</span>, <span class="hlFld-ContribAuthor ">Deena S.  Lasheen</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (6)
                                     , 2058-2109. <a href="https://doi.org/10.1002/med.21505" title="DOI URL">https://doi.org/10.1002/med.21505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21505%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DChimeric%252BHDAC%252Binhibitors%25253A%252BComprehensive%252Breview%252Bon%252Bthe%252BHDAC-based%252Bstrategies%252Bdeveloped%252Bto%252Bcombat%252Bcancer%26aulast%3DHesham%26aufirst%3DHeba%2BM.%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D6%26spage%3D2058%26epage%3D2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony F.  Palermo</span>, <span class="hlFld-ContribAuthor ">Marine  Diennet</span>, <span class="hlFld-ContribAuthor ">Mohamed  El Ezzy</span>, <span class="hlFld-ContribAuthor ">Benjamin M.  Williams</span>, <span class="hlFld-ContribAuthor ">David  Cotnoir-White</span>, <span class="hlFld-ContribAuthor ">Sylvie  Mader</span>, <span class="hlFld-ContribAuthor ">James L.  Gleason</span>. </span><span class="cited-content_cbyCitation_article-title">Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen – A new hybrid design paradigm. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (15)
                                     , 4428-4440. <a href="https://doi.org/10.1016/j.bmc.2018.07.026" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.07.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.07.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIncorporation%252Bof%252Bhistone%252Bdeacetylase%252Binhibitory%252Bactivity%252Binto%252Bthe%252Bcore%252Bof%252Btamoxifen%252B%2525E2%252580%252593%252BA%252Bnew%252Bhybrid%252Bdesign%252Bparadigm%26aulast%3DPalermo%26aufirst%3DAnthony%2BF.%26date%3D2018%26volume%3D26%26issue%3D15%26spage%3D4428%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ka  Yang</span>, <span class="hlFld-ContribAuthor ">Yanling  Song</span>, <span class="hlFld-ContribAuthor ">Haibo  Xie</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Yi-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Eric D.  Leisten</span>, <span class="hlFld-ContribAuthor ">Weiping  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of the first small molecule histone deacetylase 6 (HDAC6) degraders. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (14)
                                     , 2493-2497. <a href="https://doi.org/10.1016/j.bmcl.2018.05.057" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bthe%252Bfirst%252Bsmall%252Bmolecule%252Bhistone%252Bdeacetylase%252B6%252B%252528HDAC6%252529%252Bdegraders%26aulast%3DYang%26aufirst%3DKa%26date%3D2018%26volume%3D28%26issue%3D14%26spage%3D2493%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahmud  Hasan</span>, <span class="hlFld-ContribAuthor ">Rehana K.  Leak</span>, <span class="hlFld-ContribAuthor ">Robert E.  Stratford</span>, <span class="hlFld-ContribAuthor ">Darius P.  Zlotos</span>, <span class="hlFld-ContribAuthor ">Paula A.  Witt-Enderby</span>. </span><span class="cited-content_cbyCitation_article-title">Drug conjugates-an emerging approach to treat breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2018,</strong> <em>6 </em>
                                    (4)
                                     , e00417. <a href="https://doi.org/10.1002/prp2.417" title="DOI URL">https://doi.org/10.1002/prp2.417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.417%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DDrug%252Bconjugates-an%252Bemerging%252Bapproach%252Bto%252Btreat%252Bbreast%252Bcancer%26aulast%3DHasan%26aufirst%3DMahmud%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D4%26spage%3De00417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Hydroxamates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 435-480. <a href="https://doi.org/10.1002/9781118686263.ch12" title="DOI URL">https://doi.org/10.1002/9781118686263.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DHydroxamates%26date%3D2018%26date%3D2018%26spage%3D435%26epage%3D480%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander M.  Scherbakov</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Komkov</span>, <span class="hlFld-ContribAuthor ">Anna S.  Komendantova</span>, <span class="hlFld-ContribAuthor ">Margarita A.  Yastrebova</span>, <span class="hlFld-ContribAuthor ">Olga E.  Andreeva</span>, <span class="hlFld-ContribAuthor ">Valerii Z.  Shirinian</span>, <span class="hlFld-ContribAuthor ">Alakananda  Hajra</span>, <span class="hlFld-ContribAuthor ">Igor V.  Zavarzin</span>, <span class="hlFld-ContribAuthor ">Yulia A.  Volkova</span>. </span><span class="cited-content_cbyCitation_article-title">Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>8 </em><a href="https://doi.org/10.3389/fphar.2017.00979" title="DOI URL">https://doi.org/10.3389/fphar.2017.00979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2017.00979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2017.00979%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DSteroidal%252BPyrimidines%252Band%252BDihydrotriazines%252Bas%252BNovel%252BClasses%252Bof%252BAnticancer%252BAgents%252Bagainst%252BHormone-Dependent%252BBreast%252BCancer%252BCells%26aulast%3DScherbakov%26aufirst%3DAlexander%2BM.%26date%3D2018%26date%3D2018%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Hu</span>, <span class="hlFld-ContribAuthor ">Jian  Zhao</span>, <span class="hlFld-ContribAuthor ">Wuyang  Hua</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">A study on platinum(
              iv
              ) species containing an estrogen receptor modulator to reverse tamoxifen resistance of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Metallomics</span><span> <strong>2018,</strong> <em>10 </em>
                                    (2)
                                     , 346-359. <a href="https://doi.org/10.1039/C7MT00289K" title="DOI URL">https://doi.org/10.1039/C7MT00289K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MT00289K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MT00289K%26sid%3Dliteratum%253Aachs%26jtitle%3DMetallomics%26atitle%3DA%252Bstudy%252Bon%252Bplatinum%252528%252Biv%252B%252529%252Bspecies%252Bcontaining%252Ban%252Bestrogen%252Breceptor%252Bmodulator%252Bto%252Breverse%252Btamoxifen%252Bresistance%252Bof%252Bbreast%252Bcancer%26aulast%3DHu%26aufirst%3DWeiwei%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D346%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoye  Jiang</span>, <span class="hlFld-ContribAuthor ">Shiyou  Sun</span>, <span class="hlFld-ContribAuthor ">Yongqiong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel quinolone derivatives dual targeting histone deacetylase and tubulin polymerization as antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (30)
                                     , 16494-16502. <a href="https://doi.org/10.1039/C8RA02578A" title="DOI URL">https://doi.org/10.1039/C8RA02578A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA02578A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA02578A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bquinolone%252Bderivatives%252Bdual%252Btargeting%252Bhistone%252Bdeacetylase%252Band%252Btubulin%252Bpolymerization%252Bas%252Bantiproliferative%252Bagents%26aulast%3DWang%26aufirst%3DXuan%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D30%26spage%3D16494%26epage%3D16502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Li</span>, <span class="hlFld-ContribAuthor ">Syed M.  Meeran</span>, <span class="hlFld-ContribAuthor ">Trygve O.  Tollefsbol</span>. </span><span class="cited-content_cbyCitation_article-title">Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-09764-3" title="DOI URL">https://doi.org/10.1038/s41598-017-09764-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-09764-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-09764-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCombinatorial%252Bbioactive%252Bbotanicals%252Bre-sensitize%252Btamoxifen%252Btreatment%252Bin%252BER-negative%252Bbreast%252Bcancer%252Bvia%252Bepigenetic%252Breactivation%252Bof%252BER%2525CE%2525B1%252Bexpression%26aulast%3DLi%26aufirst%3DYuanyuan%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong-geng  Fu</span>, <span class="hlFld-ContribAuthor ">Yuan  Sun</span>, <span class="hlFld-ContribAuthor ">Wen-bing  Sheng</span>, <span class="hlFld-ContribAuthor ">Duan-fang  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Designing multi-targeted agents: An emerging anticancer drug discovery paradigm. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>136 </em>, 195-211. <a href="https://doi.org/10.1016/j.ejmech.2017.05.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252Bmulti-targeted%252Bagents%25253A%252BAn%252Bemerging%252Banticancer%252Bdrug%252Bdiscovery%252Bparadigm%26aulast%3DFu%26aufirst%3DRong-geng%26date%3D2017%26volume%3D136%26spage%3D195%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Changhao  Li</span>, <span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Kathryn E.  Carlson</span>, <span class="hlFld-ContribAuthor ">Junjie  Luo</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">John A.  Katzenellenbogen</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (3)
                                     , 235-249. <a href="https://doi.org/10.1002/cmdc.201600593" title="DOI URL">https://doi.org/10.1002/cmdc.201600593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600593%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSelenophenes%25253A%252BIntroducing%252Ba%252BNew%252BElement%252Binto%252Bthe%252BCore%252Bof%252BNon-Steroidal%252BEstrogen%252BReceptor%252BLigands%26aulast%3DZhang%26aufirst%3DSilong%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D3%26spage%3D235%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Idris  Raji</span>, <span class="hlFld-ContribAuthor ">Fatima  Yadudu</span>, <span class="hlFld-ContribAuthor ">Emily  Janeira</span>, <span class="hlFld-ContribAuthor ">Shaghayegh  Fathi</span>, <span class="hlFld-ContribAuthor ">Lindsey  Szymczak</span>, <span class="hlFld-ContribAuthor ">James Richard  Kornacki</span>, <span class="hlFld-ContribAuthor ">Kensei  Komatsu</span>, <span class="hlFld-ContribAuthor ">Jian-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Milan  Mrksich</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional conjugates with potent inhibitory activity towards cyclooxygenase and histone deacetylase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 1202-1218. <a href="https://doi.org/10.1016/j.bmc.2016.12.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.12.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.12.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252Bconjugates%252Bwith%252Bpotent%252Binhibitory%252Bactivity%252Btowards%252Bcyclooxygenase%252Band%252Bhistone%252Bdeacetylase%26aulast%3DRaji%26aufirst%3DIdris%26date%3D2017%26volume%3D25%26issue%3D3%26spage%3D1202%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ding</span>, <span class="hlFld-ContribAuthor ">Shaopeng  Chen</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Guangnan  Hu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lulu  Li</span>, <span class="hlFld-ContribAuthor ">Yu Zong  Chen</span>, <span class="hlFld-ContribAuthor ">Chunyan  Tan</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 27-37. <a href="https://doi.org/10.1016/j.bmc.2016.10.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Binvestigation%252Bof%252Bnovel%252B6-%2525281%25252C2%25252C3-triazol-4-yl%252529-4-aminoquinazolin%252Bderivatives%252Bpossessing%252Bhydroxamic%252Bacid%252Bmoiety%252Bfor%252Bcancer%252Btherapy%26aulast%3DDing%26aufirst%3DChao%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikrant  Abbot</span>, <span class="hlFld-ContribAuthor ">Poonam  Sharma</span>, <span class="hlFld-ContribAuthor ">Saurabh  Dhiman</span>, <span class="hlFld-ContribAuthor ">Malleshappa N.  Noolvi</span>, <span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Varun  Bhardwaj</span>. </span><span class="cited-content_cbyCitation_article-title">Small hybrid heteroaromatics: resourceful biological tools in cancer research. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (45)
                                     , 28313-28349. <a href="https://doi.org/10.1039/C6RA24662A" title="DOI URL">https://doi.org/10.1039/C6RA24662A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA24662A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA24662A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSmall%252Bhybrid%252Bheteroaromatics%25253A%252Bresourceful%252Bbiological%252Btools%252Bin%252Bcancer%252Bresearch%26aulast%3DAbbot%26aufirst%3DVikrant%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D45%26spage%3D28313%26epage%3D28349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudhan  Debnath</span>, <span class="hlFld-ContribAuthor ">Tanusree  Debnath</span>, <span class="hlFld-ContribAuthor ">Swapan  Majumdar</span>, <span class="hlFld-ContribAuthor ">M. K.  Arunasree</span>, <span class="hlFld-ContribAuthor ">Vema  Aparna</span>. </span><span class="cited-content_cbyCitation_article-title">A combined pharmacophore modeling, 3D QSAR, virtual screening, molecular docking, and ADME studies to identify potential HDAC8 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2016,</strong> <em>25 </em>
                                    (11)
                                     , 2434-2450. <a href="https://doi.org/10.1007/s00044-016-1652-5" title="DOI URL">https://doi.org/10.1007/s00044-016-1652-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-016-1652-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-016-1652-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DA%252Bcombined%252Bpharmacophore%252Bmodeling%25252C%252B3D%252BQSAR%25252C%252Bvirtual%252Bscreening%25252C%252Bmolecular%252Bdocking%25252C%252Band%252BADME%252Bstudies%252Bto%252Bidentify%252Bpotential%252BHDAC8%252Binhibitors%26aulast%3DDebnath%26aufirst%3DSudhan%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D11%26spage%3D2434%26epage%3D2450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajinkya A.  Patravale</span>, <span class="hlFld-ContribAuthor ">Anil H.  Gore</span>, <span class="hlFld-ContribAuthor ">Govind B.  Kolekar</span>, <span class="hlFld-ContribAuthor ">Madhukar B.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Prafulla B.  Choudhari</span>, <span class="hlFld-ContribAuthor ">Manish S.  Bhatia</span>, <span class="hlFld-ContribAuthor ">Shivadatta  Prabhu</span>, <span class="hlFld-ContribAuthor ">Mahendra D.  Jamdhade</span>, <span class="hlFld-ContribAuthor ">Milind S.  Patole</span>, <span class="hlFld-ContribAuthor ">Prashant V.  Anbhule</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular docking studies of some novel indenospiro derivatives as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Taiwan Institute of Chemical Engineers</span><span> <strong>2016,</strong> <em>68 </em>, 105-118. <a href="https://doi.org/10.1016/j.jtice.2016.09.034" title="DOI URL">https://doi.org/10.1016/j.jtice.2016.09.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtice.2016.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtice.2016.09.034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Taiwan%2520Institute%2520of%2520Chemical%2520Engineers%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bsome%252Bnovel%252Bindenospiro%252Bderivatives%252Bas%252Banticancer%252Bagents%26aulast%3DPatravale%26aufirst%3DAjinkya%2BA.%26date%3D2016%26volume%3D68%26spage%3D105%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joëlle  Roche</span>, <span class="hlFld-ContribAuthor ">Philippe  Bertrand</span>. </span><span class="cited-content_cbyCitation_article-title">Inside HDACs with more selective HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 451-483. <a href="https://doi.org/10.1016/j.ejmech.2016.05.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInside%252BHDACs%252Bwith%252Bmore%252Bselective%252BHDAC%252Binhibitors%26aulast%3DRoche%26aufirst%3DJo%25C3%25ABlle%26date%3D2016%26volume%3D121%26spage%3D451%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yixuan  Li</span>, <span class="hlFld-ContribAuthor ">Edward  Seto</span>. </span><span class="cited-content_cbyCitation_article-title">HDACs and HDAC Inhibitors in Cancer Development and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Medicine</span><span> <strong>2016,</strong> <em>6 </em>
                                    (10)
                                     , a026831. <a href="https://doi.org/10.1101/cshperspect.a026831" title="DOI URL">https://doi.org/10.1101/cshperspect.a026831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a026831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a026831%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Medicine%26atitle%3DHDACs%252Band%252BHDAC%252BInhibitors%252Bin%252BCancer%252BDevelopment%252Band%252BTherapy%26aulast%3DLi%26aufirst%3DYixuan%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D10%26spage%3Da026831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian-Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Rong  Chai</span>, <span class="hlFld-ContribAuthor ">Yan-Long  Jia</span>, <span class="hlFld-ContribAuthor ">Jian-Hui  Gao</span>, <span class="hlFld-ContribAuthor ">Xiao-Jun  Peng</span>, <span class="hlFld-ContribAuthor ">Hua-Feng  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Crosstalk among the proteome, lysine phosphorylation, and acetylation in romidepsin-treated colon cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (33)
                                     , 53471-53501. <a href="https://doi.org/10.18632/oncotarget.10840" title="DOI URL">https://doi.org/10.18632/oncotarget.10840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.10840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.10840%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCrosstalk%252Bamong%252Bthe%252Bproteome%25252C%252Blysine%252Bphosphorylation%25252C%252Band%252Bacetylation%252Bin%252Bromidepsin-treated%252Bcolon%252Bcancer%252Bcells%26aulast%3DWang%26aufirst%3DTian-Yun%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D33%26spage%3D53471%26epage%3D53501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changhao  Li</span>, <span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Chenxi  Zhao</span>, <span class="hlFld-ContribAuthor ">Chenlu  Li</span>, <span class="hlFld-ContribAuthor ">Silong  Zhang</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of novel hybrid ferrocenyl compounds based on a bicyclic core skeleton for breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (13)
                                     , 3062-3074. <a href="https://doi.org/10.1016/j.bmc.2016.05.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnovel%252Bhybrid%252Bferrocenyl%252Bcompounds%252Bbased%252Bon%252Ba%252Bbicyclic%252Bcore%252Bskeleton%252Bfor%252Bbreast%252Bcancer%252Btherapy%26aulast%3DLi%26aufirst%3DChanghao%26date%3D2016%26volume%3D24%26issue%3D13%26spage%3D3062%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyu  Wang</span>, <span class="hlFld-ContribAuthor ">Shixiang  Sun</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, . </span><span class="cited-content_cbyCitation_article-title">Randomness in Sequence Evolution Increases over Time. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (5)
                                     , e0155935. <a href="https://doi.org/10.1371/journal.pone.0155935" title="DOI URL">https://doi.org/10.1371/journal.pone.0155935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0155935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0155935%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DRandomness%252Bin%252BSequence%252BEvolution%252BIncreases%252Bover%252BTime%26aulast%3DWang%26aufirst%3DGuangyu%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D5%26spage%3De0155935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feifei  Yang</span>, <span class="hlFld-ContribAuthor ">Shihong  Peng</span>, <span class="hlFld-ContribAuthor ">Yunqi  Li</span>, <span class="hlFld-ContribAuthor ">Liqiang  Su</span>, <span class="hlFld-ContribAuthor ">Yangrui  Peng</span>, <span class="hlFld-ContribAuthor ">Jing  Wu</span>, <span class="hlFld-ContribAuthor ">Huang  Chen</span>, <span class="hlFld-ContribAuthor ">Mingyao  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengfang  Yi</span>, <span class="hlFld-ContribAuthor ">Yihua  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (5)
                                     , 1727-1735. <a href="https://doi.org/10.1039/C5OB02250A" title="DOI URL">https://doi.org/10.1039/C5OB02250A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02250A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02250A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bhybrid%252Bof%252Bthiazolidinone%252Bwith%252Bthe%252Bhydroxamate%252Bscaffold%252Bfor%252Bdeveloping%252Bnovel%252Bhistone%252Bdeacetylase%252Binhibitors%252Bwith%252Bantitumor%252Bactivities%26aulast%3DYang%26aufirst%3DFeifei%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D5%26spage%3D1727%26epage%3D1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Mendoza-Sanchez</span>, <span class="hlFld-ContribAuthor ">David  Cotnoir-White</span>, <span class="hlFld-ContribAuthor ">Justyna  Kulpa</span>, <span class="hlFld-ContribAuthor ">Isabel  Jutras</span>, <span class="hlFld-ContribAuthor ">Joshua  Pottel</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>, <span class="hlFld-ContribAuthor ">Sylvie  Mader</span>, <span class="hlFld-ContribAuthor ">James L.  Gleason</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (24)
                                     , 7597-7606. <a href="https://doi.org/10.1016/j.bmc.2015.11.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bantiestrogen%252Band%252Bhistone%252Bdeacetylase%252Binhibitor%252Bmolecular%252Bhybrids%26aulast%3DMendoza-Sanchez%26aufirst%3DRodrigo%26date%3D2015%26volume%3D23%26issue%3D24%26spage%3D7597%26epage%3D7606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minghong  Ni</span>, <span class="hlFld-ContribAuthor ">Emiliano  Esposito</span>, <span class="hlFld-ContribAuthor ">Victor Paul  Raj</span>, <span class="hlFld-ContribAuthor ">Laura  Muzi</span>, <span class="hlFld-ContribAuthor ">Franco  Zunino</span>, <span class="hlFld-ContribAuthor ">Valentina  Zuco</span>, <span class="hlFld-ContribAuthor ">Denis  Cominetti</span>, <span class="hlFld-ContribAuthor ">Sergio  Penco</span>, <span class="hlFld-ContribAuthor ">Alma  Dal Pozzo</span>. </span><span class="cited-content_cbyCitation_article-title">New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (21)
                                     , 6785-6793. <a href="https://doi.org/10.1016/j.bmc.2015.10.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bmacrocyclic%252Banalogs%252Bof%252Bthe%252Bnatural%252Bhistone%252Bdeacetylase%252Binhibitor%252BFK228%25253B%252Bdesign%25252C%252Bsynthesis%252Band%252Bpreliminary%252Bbiological%252Bevaluation%26aulast%3DNi%26aufirst%3DMinghong%26date%3D2015%26volume%3D23%26issue%3D21%26spage%3D6785%26epage%3D6793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Ho  Seo</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Inhibitors Against Topoisomerases and Histone Deacetylases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Prevention</span><span> <strong>2015,</strong> <em>20 </em>
                                    (2)
                                     , 85-91. <a href="https://doi.org/10.15430/JCP.2015.20.2.85" title="DOI URL">https://doi.org/10.15430/JCP.2015.20.2.85</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15430/JCP.2015.20.2.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15430%2FJCP.2015.20.2.85%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Prevention%26atitle%3DDual%252BInhibitors%252BAgainst%252BTopoisomerases%252Band%252BHistone%252BDeacetylases%26aulast%3DSeo%26aufirst%3DYoung%2BHo%26date%3D2015%26volume%3D20%26issue%3D2%26spage%3D85%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Quaovi H.  Sodji</span>, <span class="hlFld-ContribAuthor ">James R.  Kornacki</span>, <span class="hlFld-ContribAuthor ">John F.  McDonald</span>, <span class="hlFld-ContribAuthor ">Milan  Mrksich</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>. </span><span class="cited-content_cbyCitation_article-title">Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>96 </em>, 340-359. <a href="https://doi.org/10.1016/j.ejmech.2015.04.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.04.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.04.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bstructure%252Bactivity%252Brelationship%252Bof%252Btumor-homing%252Bhistone%252Bdeacetylase%252Binhibitors%252Bconjugated%252Bto%252Bfolic%252Band%252Bpteroic%252Bacids%26aulast%3DSodji%26aufirst%3DQuaovi%2BH.%26date%3D2015%26volume%3D96%26spage%3D340%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James I  MacDonald</span>, <span class="hlFld-ContribAuthor ">Henrik K  Munch</span>, <span class="hlFld-ContribAuthor ">Troy  Moore</span>, <span class="hlFld-ContribAuthor ">Matthew B  Francis</span>. </span><span class="cited-content_cbyCitation_article-title">One-step site-specific modification of native proteins with 2-pyridinecarboxyaldehydes. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (5)
                                     , 326-331. <a href="https://doi.org/10.1038/nchembio.1792" title="DOI URL">https://doi.org/10.1038/nchembio.1792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.1792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.1792%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DOne-step%252Bsite-specific%252Bmodification%252Bof%252Bnative%252Bproteins%252Bwith%252B2-pyridinecarboxyaldehydes%26aulast%3DMacDonald%26aufirst%3DJames%2BI%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D5%26spage%3D326%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katharina  Mahal</span>, <span class="hlFld-ContribAuthor ">Sebastian  Schruefer</span>, <span class="hlFld-ContribAuthor ">Gustav  Steinemann</span>, <span class="hlFld-ContribAuthor ">Franziska  Rausch</span>, <span class="hlFld-ContribAuthor ">Rainer  Schobert</span>, <span class="hlFld-ContribAuthor ">Bernhard  Biersack</span>, <span class="hlFld-ContribAuthor ">Michael  Höpfner</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation of 4,5-diarylimidazoles with hydroxamic acid appendages as novel dual mode anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2015,</strong> <em>75 </em>
                                    (4)
                                     , 691-700. <a href="https://doi.org/10.1007/s00280-015-2685-z" title="DOI URL">https://doi.org/10.1007/s00280-015-2685-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-015-2685-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-015-2685-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DBiological%252Bevaluation%252Bof%252B4%25252C5-diarylimidazoles%252Bwith%252Bhydroxamic%252Bacid%252Bappendages%252Bas%252Bnovel%252Bdual%252Bmode%252Banticancer%252Bagents%26aulast%3DMahal%26aufirst%3DKatharina%26date%3D2015%26date%3D2015%26volume%3D75%26issue%3D4%26spage%3D691%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yantao  Han</span>, <span class="hlFld-ContribAuthor ">Qixiao  Jiang</span>, <span class="hlFld-ContribAuthor ">Chunbo  Wang</span>, <span class="hlFld-ContribAuthor ">Xuehong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Li</span>, <span class="hlFld-ContribAuthor ">Fuming  Xu</span>, <span class="hlFld-ContribAuthor ">Yuqi  Jiang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (1)
                                     , 63-84. <a href="https://doi.org/10.1002/med.21320" title="DOI URL">https://doi.org/10.1002/med.21320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21320%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTrend%252Bof%252BHistone%252BDeacetylase%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BIsoform%252BSelectivity%252Bor%252BMultitargeted%252BStrategy%26aulast%3DZhang%26aufirst%3DLei%26date%3D2015%26date%3D2014%26volume%3D35%26issue%3D1%26spage%3D63%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katrina J.  Falkenberg</span>, <span class="hlFld-ContribAuthor ">Ricky W.  Johnstone</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (9)
                                     , 673-691. <a href="https://doi.org/10.1038/nrd4360" title="DOI URL">https://doi.org/10.1038/nrd4360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4360%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DHistone%252Bdeacetylases%252Band%252Btheir%252Binhibitors%252Bin%252Bcancer%25252C%252Bneurological%252Bdiseases%252Band%252Bimmune%252Bdisorders%26aulast%3DFalkenberg%26aufirst%3DKatrina%2BJ.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D9%26spage%3D673%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiu  Tan</span>, <span class="hlFld-ContribAuthor ">Zhitao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Hui</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (1)
                                     , 358-365. <a href="https://doi.org/10.1016/j.bmc.2013.11.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivities%252Bof%252Bthieno%25255B3%25252C2-d%25255Dpyrimidines%252Bas%252Bnovel%252BHDAC%252Binhibitors%26aulast%3DTan%26aufirst%3DQiu%26date%3D2014%26volume%3D22%26issue%3D1%26spage%3D358%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin  Bao</span>, <span class="hlFld-ContribAuthor ">Xiuhua  Yu</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Qingqing  Huang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Li  Sheng</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Xiongwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (22)
                                     , 6981-6995. <a href="https://doi.org/10.1016/j.bmc.2013.09.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bdual%252Binhibitors%252Bof%252Btopoisomerase%252Bii%252Band%252Bhistone%252Bdeacetylase%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2013%26volume%3D21%26issue%3D22%26spage%3D6981%26epage%3D6995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of dual-acting ER ligand–HDACi conjugates. (A) Crystal structures of antagonist tamoxifen (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT">3ERT</a>, blue) and agonist TFMPV-E2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>, teal) bound to ERα, and molecular determinants of agonism or antagonism for E2 and tamoxifen scaffolds. (B) EED/Tamoxifen–HDACi conjugates, with SAHA bound to HDAC (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZZ1">1ZZ1</a>, gold) showing the solvent exposed cap group for chemical modification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of EED Based Conjugates (<b>1a</b>–<b>e</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, DIPEA, DMSO, argon, rt, 18 h; (b) TFA, TIPS, DCM, rt, 15 min.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Tam-HDACi (<b>3</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TMSCl, pyridine, DMAP; (b) MsCl, DCM, TEA; (c) DIPEA, DMSO; (d) aq NH<sub>2</sub>OH, KCN, THF, MeOH.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Triazole Containing Tam-HDACi (<b>2</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIPEA, DMSO, 80 °C; (b) CuI, DIPEA, THF; (c) aq NH<sub>2</sub>OH, KCN, THF, MeOH.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HDACi conjugates exhibit either ERα agonist or antagonist activity. Agonist activity (fold activation, relative to control no drug) was measured at 10 μM. Antagonist activity was measured by competition with 300 pM estradiol. Dose response curves for antagonist effect are shown for Tam-HDACi only, as EED-HDACi showed no antagonist activity at any concentration. All cells were grown in charcoal stripped serum. Antagonist dose response inset is a representative single experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures agonist bound ERα <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> (A), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT">2YAT</a> (B), and antagonist bound <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT">3ERT</a> (C) were used in docking analysis of dual ER modulator/HDACi compounds. Their original ligands are shown in dark blue–purple, and helix-12 in red. (D) Binding affinities (BA) calculated for <b>1a</b>–<b>e</b> (EED-HDACi, cyan), <b>2</b>, <b>3</b> (Tam-HDACi, orange), and their hydroxylated metabolites (<b>2</b>-<b>OH</b> and <b>3</b>-<b>OH</b>). Only the highest ranked poses with strongest BA were selected. Poses where the EED or tamoxifen moiety is in the ligand binding domain are shown as thicker molecules, and poses where they are outside the pocket are shown as thin lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In silico docking results of coiled (A, magenta) and extended (B, pink) conformations of the HDACi alkyl chain, inside the ligand binding pocket of ERα (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>). Critical hydrogen bonding residues are labeled. Helix-12 (H12) is highlighted in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ERα and ERβ agonist activity measured in HEK-luciferase assay. (A) EED-HDACi, E2 (estradiol), and EED (ethinylestradiol) show varying degrees of agonist activity. Gray dotted line indicates basal level threshold. Doses are 10 μM. (B) The ratio of ERα to ERβ agonist activity. (C) Compound <b>1c</b> docked into both ERα (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a>, purple) and ERβ (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15">2P15</a> derived homology model, blue), with arrows indicating Met-421 (ERα) substitution with Ile-373 (ERβ) and the resulting expansion of hydrophobic space.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. EED-HDACi, Tam-HDACi, and SAHA tested for inhibition of HDAC isoforms 1, 6, and 8. ND, not determinable, up to maximum concentrations tested (100 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/medium/jm-2013-00467w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cell-type selective antiproliferative activity of ER ligand–HDACi. (A) Whole cell antiproliferative activity (IC<sub>50</sub>, μM) measured 72 h after drug dosing, across ERα+/β+ (MCF-7) and ERα–/β– (MDA-MB-231) breast cancer, metastatic prostate cancer (DU-145), and healthy kidney epithelial cells (VERO). (B) Dose response curves for antiproliferative activity of SAHA and Tam-HDACi compound <b>3</b> against ER+ (MCF-7) and ER– (MDA-MB-231) breast cancer cells. (C) In vitro therapeutic index of EED-HDACi <b>1a</b>, Tam-HDACi <b>2</b> and <b>3</b>, SAHA, and tamoxifen. IC<sub>50</sub> values are an average of at least two independent experiments, ± standard deviation. <sup><i>a</i></sup>Not determinable, IC<sub>50</sub> greater than 40 μM or <sup><i>b</i></sup>greater than 20 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400467w/production/images/large/jm-2013-00467w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400467w&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lehrmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel-Bellan, A.</span><span> </span><span class="NLM_article-title">Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=41-65&author=H.+Lehrmannauthor=L.+L.+Pritchardauthor=A.+Harel-Bellan&title=Histone+acetyltransferases+and+deacetylases+in+the+control+of+cell+proliferation+and+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehrmann%26aufirst%3DH.%26aulast%3DPritchard%26aufirst%3DL.%2BL.%26aulast%3DHarel-Bellan%26aufirst%3DA.%26atitle%3DHistone%2520acetyltransferases%2520and%2520deacetylases%2520in%2520the%2520control%2520of%2520cell%2520proliferation%2520and%2520differentiation%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2002%26volume%3D86%26spage%3D41%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer: causes and therapies</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1038%2F35106079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=11902574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=194-202&issue=3&author=P.+Marksauthor=R.+A.+Rifkindauthor=V.+M.+Richonauthor=R.+Breslowauthor=T.+Millerauthor=W.+K.+Kelly&title=Histone+deacetylases+and+cancer%3A+causes+and+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer: causes and therapies</span></div><div class="casAuthors">Marks, Paul A.; Rifkind, Richard A.; Richon, Victoria M.; Breslow, Ronald; Miller, Thomas; Kelly, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Together, histone acetyltransferases and histone deacetylases (HDACs) det. the acetylation status of histones.  This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumors cells by altering the transcription of a small no. of genes.  HDAC inhibitors are proving to be an exciting therapeutic approach to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNXyL8yvd0OrVg90H21EOLACvtfcHk0lgOWzILpQ0YIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D&md5=ea50a1a72a6df9ea3a0e1a6a0d5cda5e</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2F35106079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106079%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%253A%2520causes%2520and%2520therapies%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26issue%3D3%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bolden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Anticancer activities of histone deacetylase inhibitors</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=769-784&issue=9&author=J.+E.+Boldenauthor=M.+J.+Peartauthor=R.+W.+Johnstone&title=Anticancer+activities+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolden%26aufirst%3DJ.%2BE.%26aulast%3DPeart%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DAnticancer%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D9%26spage%3D769%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gryder, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodji, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.4155%2Ffmc.12.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22416777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=505-524&issue=4&author=B.+E.+Gryderauthor=Q.+H.+Sodjiauthor=A.+K.+Oyelere&title=Targeted+cancer+therapy%3A+giving+histone+deacetylase+inhibitors+all+they+need+to+succeed"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span></div><div class="casAuthors">Gryder, Berkley E.; Sodji, Quaovi H.; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-524</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of small-mol. therapeutics acting through the regulation of the acetylation states of histone proteins (a form of epigenetic modulation) and other non-histone protein targets.  Over 490 clin. trials have been initiated in the last 10 years, culminating in the approval of two structurally distinct HDACis-SAHA (vorinostat, Zolinza) and FK228 (romidepsin, Istodax).  However, the current HDACis have serious limitations, including ineffectively low concns. in solid tumors and cardiac toxicity, which is hindering their progress in the clinic.  Herein, we review the primary paradigms being pursued to overcome these hindrances, including HDAC isoform selectivity, localized administration, and targeting cap groups to achieve selective tissue and cell type distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwrW1IVCIULVg90H21EOLACvtfcHk0ljDppKWgsxb4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D&md5=234080d1b0862680a68062a03afee20c</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.3%26sid%3Dliteratum%253Aachs%26aulast%3DGryder%26aufirst%3DB.%2BE.%26aulast%3DSodji%26aufirst%3DQ.%2BH.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DTargeted%2520cancer%2520therapy%253A%2520giving%2520histone%2520deacetylase%2520inhibitors%2520all%2520they%2520need%2520to%2520succeed%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26issue%3D4%26spage%3D505%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. S.</span><span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors: Potential in Cancer Therapy</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2009&pages=600-608&issue=4&author=P.+A.+Marksauthor=W.+S.+Xu&title=Histone+Deacetylase+Inhibitors%3A+Potential+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DXu%26aufirst%3DW.%2BS.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%253A%2520Potential%2520in%2520Cancer%2520Therapy%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2009%26volume%3D107%26issue%3D4%26spage%3D600%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gryder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span> </span><span class="NLM_article-title">Biosemiotic Entropy of the Genome: Mutations and Epigenetic Imbalances Resulting in Cancer</span> <span class="citation_source-journal">Entropy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=234-261&issue=1&author=B.+Gryderauthor=C.+Nelsonauthor=S.+Shepard&title=Biosemiotic+Entropy+of+the+Genome%3A+Mutations+and+Epigenetic+Imbalances+Resulting+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGryder%26aufirst%3DB.%26aulast%3DNelson%26aufirst%3DC.%26aulast%3DShepard%26aufirst%3DS.%26atitle%3DBiosemiotic%2520Entropy%2520of%2520the%2520Genome%253A%2520Mutations%2520and%2520Epigenetic%2520Imbalances%2520Resulting%2520in%2520Cancer%26jtitle%3DEntropy%26date%3D2013%26volume%3D15%26issue%3D1%26spage%3D234%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span> </span><span class="NLM_article-title">Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=21455583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVWhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1677-1681&issue=6&author=S.+Y.+Parkauthor=J.+A.+Junauthor=K.+T.+Jeongauthor=H.+J.+Heoauthor=J.+S.+Sohnauthor=H.+Y.+Leeauthor=C.+G.+Parkauthor=J.+Kang&title=Histone+deacetylases+1%2C+6+and+8+are+critical+for+invasion+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer</span></div><div class="casAuthors">Park, Soon Young; Jun, Ji Ae; Jeong, Kang Jin; Heo, Hoi Jeong; Sohn, Jang Sihn; Lee, Hoi Young; Park, Chang Gyo; Kang, Jaeku</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1677-1681</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are assocd. with the development and progression of cancer, but it is not known which of the HDAC isoforms play important roles in breast cancer metastasis.  This study identified the specific HDAC isoforms that are necessary for invasion and/or migration in human breast cancer cell lines.  MDA-MB-231 cells were significantly more invasive and expressed higher levels of matrix metalloproteinase-9 (MMP-9) compared to MCF-7 cells.  We compared the expression of HDAC isoforms between MCF-7 and MDA-MB-231 cells and found greater expression of HDAC4, 6 and 8 in MDA-MB-231 cells by RT-PCR and Western blot analyses.  In addn., apicidin, a histone deacetylase inhibitor, was shown to attenuate the invasion, migration and MMP-9 expression in MDA-MB-231 cells.  Using specific siRNAs directed against HDAC1, 4, 6 and 8, we show that inhibition of HDAC1,6 and 8, but not HDAC4, are responsible for invasion and MMP-9 expression in MDA-MB-231 cells.  We analyzed the invasiveness of MCF-7 cells overexpressing HDAC1, 4, 6 or 8 and found that overexpression of HDAC1, 6 or 8 increased invasion and MMP-9 expression.  By developing HDAC isoforms as potential biomarkers for breast cancer metastasis, the present study can be extended to developing therapies for breast cancer invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFSJ-L_l4YjLVg90H21EOLACvtfcHk0ljDppKWgsxb4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVWhtLs%253D&md5=ad1df87a667af5e0c4bb325c6c94a9e5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DJun%26aufirst%3DJ.%2BA.%26aulast%3DJeong%26aufirst%3DK.%2BT.%26aulast%3DHeo%26aufirst%3DH.%2BJ.%26aulast%3DSohn%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DC.%2BG.%26aulast%3DKang%26aufirst%3DJ.%26atitle%3DHistone%2520deacetylases%25201%252C%25206%2520and%25208%2520are%2520critical%2520for%2520invasion%2520in%2520breast%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2011%26volume%3D25%26issue%3D6%26spage%3D1677%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Discovery and development of SAHA as an anticancer agent</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1351-1356&issue=9&author=P.+A.+Marks&title=Discovery+and+development+of+SAHA+as+an+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520and%2520development%2520of%2520SAHA%2520as%2520an%2520anticancer%2520agent%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26issue%3D9%26spage%3D1351%26epage%3D1356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Grant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piekarz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batest, S. E.</span><span> </span><span class="NLM_article-title">Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1586%2Fera.10.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=20645688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=997-1008&issue=7&author=C.+Grantauthor=F.+Rahmanauthor=R.+Piekarzauthor=C.+Peerauthor=R.+Fryeauthor=R.+W.+Robeyauthor=E.+R.+Gardnerauthor=W.+D.+Figgauthor=S.+E.+Batest&title=Romidepsin%3A+a+new+therapy+for+cutaneous+T-cell+lymphoma+and+a+potential+therapy+for+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span></div><div class="casAuthors">Grant, Cliona; Rahman, Fahd; Piekarz, Richard; Peer, Cody; Frye, Robin; Robey, Robert W.; Gardner, Erin R.; Figg, William D.; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">997-1008</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Romidepsin is a histone deacetylase inhibitor (HDI), approved by the US FDA for the treatment of cutaneous T-cell lymphoma (CTCL).  Although various mechanisms have been proposed for the activity of HDIs, including induction of genes controlling cell cycle, acetylation of cytoplasmic proteins and direct induction of apoptosis, the mechanism underlying activity of romidepsin and other HDIs in CTCL is not known.  Romidepsin induces long-lasting responses.  The side-effect profile is similar to that of other HDIs, causing fatigue, nausea and thrombocytopenia.  Management of the CTCL population requires vigilence to prevent infection with skin contaminants, and monitoring of potassium and magnesium, electrolytes found to be low in a large proportion of patients.  Electrocardiog. (ECG) changes are common but are not assocd. with myocardial damage.  When mol. end points were evaluated in 61 patients enrolled on a Phase II trial with romidepsin, response was assocd. with persistence of acetylated histone H3, suggesting that drug exposure is important in effective therapy with romidepsin.  Future studies will endeavor to identify combination strategies to increase the efficacy both in resistant CTCL and in solid tumors and to identify biomarkers of response that will allow selection of patients most likely to benefit from the therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhGXcIbdqpk7Vg90H21EOLACvtfcHk0lhqNix17yKUUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D&md5=b28fd17c77991e4662f7c0e08d6d7297</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1586%2Fera.10.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.10.88%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DC.%26aulast%3DRahman%26aufirst%3DF.%26aulast%3DPiekarz%26aufirst%3DR.%26aulast%3DPeer%26aufirst%3DC.%26aulast%3DFrye%26aufirst%3DR.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DGardner%26aufirst%3DE.%2BR.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DBatest%26aufirst%3DS.%2BE.%26atitle%3DRomidepsin%253A%2520a%2520new%2520therapy%2520for%2520cutaneous%2520T-cell%2520lymphoma%2520and%2520a%2520potential%2520therapy%2520for%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2010%26volume%3D10%26issue%3D7%26spage%3D997%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Schneider, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalemkerian, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daignault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, M.</span><span> </span><span class="NLM_article-title">Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=249-257&issue=1&author=B.+J.+Schneiderauthor=G.+P.+Kalemkerianauthor=D.+Bradleyauthor=D.+C.+Smithauthor=M.+J.+Egorinauthor=S.+Daignaultauthor=R.+Dunnauthor=M.+Hussain&title=Phase+I+study+of+vorinostat+%28suberoylanilide+hydroxamic+acid%2C+NSC+701852%29+in+combination+with+docetaxel+in+patients+with+advanced+and+relapsed+solid+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DB.%2BJ.%26aulast%3DKalemkerian%26aufirst%3DG.%2BP.%26aulast%3DBradley%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DDaignault%26aufirst%3DS.%26aulast%3DDunn%26aufirst%3DR.%26aulast%3DHussain%26aufirst%3DM.%26atitle%3DPhase%2520I%2520study%2520of%2520vorinostat%2520%2528suberoylanilide%2520hydroxamic%2520acid%252C%2520NSC%2520701852%2529%2520in%2520combination%2520with%2520docetaxel%2520in%2520patients%2520with%2520advanced%2520and%2520relapsed%2520solid%2520malignancies%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26issue%3D1%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Shah, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbogast, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collamore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farra, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3997</span><span class="NLM_x">–</span> <span class="NLM_lpage">4003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1158%2F1078-0432.CCR-05-2689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=16818698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsValurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3997-4003&issue=13&author=M.+H.+Shahauthor=P.+Binkleyauthor=K.+Chanauthor=J.+Xiaoauthor=D.+Arbogastauthor=M.+Collamoreauthor=Y.+Farraauthor=D.+Youngauthor=M.+Grever&title=Cardiotoxicity+of+Histone+Deacetylase+Inhibitor+Depsipeptide+in+Patients+with+Metastatic+Neuroendocrine+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors</span></div><div class="casAuthors">Shah, Manisha H.; Binkley, Philip; Chan, Kenneth; Xiao, Jim; Arbogast, Daria; Collamore, Minden; Farra, Yasser; Young, Donn; Grever, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3997-4003</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: This phase II study was undertaken to assess objective response and toxicity of histone deacetylase inhibitor depsipeptide in patients with neuroendocrine tumors.  Exptl. Design: A total of 15 patients with metastatic neuroendocrine tumors received a 4-h i.v. infusion of depsipeptide at 14 mg/m2 on days 1, 8, and 15 every 28 days.  Tumor response was assessed at 8-wk intervals using Response Evaluation Criteria in Solid Tumors.  Most patients were chemo-naive (n = 12) but receiving long-acting octreotide for carcinoid syndrome (n = 11).  All patients had Eastern Cooperative Oncol. Group performance status of 0 to 1.  Results: The study was terminated prematurely due to an unexpected high no. of serious cardiac adverse events so the objective response rate could not be detd.  A total of 77 doses of depsipeptide with a median of four doses (range, 2-13) per patient were administered.  The most common adverse events included nausea (86%), anorexia (73%), vomiting (66%), and fatigue (73%).  A sudden death attributed to possible fatal ventricular arrhythmia occurred within 24 h after the fifth dose of depsipeptide.  Furthermore, asymptomatic grade 2 ventricular tachycardia (n = 2) and prolonged QTc (n = 3) probably related to depsipeptide were obsd.  Plasma depsipeptide levels measured in a subset of patients failed to reveal differences among patients with or without cardiac adverse events.  Conclusions: Depsipeptide was assocd. with a high no. of potentially serious cardiac adverse events in patients with metastatic neuroendocrine tumor.  As sudden death possibly assocd. with depsipeptide was obsd. in this trial, the risks for potentially life-threatening arrhythmia assocd. with this agent need to be comprehensively evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr29P_uZcrVv7Vg90H21EOLACvtfcHk0lhqNix17yKUUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsValurw%253D&md5=af1cd4cd67eb3f134a7cc3efe2206fb2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-2689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-2689%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%2BH.%26aulast%3DBinkley%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DArbogast%26aufirst%3DD.%26aulast%3DCollamore%26aufirst%3DM.%26aulast%3DFarra%26aufirst%3DY.%26aulast%3DYoung%26aufirst%3DD.%26aulast%3DGrever%26aufirst%3DM.%26atitle%3DCardiotoxicity%2520of%2520Histone%2520Deacetylase%2520Inhibitor%2520Depsipeptide%2520in%2520Patients%2520with%2520Metastatic%2520Neuroendocrine%2520Tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26issue%3D13%26spage%3D3997%26epage%3D4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.2174%2F092986712798918842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22204328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=475-487&issue=4&author=T.+Aiauthor=H.+Cuiauthor=L.+Chen&title=Multi-Targeted+Histone+Deacetylase+Inhibitors+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-targeted histone deacetylase inhibitors in cancer therapy</span></div><div class="casAuthors">Ai, T.; Cui, H.; Chen, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">475-487</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The heterogeneous nature of cancer requires a comprehensive approach for attacking the multiple mechanisms underlying the initiation and progression of cancers.  Histone deacetylase inhibitors (HDACi) have emerged as a new class of anticancer agents, targeting the biol. processes including cell cycle, apoptosis and differentiation.  Studies have revealed that HDACi are synergistic with diverse classes of anticancer therapies including targeted therapeutics and conventional anticancer agents.  Extensive medicinal chem. efforts have yielded a wide range of chem. structures, indicative of the structural flexibility of HDACi.  These findings have supported a strategy to generate multi-targeted HDACi by combining structural features from HDACi and other anticancer agents.  HDACi can also be connected to a motif that allows for a selective delivery.  Highlighting current examples, this brief review focuses on the rational design of multi-targeted inhibitors based on the examn. and manipulation of chem. structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtZJdxdSYVbVg90H21EOLACvtfcHk0ljR4RtvAohtpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqt74%253D&md5=c550eb21bc4849713ae2f816736f175a</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.2174%2F092986712798918842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712798918842%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DMulti-Targeted%2520Histone%2520Deacetylase%2520Inhibitors%2520in%2520Cancer%2520Therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26issue%3D4%26spage%3D475%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Seo, S. Y.</span><span> </span><span class="NLM_article-title">Multi-Targeted Hybrids Based on HDAC Inhibitors for Anti-Cancer Drug Discovery</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1007%2Fs12272-012-0221-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22370774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XivFyns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=197-200&issue=2&author=S.+Y.+Seo&title=Multi-Targeted+Hybrids+Based+on+HDAC+Inhibitors+for+Anti-Cancer+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery</span></div><div class="casAuthors">Seo, Seung-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-200</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Multi-targeted hybrids combine two drugs in a single mol. to have greater medicinal effects than its individual components.  Recently, a no. of anti-cancer drug candidates such as CUDC-101 (Curis) have been designed based on linking properly two selected pharmacophores endowed with activity against different therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSulm2ApOOprVg90H21EOLACvtfcHk0ljR4RtvAohtpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivFyns7o%253D&md5=3285f75262c7a19e05822ad48624fc05</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0221-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0221-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DS.%2BY.%26atitle%3DMulti-Targeted%2520Hybrids%2520Based%2520on%2520HDAC%2520Inhibitors%2520for%2520Anti-Cancer%2520Drug%2520Discovery%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2012%26volume%3D35%26issue%3D2%26spage%3D197%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balusu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudunuru, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkannagari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembruff, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K. N.</span><span> </span><span class="NLM_article-title">Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1158%2F1535-7163.MCT-11-0979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=22367781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=973-983&issue=4&author=R.+Raoauthor=R.+Balusuauthor=W.+Fiskusauthor=U.+Mudunuruauthor=S.+Venkannagariauthor=L.+Chauhanauthor=J.+E.+Smithauthor=S.+L.+Hembruffauthor=K.+Haauthor=P.+Atadjaauthor=K.+N.+Bhalla&title=Combination+of+Pan-Histone+Deacetylase+Inhibitor+and+Autophagy+Inhibitor+Exerts+Superior+Efficacy+against+Triple-Negative+Human+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells</span></div><div class="casAuthors">Rao, Rekha; Balusu, Ramesh; Fiskus, Warren; Mudunuru, Uma; Venkannagari, Sreedhar; Chauhan, Lata; Smith, Jacqueline E.; Hembruff, Stacey L.; Ha, Kyungsoo; Atadja, Peter; Bhalla, Kapil N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">973-983</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors (HDI) induce endoplasmic reticulum (ER) stress and apoptosis, while promoting autophagy, which promotes cancer cell survival when apoptosis is compromised.  Here, we detd. the in vitro and in vivo activity of the combination of the pan-HDI panobinostat and the autophagy inhibitor chloroquine against human estrogen/progesterone receptor and HER2 (triple)-neg. breast cancer (TNBC) cells.  Treatment of MB-231 and SUM159PT cells with panobinostat disrupted the hsp90/histone deacetylase 6/HSF1/p97 complex, resulting in the upregulation of hsp.  This was accompanied by the induction of enhanced autophagic flux as evidenced by increased expression of LC3B-II and the degrdn. of the autophagic substrate p62.  Treatment with panobinostat also induced the accumulation and colocalization of p62 with LC3B-II in cytosolic foci as evidenced by immunofluorescent confocal microscopy.  Inhibition of panobinostat-induced autophagic flux by chloroquine markedly induced the accumulation of polyubiquitylated proteins and p62, caused synergistic cell death of MB-231 and SUM159PT cells, and inhibited mammosphere formation in MB-231 cells, compared with treatment with each agent alone.  Finally, in mouse mammary fat pad xenografts of MB-231 cells, a tumor size-dependent induction of heat shock response, ER stress and autophagy were obsd.  Cotreatment with panobinostat and chloroquine resulted in reduced tumor burden and increased the survival of MB-231 breast cancer xenografts.  Collectively,these findings show that cotreatment with an autophagy inhibitor and pan-HDI, for example, chloroquine and panobinostat results in accumulation of toxic polyubiquitylated proteins, exerts superior inhibitory effects on TNBC cell growth, and increases the survival of TNBC xenografts.  Mol Cancer Ther; 11(4); 973-83.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_T3FzhT-9LVg90H21EOLACvtfcHk0ljmLz0yzLdd2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2nuro%253D&md5=3eff7850dd1b33306b5314a7814beaf5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0979%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%26aulast%3DBalusu%26aufirst%3DR.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DMudunuru%26aufirst%3DU.%26aulast%3DVenkannagari%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DJ.%2BE.%26aulast%3DHembruff%26aufirst%3DS.%2BL.%26aulast%3DHa%26aufirst%3DK.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DCombination%2520of%2520Pan-Histone%2520Deacetylase%2520Inhibitor%2520and%2520Autophagy%2520Inhibitor%2520Exerts%2520Superior%2520Efficacy%2520against%2520Triple-Negative%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26issue%3D4%26spage%3D973%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Munster, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacevic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail-Khan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melisko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minton, S. E.</span><span> </span><span class="NLM_article-title">Clinical Phase II Study of Vorinostat, a Hydroxamic Type Histone Deacetylase Inhibitor, in Combination with Tamoxifen To Reverse Acquired Hormone Resistance in Breast Cancer Patients Who Progressed on Hormone Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">856S</span><span class="NLM_x">–</span> <span class="NLM_lpage">856S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=856S-856S&issue=24&author=P.+N.+Munsterauthor=M.+Lacevicauthor=S.+Thomasauthor=R.+Ismail-Khanauthor=H.+Rugoauthor=M.+Meliskoauthor=S.+E.+Minton&title=Clinical+Phase+II+Study+of+Vorinostat%2C+a+Hydroxamic+Type+Histone+Deacetylase+Inhibitor%2C+in+Combination+with+Tamoxifen+To+Reverse+Acquired+Hormone+Resistance+in+Breast+Cancer+Patients+Who+Progressed+on+Hormone+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunster%26aufirst%3DP.%2BN.%26aulast%3DLacevic%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DIsmail-Khan%26aufirst%3DR.%26aulast%3DRugo%26aufirst%3DH.%26aulast%3DMelisko%26aufirst%3DM.%26aulast%3DMinton%26aufirst%3DS.%2BE.%26atitle%3DClinical%2520Phase%2520II%2520Study%2520of%2520Vorinostat%252C%2520a%2520Hydroxamic%2520Type%2520Histone%2520Deacetylase%2520Inhibitor%252C%2520in%2520Combination%2520with%2520Tamoxifen%2520To%2520Reverse%2520Acquired%2520Hormone%2520Resistance%2520in%2520Breast%2520Cancer%2520Patients%2520Who%2520Progressed%2520on%2520Hormone%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D24%26spage%3D856S%26epage%3D856S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ring, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span> </span><span class="NLM_article-title">Mechanisms of tamoxifen resistance</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=643-658&issue=4&author=A.+Ringauthor=M.+Dowsett&title=Mechanisms+of+tamoxifen+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DA.%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520tamoxifen%2520resistance%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2004%26volume%3D11%26issue%3D4%26spage%3D643%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Speirs, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkin, S. L.</span><span> </span><span class="NLM_article-title">Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">5421</span><span class="NLM_x">–</span> <span class="NLM_lpage">5424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5421-5424&issue=21&author=V.+Speirsauthor=C.+Maloneauthor=D.+S.+Waltonauthor=M.+J.+Kerinauthor=S.+L.+Atkin&title=Increased+expression+of+estrogen+receptor+beta+mRNA+in+tamoxifen-resistant+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpeirs%26aufirst%3DV.%26aulast%3DMalone%26aufirst%3DC.%26aulast%3DWalton%26aufirst%3DD.%2BS.%26aulast%3DKerin%26aufirst%3DM.%2BJ.%26aulast%3DAtkin%26aufirst%3DS.%2BL.%26atitle%3DIncreased%2520expression%2520of%2520estrogen%2520receptor%2520beta%2520mRNA%2520in%2520tamoxifen-resistant%2520breast%2520cancer%2520patients%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D21%26spage%3D5421%26epage%3D5424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sharma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vertino, P. M.</span><span> </span><span class="NLM_article-title">Restoration of Tamoxifen Sensitivity in Estrogen Receptor-Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor Complexes</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">6370</span><span class="NLM_x">–</span> <span class="NLM_lpage">6378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=6370-6378&issue=12&author=D.+Sharmaauthor=N.+K.+Saxenaauthor=N.+E.+Davidsonauthor=P.+M.+Vertino&title=Restoration+of+Tamoxifen+Sensitivity+in+Estrogen+Receptor-Negative+Breast+Cancer+Cells%3A+Tamoxifen-Bound+Reactivated+ER+Recruits+Distinctive+Corepressor+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DN.%2BK.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26aulast%3DVertino%26aufirst%3DP.%2BM.%26atitle%3DRestoration%2520of%2520Tamoxifen%2520Sensitivity%2520in%2520Estrogen%2520Receptor-Negative%2520Breast%2520Cancer%2520Cells%253A%2520Tamoxifen-Bound%2520Reactivated%2520ER%2520Recruits%2520Distinctive%2520Corepressor%2520Complexes%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D12%26spage%3D6370%26epage%3D6378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Levin, E. R.</span><span> </span><span class="NLM_article-title">Plasma membrane estrogen receptors</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1016%2Fj.tem.2009.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=19783454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=477-482&issue=10&author=E.+R.+Levin&title=Plasma+membrane+estrogen+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane estrogen receptors</span></div><div class="casAuthors">Levin, Ellis R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It is now firmly established that estrogen and all sex steroid receptors exist in discrete cellular pools outside the nucleus.  Estrogen receptors (ER) have been localized to the plasma membrane where both ERα and ERβ function in a wide variety of cells and organs.  ERs have also been found in discrete cytoplasmic organelles including mitochondria and the endoplasmic reticulum.  In ligand-dependent fashion, each ER pool contributes to the overall, integrated effects of estrogens producing biol. outcomes.  I highlight the recent work establishing new roles and targets of membrane ER signaling.  Such actions include prevention of vascular injury or cardiac hypertrophy, sexual behavior, and pain perception mediated through the central nervous system, osteoblast survival, and fluid resorption in the colon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBkbQK_CyFMbVg90H21EOLACvtfcHk0ljmLz0yzLdd2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrur3P&md5=ec58841eec1d7f1372af471c9cb32f65</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2009.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2009.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BR.%26atitle%3DPlasma%2520membrane%2520estrogen%2520receptors%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26issue%3D10%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cheng, S.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeber, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filardo, E. J.</span><span> </span><span class="NLM_article-title">Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=892-896&issue=9&author=S.-B.+Chengauthor=C.+T.+Graeberauthor=J.+A.+Quinnauthor=E.+J.+Filardo&title=Retrograde+transport+of+the+transmembrane+estrogen+receptor%2C+G-protein-coupled-receptor-30+%28GPR30%2FGPER%29+from+the+plasma+membrane+towards+the+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.-B.%26aulast%3DGraeber%26aufirst%3DC.%2BT.%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DFilardo%26aufirst%3DE.%2BJ.%26atitle%3DRetrograde%2520transport%2520of%2520the%2520transmembrane%2520estrogen%2520receptor%252C%2520G-protein-coupled-receptor-30%2520%2528GPR30%252FGPER%2529%2520from%2520the%2520plasma%2520membrane%2520towards%2520the%2520nucleus%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26issue%3D9%26spage%3D892%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y. H.</span><span> </span><span class="NLM_article-title">Non-Peptide Macrocyclic Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801128g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=456-468&issue=2&author=A.+K.+Oyelereauthor=P.+C.+Chenauthor=W.+Guerrantauthor=S.+C.+Mwakwariauthor=R.+Hoodauthor=Y.+Z.+Zhangauthor=Y.+H.+Fan&title=Non-Peptide+Macrocyclic+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm801128g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801128g%26sid%3Dliteratum%253Aachs%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DHood%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26aulast%3DFan%26aufirst%3DY.%2BH.%26atitle%3DNon-Peptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D456%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canzoneri, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1465</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200799p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1465-1477&issue=4&author=W.+Guerrantauthor=V.+Patilauthor=J.+C.+Canzoneriauthor=A.+K.+Oyelere&title=Dual+Targeting+of+Histone+Deacetylase+and+Topoisomerase+II+with+Novel+Bifunctional+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors</span></div><div class="casAuthors">Guerrant, William; Patil, Vishal; Canzoneri, Joshua C.; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1465-1477</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Strategies to ameliorate the flaws of current chemotherapeutic agents, while maintaining potent anticancer activity, are of particular interest.  Agents which can modulate multiple targets may have superior utility and fewer side effects than current single-target drugs.  To explore the prospect in cancer therapy of a bivalent agent that combines two complementary chemo-active groups within a single mol. architecture, we have synthesized dual-acting histone deacetylase and topoisomerase II inhibitors.  These dual-acting agents are derived from suberoylanilide hydroxamic acid (SAHA) and anthracycline daunorubicin, prototypical histone deacetylase (HDAC) and topoisomerase II (Topo II) inhibitors, resp.  For example, 4-aminobenzyl alc. reacted with suberic anhydride to give 4-HOCH2C6H4NHCO(CH2)6CO2H, which was oxidized to the corresponding benzaldehyde.  This benzaldehyde reacted with H2NOCPh3 to give the terminal O-tritylated amide, which, after addn. to daunorubicin HCl and removal of the trityl group, produced conjugate I.  We report herein that these agents present the signatures of inhibition of HDAC and Topo II in both cell-free and whole-cell assays.  Moreover, these agents potently inhibit the proliferation of representative cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Yf6AQQjHxLVg90H21EOLACvtfcHk0lhH_bsQu0UZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyhuw%253D%253D&md5=f0d6a8b98bb524de8e9fbbf1680610a1</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm200799p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200799p%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DCanzoneri%26aufirst%3DJ.%2BC.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DDual%2520Targeting%2520of%2520Histone%2520Deacetylase%2520and%2520Topoisomerase%2520II%2520with%2520Novel%2520Bifunctional%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D4%26spage%3D1465%26epage%3D1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurard-Levin, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrksich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Non-Peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">6100</span><span class="NLM_x">–</span> <span class="NLM_lpage">6111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100507q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6100-6111&issue=16&author=S.+C.+Mwakwariauthor=W.+Guerrantauthor=V.+Patilauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=Z.+A.+Gurard-Levinauthor=M.+Mrksichauthor=A.+K.+Oyelere&title=Non-Peptide+Macrocyclic+Histone+Deacetylase+Inhibitors+Derived+from+Tricyclic+Ketolide+Skeleton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm100507q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100507q%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DGurard-Levin%26aufirst%3DZ.%2BA.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DNon-Peptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%2520Derived%2520from%2520Tricyclic%2520Ketolide%2520Skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D16%26spage%3D6100%26epage%3D6111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gryder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benicewicz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=415-425&issue=1&author=V.+Patilauthor=W.+Guerrantauthor=P.+C.+Chenauthor=B.+Gryderauthor=D.+B.+Benicewiczauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=A.+K.+Oyelere&title=Antimalarial+and+antileishmanial+activities+of+histone+deacetylase+inhibitors+with+triazole-linked+cap+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGryder%26aufirst%3DB.%26aulast%3DBenicewicz%26aufirst%3DD.%2BB.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DAntimalarial%2520and%2520antileishmanial%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%2520with%2520triazole-linked%2520cap%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26issue%3D1%26spage%3D415%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guh, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-I.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4042</span><span class="NLM_x">–</span> <span class="NLM_lpage">4049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4042-4049&issue=9&author=W.-J.+Huangauthor=C.-C.+Chenauthor=S.-W.+Chaoauthor=C.-C.+Yuauthor=C.-Y.+Yangauthor=J.-H.+Guhauthor=Y.-C.+Linauthor=C.-I.+Kuoauthor=P.+Yangauthor=C.-I.+Chang&title=Synthesis+and+evaluation+of+aliphatic-chain+hydroxamates+capped+with+osthole+derivatives+as+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.-J.%26aulast%3DChen%26aufirst%3DC.-C.%26aulast%3DChao%26aufirst%3DS.-W.%26aulast%3DYu%26aufirst%3DC.-C.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DGuh%26aufirst%3DJ.-H.%26aulast%3DLin%26aufirst%3DY.-C.%26aulast%3DKuo%26aufirst%3DC.-I.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.-I.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520aliphatic-chain%2520hydroxamates%2520capped%2520with%2520osthole%2520derivatives%2520as%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D4042%26epage%3D4049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Butler, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemical origins of isoform selectivity in histone deacetylase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.2174%2F138161208783885353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=18336297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=505-528&issue=6&author=K.+V.+Butlerauthor=A.+P.+Kozikowski&title=Chemical+origins+of+isoform+selectivity+in+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical origins of isoform selectivity in histone deacetylase inhibitors</span></div><div class="casAuthors">Butler, Kyle V.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">505-528</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histones undergo extensive posttranslational modifications that affect gene expression.  Acetylation is a key histone modification that is primarily regulated by two enzymes, one of which is histone deacetylase (HDAC).  The activity of HDAC causes transcriptional silencing of DNA.  Eleven distinct zinc-dependent histone deacetylase isoforms have been identified in humans.  Each isoform has a unique structure and function, and regulates a unique set of genes.  HDAC is responsible for the regulation of many genes involved in cancer cell proliferation, and it has been implicated in the pathogenesis of many neurol. conditions.  HDAC inhibitors are known to be very effective anti-cancer agents, and research has shown them to be potential treatments for many other conditions.  Histone deacetylase inhibitors modify the expression of many genes, and it is possible that inhibition of one isoform could cause epigenetic changes that are beneficial to treatment of a disease, while inhibition of another isoform could cause contradictory changes.  Selective HDAC inhibitors will be better able to avoid these types of situations than non-specific inhibitors, and may also be less toxic than pan-HDAC inhibitors.  Many potent pan-HDAC inhibitors have already been developed, leaving the development of selective inhibitors at the forefront of HDAC drug development.  Certain structural moieties may be added to HDAC inhibitors to give isoform selectivity, and these will be discussed in this review.  This review will focus on the applications of selective HDAC inhibitors, inhibitors reported to show selectivity, and the relationship between inhibitor structure and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7uBS33WLxbbVg90H21EOLACvtfcHk0lgXjhHkf-QvvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVGksbw%253D&md5=7cb09f53ee939192450879caec4821bf</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.2174%2F138161208783885353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208783885353%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemical%2520origins%2520of%2520isoform%2520selectivity%2520in%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26issue%3D6%26spage%3D505%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4839</span><span class="NLM_x">–</span> <span class="NLM_lpage">4853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4839-4853&issue=9&author=P.+C.+Chenauthor=V.+Patilauthor=W.+Guerrantauthor=P.+Greenauthor=A.+K.+Oyelere&title=Synthesis+and+structure%E2%80%93activity+relationship+of+histone+deacetylase+%28HDAC%29+inhibitors+with+triazole-linked+cap+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%2520with%2520triazole-linked%2520cap%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D9%26spage%3D4839%26epage%3D4853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cyrus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehenkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span> </span><span class="NLM_article-title">Jostling for Position: Optimizing Linker Location in the Design of Estrogen Receptor-Targeting PROTACs</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=979-985&issue=7&author=K.+Cyrusauthor=M.+Wehenkelauthor=E.+Y.+Choiauthor=H.+Leeauthor=H.+Swansonauthor=K.+B.+Kim&title=Jostling+for+Position%3A+Optimizing+Linker+Location+in+the+Design+of+Estrogen+Receptor-Targeting+PROTACs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCyrus%26aufirst%3DK.%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DE.%2BY.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DSwanson%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BB.%26atitle%3DJostling%2520for%2520Position%253A%2520Optimizing%2520Linker%2520Location%2520in%2520the%2520Design%2520of%2520Estrogen%2520Receptor-Targeting%2520PROTACs%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26issue%3D7%26spage%3D979%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dao, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawant, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torchilin, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Initial Biological Evaluation of a Steroidal Anti-Estrogen-Doxorubicin Bioconjugate for Targeting Estrogen Receptor-Positive Breast Cancer Cells</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc200645n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFehtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=785-795&issue=4&author=K.+L.+Daoauthor=R.+R.+Sawantauthor=J.+A.+Hendricksauthor=V.+Rongaauthor=V.+P.+Torchilinauthor=R.+N.+Hanson&title=Design%2C+Synthesis%2C+and+Initial+Biological+Evaluation+of+a+Steroidal+Anti-Estrogen-Doxorubicin+Bioconjugate+for+Targeting+Estrogen+Receptor-Positive+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Initial Biological Evaluation of a Steroidal Anti-Estrogen-Doxorubicin Bioconjugate for Targeting Estrogen Receptor-Positive Breast Cancer Cells</span></div><div class="casAuthors">Dao, Kinh-Luan; Sawant, Rupa R.; Hendricks, J. Adam; Ronga, Victoria; Torchilin, Vladimir P.; Hanson, Robert N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">785-795</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our program to develop breast cancer specific therapeutic agents, we have synthesized a conjugate agent that is a conjugate of the steroidal anti-estrogen and the potent cytotoxin doxorubicin.  In this effort, we employed a modular assembly approach to prep. a novel 11β-substituted steroidal anti-estrogen functionalized with an azido-tetraethylene glycol moiety, which could be coupled to a complementary doxorubicin benzoyl hydrazone functionalized with a propargyl tetraethylene glycol moiety.  Huisgen [3 + 2] cycloaddn. chem. gave the final hybrid that was evaluated for selective uptake and cytotoxicity in ER(+)-MCF-7 and ER(-)-MDA-MB-231 breast cancer cell lines.  The results demonstrated that the presence of the anti-estrogenic component in the hybrid compd. was crit. for selectivity and cytotoxicity in ER(+)-MCF-7 human breast cancer cells as the hybrid was ∼70-fold more potent than doxorubicin in inhibition of cell proliferation and promoting cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJbOft1UFN2bVg90H21EOLACvtfcHk0linZRwkjzXqbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFehtLo%253D&md5=40b61cd9934223ce0e284af7ba9df0be</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fbc200645n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200645n%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DK.%2BL.%26aulast%3DSawant%26aufirst%3DR.%2BR.%26aulast%3DHendricks%26aufirst%3DJ.%2BA.%26aulast%3DRonga%26aufirst%3DV.%26aulast%3DTorchilin%26aufirst%3DV.%2BP.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Initial%2520Biological%2520Evaluation%2520of%2520a%2520Steroidal%2520Anti-Estrogen-Doxorubicin%2520Bioconjugate%2520for%2520Targeting%2520Estrogen%2520Receptor-Positive%2520Breast%2520Cancer%2520Cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26issue%3D4%26spage%3D785%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Peng, K.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijewickrama, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Selective Estrogen Receptor Modulator Delivery of Quinone Warheads to DNA Triggering Apoptosis in Breast Cancer Cells</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb9001848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1039-1049&issue=12&author=K.-w.+Pengauthor=H.+Wangauthor=Z.+Qinauthor=G.+T.+Wijewickramaauthor=M.+Luauthor=Z.+Wangauthor=J.+L.+Boltonauthor=G.+R.+J.+Thatcher&title=Selective+Estrogen+Receptor+Modulator+Delivery+of+Quinone+Warheads+to+DNA+Triggering+Apoptosis+in+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fcb9001848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9001848%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DK.-w.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DWijewickrama%26aufirst%3DG.%2BT.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBolton%26aufirst%3DJ.%2BL.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DSelective%2520Estrogen%2520Receptor%2520Modulator%2520Delivery%2520of%2520Quinone%2520Warheads%2520to%2520DNA%2520Triggering%2520Apoptosis%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26issue%3D12%26spage%3D1039%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nettles, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruning, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSombre, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, G. L.</span><span> </span><span class="NLM_article-title">Structural plasticity in the oestrogen receptor ligand-binding domain</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=563-568&issue=6&author=K.+W.+Nettlesauthor=J.+B.+Bruningauthor=G.+Gilauthor=E.+E.+O%E2%80%99Neillauthor=J.+Nowakauthor=A.+Hughsauthor=Y.+Kimauthor=E.+R.+DeSombreauthor=R.+Dilisauthor=R.+N.+Hansonauthor=A.+Joachimiakauthor=G.+L.+Greene&title=Structural+plasticity+in+the+oestrogen+receptor+ligand-binding+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNettles%26aufirst%3DK.%2BW.%26aulast%3DBruning%26aufirst%3DJ.%2BB.%26aulast%3DGil%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BE.%26aulast%3DNowak%26aufirst%3DJ.%26aulast%3DHughs%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DDeSombre%26aufirst%3DE.%2BR.%26aulast%3DDilis%26aufirst%3DR.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26atitle%3DStructural%2520plasticity%2520in%2520the%2520oestrogen%2520receptor%2520ligand-binding%2520domain%26jtitle%3DEMBO%2520Rep.%26date%3D2007%26volume%3D8%26issue%3D6%26spage%3D563%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olmsted, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tongcharoensirikul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaskill, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandiaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labaree, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochberg, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 17α-<i>E</i>-20-(heteroaryl)norpregn-1,3,5(10),20 tetraene-3,17β-diols [17α-(heteroaryl)vinyl estradiols] as ligands for the estrogen receptor-α ligand binding domain (ERα-LBD)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=977-979&issue=2&author=S.+L.+Olmstedauthor=P.+Tongcharoensirikulauthor=E.+McCaskillauthor=K.+Gandiagaauthor=D.+Labareeauthor=R.+B.+Hochbergauthor=R.+N.+Hanson&title=Synthesis+and+evaluation+of+17%CE%B1-E-20-%28heteroaryl%29norpregn-1%2C3%2C5%2810%29%2C20+tetraene-3%2C17%CE%B2-diols+%5B17%CE%B1-%28heteroaryl%29vinyl+estradiols%5D+as+ligands+for+the+estrogen+receptor-%CE%B1+ligand+binding+domain+%28ER%CE%B1-LBD%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlmsted%26aufirst%3DS.%2BL.%26aulast%3DTongcharoensirikul%26aufirst%3DP.%26aulast%3DMcCaskill%26aufirst%3DE.%26aulast%3DGandiaga%26aufirst%3DK.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DHochberg%26aufirst%3DR.%2BB.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%252017%25CE%25B1-E-20-%2528heteroaryl%2529norpregn-1%252C3%252C5%252810%2529%252C20%2520tetraene-3%252C17%25CE%25B2-diols%2520%255B17%25CE%25B1-%2528heteroaryl%2529vinyl%2520estradiols%255D%2520as%2520ligands%2520for%2520the%2520estrogen%2520receptor-%25CE%25B1%2520ligand%2520binding%2520domain%2520%2528ER%25CE%25B1-LBD%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D977%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Maximov, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curpan, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis-Wambi, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Structure–Function Relationships of Estrogenic Triphenylethylenes Related to Endoxifen and 4-Hydroxytamoxifen</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3273</span><span class="NLM_x">–</span> <span class="NLM_lpage">3283</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901907u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3273-3283&issue=8&author=P.+Y.+Maximovauthor=C.+B.+Myersauthor=R.+F.+Curpanauthor=J.+S.+Lewis-Wambiauthor=V.+C.+Jordan&title=Structure%E2%80%93Function+Relationships+of+Estrogenic+Triphenylethylenes+Related+to+Endoxifen+and+4-Hydroxytamoxifen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm901907u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901907u%26sid%3Dliteratum%253Aachs%26aulast%3DMaximov%26aufirst%3DP.%2BY.%26aulast%3DMyers%26aufirst%3DC.%2BB.%26aulast%3DCurpan%26aufirst%3DR.%2BF.%26aulast%3DLewis-Wambi%26aufirst%3DJ.%2BS.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DStructure%25E2%2580%2593Function%2520Relationships%2520of%2520Estrogenic%2520Triphenylethylenes%2520Related%2520to%2520Endoxifen%2520and%25204-Hydroxytamoxifen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D8%26spage%3D3273%26epage%3D3283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Burke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of doxorubicin–formaldehyde conjugates targeted to breast cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030352r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1193-1206&issue=5&author=P.+J.+Burkeauthor=T.+H.+Koch&title=Design%2C+synthesis%2C+and+biological+evaluation+of+doxorubicin%E2%80%93formaldehyde+conjugates+targeted+to+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm030352r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030352r%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DP.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520doxorubicin%25E2%2580%2593formaldehyde%2520conjugates%2520targeted%2520to%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D5%26spage%3D1193%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2596</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2596-2599&issue=14&author=V.+V.+Rostovtsevauthor=L.+G.+Greenauthor=V.+V.+Fokinauthor=K.+B.+Sharpless&title=A+stepwise+Huisgen+cycloaddition+process%3A+Copper%28I%29-catalyzed+regioselective+%E2%80%9Cligation%E2%80%9D+of+azides+and+terminal+alkynes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520stepwise%2520Huisgen%2520cycloaddition%2520process%253A%2520Copper%2528I%2529-catalyzed%2520regioselective%2520%25E2%2580%259Cligation%25E2%2580%259D%2520of%2520azides%2520and%2520terminal%2520alkynes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26issue%3D14%26spage%3D2596%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Olofson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piteau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malfroot, T.</span><span> </span><span class="NLM_article-title">A New Reagent For The Selective, High-Yield <i>N</i>-Dealkylation Of Tertiary-Amines—Improved Syntheses Of Naltrexone And Nalbuphine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00185a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=2081-2082&issue=11&author=R.+A.+Olofsonauthor=J.+T.+Martzauthor=J.+P.+Senetauthor=M.+Piteauauthor=T.+Malfroot&title=A+New+Reagent+For+The+Selective%2C+High-Yield+N-Dealkylation+Of+Tertiary-Amines%E2%80%94Improved+Syntheses+Of+Naltrexone+And+Nalbuphine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00185a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00185a072%26sid%3Dliteratum%253Aachs%26aulast%3DOlofson%26aufirst%3DR.%2BA.%26aulast%3DMartz%26aufirst%3DJ.%2BT.%26aulast%3DSenet%26aufirst%3DJ.%2BP.%26aulast%3DPiteau%26aufirst%3DM.%26aulast%3DMalfroot%26aufirst%3DT.%26atitle%3DA%2520New%2520Reagent%2520For%2520The%2520Selective%252C%2520High-Yield%2520N-Dealkylation%2520Of%2520Tertiary-Amines%25E2%2580%2594Improved%2520Syntheses%2520Of%2520Naltrexone%2520And%2520Nalbuphine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26issue%3D11%26spage%3D2081%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A Medicinal Chemist’s Guide to Molecular Interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&issue=14&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+Medicinal+Chemist%E2%80%99s+Guide+to+Molecular+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520Medicinal%2520Chemist%25E2%2580%2599s%2520Guide%2520to%2520Molecular%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D14%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Li, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dym, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albeck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pais, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunanathan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Structure of Estradiol Metal Chelate and Estrogen Receptor Complex: The Basis for Designing a New Class of Selective Estrogen Receptor Modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3575</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200192y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3575-3580&issue=10&author=M.-J.+Liauthor=H.+M.+Greenblattauthor=O.+Dymauthor=S.+Albeckauthor=A.+Paisauthor=C.+Gunanathanauthor=D.+Milsteinauthor=H.+Deganiauthor=J.+L.+Sussman&title=Structure+of+Estradiol+Metal+Chelate+and+Estrogen+Receptor+Complex%3A+The+Basis+for+Designing+a+New+Class+of+Selective+Estrogen+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm200192y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200192y%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.-J.%26aulast%3DGreenblatt%26aufirst%3DH.%2BM.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DAlbeck%26aufirst%3DS.%26aulast%3DPais%26aufirst%3DA.%26aulast%3DGunanathan%26aufirst%3DC.%26aulast%3DMilstein%26aufirst%3DD.%26aulast%3DDegani%26aufirst%3DH.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520Estradiol%2520Metal%2520Chelate%2520and%2520Estrogen%2520Receptor%2520Complex%253A%2520The%2520Basis%2520for%2520Designing%2520a%2520New%2520Class%2520of%2520Selective%2520Estrogen%2520Receptor%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D10%26spage%3D3575%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Thomas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, J. A.</span><span> </span><span class="NLM_article-title">The different roles of ER subtypes in cancer biology and therapy</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1038%2Fnrc3093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=21779010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1aqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=597-608&issue=8&author=C.+Thomasauthor=J.+A.+Gustafsson&title=The+different+roles+of+ER+subtypes+in+cancer+biology+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The different roles of ER subtypes in cancer biology and therapy</span></div><div class="casAuthors">Thomas, Christoforos; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  By eliciting distinct transcriptional responses, the estrogen receptors (ERs) ERα and ERβ exert opposite effects on cellular processes that include proliferation, apoptosis and migration and that differentially influence the development and the progression of cancer.  Perturbation of ER subtype-specific expression has been detected in various types of cancer, and the differences in the expression of ERs are correlated with the clin. outcome.  The changes in the bioavailability of ERs in tumors, together with their specific biol. functions, promote the selective restoration of their activity as one of the major therapeutic approaches for hormone-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQgsx59rM16LVg90H21EOLACvtfcHk0ljFkJ-OHwsz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1aqt7g%253D&md5=97cdcb21bff3447afbccac915ec6af77</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrc3093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3093%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520different%2520roles%2520of%2520ER%2520subtypes%2520in%2520cancer%2520biology%2520and%2520therapy%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D8%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fox, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shupnik, M. A.</span><span> </span><span class="NLM_article-title">ER beta in breast cancer—onlooker, passive player, or active protector?</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1039-1051&issue=11&author=E.+M.+Foxauthor=R.+J.+Davisauthor=M.+A.+Shupnik&title=ER+beta+in+breast+cancer%E2%80%94onlooker%2C+passive+player%2C+or+active+protector%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DShupnik%26aufirst%3DM.%2BA.%26atitle%3DER%2520beta%2520in%2520breast%2520cancer%25E2%2580%2594onlooker%252C%2520passive%2520player%252C%2520or%2520active%2520protector%253F%26jtitle%3DSteroids%26date%3D2008%26volume%3D73%26issue%3D11%26spage%3D1039%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. H.</span><span> </span><span class="NLM_article-title">In Silico Prediction of Estrogen Receptor Subtype Binding Affinity and Selectivity Using Statistical Methods and Molecular Docking with 2-Arylnaphthalenes and 2-Arylquinolines</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3434</span><span class="NLM_x">–</span> <span class="NLM_lpage">3458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.3390%2Fijms11093434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Oiur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=3434-3458&issue=9&author=Z.+Z.+Wangauthor=Y.+Liauthor=C.+Z.+Aiauthor=Y.+H.+Wang&title=In+Silico+Prediction+of+Estrogen+Receptor+Subtype+Binding+Affinity+and+Selectivity+Using+Statistical+Methods+and+Molecular+Docking+with+2-Arylnaphthalenes+and+2-Arylquinolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines</span></div><div class="casAuthors">Wang, Zhizhong; Li, Yan; Ai, Chunzhi; Wang, Yonghua</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3434-3458</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">Over the years development of selective estrogen receptor (ER) ligands has been of great concern to researchers involved in the chem. and pharmacol. of anticancer drugs, resulting in numerous synthesized selective ER subtype inhibitors.  A data set of 82 ER ligands with ERα and ERβ inhibitory activities was built, and quant. structure-activity relationship (QSAR) methods based on the two linear (multiple linear regression, MLR, partial least squares regression, PLSR) and a nonlinear statistical method (Bayesian regularized neural network, BRNN) were applied to investigate the potential relationship of mol. structural features related to the activity and selectivity of these ligands.  For ERα and ERβ, the performances of the MLR and PLSR models are superior to the BRNN model, giving more reasonable statistical properties (ERα: for MLR, RtR2 = 0.72, QtE2 = 0.63; for PLSR, RtR2 = 0.92, QtE2 = 0.84; ERβ: for MLR, RtR2 = 0.75, QtE2 = 0.75; for PLSR, RtR2 = 0.98, QtE2 = 0.80).  The MLR method is also more powerful than other two methods for generating the subtype selectivity models, resulting in RtR2 = 0.74 and QtE2 = 0.80.  In addn., the mol. docking method was also used to explore the possible binding modes of the ligands and a relationship between the 3D-binding modes and the 2D-mol. structural features of ligands was further explored.  The results show that the binding affinity strength for both ERα and ERβ is more correlated with the atom fragment type, polarity, electronegativities and hydrophobicity.  The substituent in position 8 of the naphthalene or the quinoline plane and the space orientation of these two planes contribute the most to the subtype selectivity on the basis of similar hydrogen bond interactions between binding ligands and both ER subtypes.  The QSAR models built together with the docking procedure should be of great advantage for screening and designing ER ligands with improved affinity and subtype selectivity property.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU767KgAYF07Vg90H21EOLACvtfcHk0ljFkJ-OHwsz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Oiur3L&md5=61af2ca611e645bba3ceb5ca50556714</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fijms11093434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms11093434%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DC.%2BZ.%26aulast%3DWang%26aufirst%3DY.%2BH.%26atitle%3DIn%2520Silico%2520Prediction%2520of%2520Estrogen%2520Receptor%2520Subtype%2520Binding%2520Affinity%2520and%2520Selectivity%2520Using%2520Statistical%2520Methods%2520and%2520Molecular%2520Docking%2520with%25202-Arylnaphthalenes%2520and%25202-Arylquinolines%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2010%26volume%3D11%26issue%3D9%26spage%3D3434%26epage%3D3458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Allred, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, D.</span><span> </span><span class="NLM_article-title">The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1186%2Fbcr938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=15535853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1ajtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=240-245&issue=6&author=D.+C.+Allredauthor=P.+Brownauthor=D.+Medina&title=The+origins+of+estrogen+receptor+alpha-positive+and+estrogen+receptor+alpha-negative+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer</span></div><div class="casAuthors">Allred, D. Craig; Brown, Powel; Medina, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">240-245</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Current hormonal therapies have benefited millions of patients with breast cancer.  Their success, however, is often temporary and limited to a subset of patients whose tumors express estrogen receptor alpha (ER).  The therapies are entirely ineffective in ER-neg. disease.  Recent studies suggest that there are many biol. pathways and alterations involved in detg. whether ER is expressed and how it is regulated during breast cancer evolution.  Improving hormonal therapies, in addn. to perfecting current strategies, will also target these newly discovered pathways and alterations, and others yet to be found.  The present commentary will briefly highlight a few important observations and unanswered questions regarding ER status and growth regulation during breast cancer evolution, which hopefully will help to stimulate new thinking and progress in this important area of medial research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZgdKpwipVZrVg90H21EOLACvtfcHk0lg2hrs3DDnRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1ajtr8%253D&md5=ccc5537f91918096dc45c3c4e62cfe91</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1186%2Fbcr938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr938%26sid%3Dliteratum%253Aachs%26aulast%3DAllred%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DMedina%26aufirst%3DD.%26atitle%3DThe%2520origins%2520of%2520estrogen%2520receptor%2520alpha-positive%2520and%2520estrogen%2520receptor%2520alpha-negative%2520human%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2004%26volume%3D6%26issue%3D6%26spage%3D240%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sabnis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goloubeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumsri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, A. M. H.</span><span> </span><span class="NLM_article-title">Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1893-1903&issue=5&author=G.+J.+Sabnisauthor=O.+Goloubevaauthor=S.+Chumsriauthor=N.+Nguyenauthor=S.+Sukumarauthor=A.+M.+H.+Brodie&title=Functional+Activation+of+the+Estrogen+Receptor-%CE%B1+and+Aromatase+by+the+HDAC+Inhibitor+Entinostat+Sensitizes+ER-Negative+Tumors+to+Letrozole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabnis%26aufirst%3DG.%2BJ.%26aulast%3DGoloubeva%26aufirst%3DO.%26aulast%3DChumsri%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DSukumar%26aufirst%3DS.%26aulast%3DBrodie%26aufirst%3DA.%2BM.%2BH.%26atitle%3DFunctional%2520Activation%2520of%2520the%2520Estrogen%2520Receptor-%25CE%25B1%2520and%2520Aromatase%2520by%2520the%2520HDAC%2520Inhibitor%2520Entinostat%2520Sensitizes%2520ER-Negative%2520Tumors%2520to%2520Letrozole%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D5%26spage%3D1893%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nass, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butash, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N. E.</span><span> </span><span class="NLM_article-title">Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6890</span><span class="NLM_x">–</span> <span class="NLM_lpage">6894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6890-6894&issue=24&author=X.+Yangauthor=A.+T.+Fergusonauthor=S.+J.+Nassauthor=D.+L.+Phillipsauthor=K.+A.+Butashauthor=S.+M.+Wangauthor=J.+G.+Hermanauthor=N.+E.+Davidson&title=Transcriptional+activation+of+estrogen+receptor+alpha+in+human+breast+cancer+cells+by+histone+deacetylase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DFerguson%26aufirst%3DA.%2BT.%26aulast%3DNass%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DD.%2BL.%26aulast%3DButash%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DHerman%26aufirst%3DJ.%2BG.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26atitle%3DTranscriptional%2520activation%2520of%2520estrogen%2520receptor%2520alpha%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520histone%2520deacetylase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26issue%3D24%26spage%3D6890%26epage%3D6894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kreis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budman, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabro, A.</span><span> </span><span class="NLM_article-title">A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1007%2Fs002800000191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=11221966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVWmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2001&pages=78-82&issue=1&author=W.+Kreisauthor=D.+R.+Budmanauthor=A.+Calabro&title=A+reexamination+of+PSC+833+%28Valspodar%29+as+a+cytotoxic+agent+and+in+combination+with+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents</span></div><div class="casAuthors">Kreis, Willi; Budman, Daniel R.; Calabro, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-82</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The cytotoxicity of cyclosporins was examd. in defined cell lines, both as single agents and in combination with agents which may be of value in human malignant disease.  Cells were grown to confluence, and growth patterns and death were detd. by an MTT assay.  Median effect anal. was used to look for synergy, additive effects, or antagonism between the cyclosporins and drugs with antitumor effects in humans.  Cyclosporin A and PSC 833 had cytotoxic activity at clin. achievable concns. in breast, leukemia, and prostate cell lines.  Synergistic or additive effects were demonstrated in all three prostate cell lines when PSC 833 was combined with estramustine, etoposide, ketoconazole, suramin, or vinorelbine.  Cell line-selective additive effects or synergism were also identified with bicalutamide, carboplatin, cisplatin, cis-retinoic acid, dexamethasone, 5-fluorouracil, liarozole, and trans-retinoic acid.  Thus, PSC 833 or cyclosporin alone or in combination with other agents may have an anticancer effect independently of their modulatory action on multidrug resistance.  Several of the synergistic combinations which are not mediated by the multidrug resistance pump need to be tested in vivo for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOi043NQPYG7Vg90H21EOLACvtfcHk0lg2hrs3DDnRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVWmsQ%253D%253D&md5=b9d8fcd448a36ad966a4262bd80d282a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs002800000191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800000191%26sid%3Dliteratum%253Aachs%26aulast%3DKreis%26aufirst%3DW.%26aulast%3DBudman%26aufirst%3DD.%2BR.%26aulast%3DCalabro%26aufirst%3DA.%26atitle%3DA%2520reexamination%2520of%2520PSC%2520833%2520%2528Valspodar%2529%2520as%2520a%2520cytotoxic%2520agent%2520and%2520in%2520combination%2520with%2520anticancer%2520agents%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2001%26volume%3D47%26issue%3D1%26spage%3D78%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Lau, K.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaSpina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S.-M.</span><span> </span><span class="NLM_article-title">Expression of Estrogen Receptor (ER)-α and ER-β in Normal and Malignant Prostatic Epithelial Cells: Regulation by Methylation and Involvement in Growth Regulation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=3175-3182&issue=12&author=K.-M.+Lauauthor=M.+LaSpinaauthor=J.+Longauthor=S.-M.+Ho&title=Expression+of+Estrogen+Receptor+%28ER%29-%CE%B1+and+ER-%CE%B2+in+Normal+and+Malignant+Prostatic+Epithelial+Cells%3A+Regulation+by+Methylation+and+Involvement+in+Growth+Regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DK.-M.%26aulast%3DLaSpina%26aufirst%3DM.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DS.-M.%26atitle%3DExpression%2520of%2520Estrogen%2520Receptor%2520%2528ER%2529-%25CE%25B1%2520and%2520ER-%25CE%25B2%2520in%2520Normal%2520and%2520Malignant%2520Prostatic%2520Epithelial%2520Cells%253A%2520Regulation%2520by%2520Methylation%2520and%2520Involvement%2520in%2520Growth%2520Regulation%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26issue%3D12%26spage%3D3175%26epage%3D3182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Muller, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, M. N.</span><span> </span><span class="NLM_article-title">The determination and interpretation of the therapeutic index in drug development</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=751-761&issue=10&author=P.+Y.+Mullerauthor=M.+N.+Milton&title=The+determination+and+interpretation+of+the+therapeutic+index+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DP.%2BY.%26aulast%3DMilton%26aufirst%3DM.%2BN.%26atitle%3DThe%2520determination%2520and%2520interpretation%2520of%2520the%2520therapeutic%2520index%2520in%2520drug%2520development%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D10%26spage%3D751%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Owens, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Young, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyse, K. J.</span><span> </span><span class="NLM_article-title">Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1993&pages=467-473&issue=2&author=P.+C.+Owensauthor=P.+G.+Gillauthor=N.+J.+De+Youngauthor=M.+A.+Wegerauthor=S.+E.+Knowlesauthor=K.+J.+Moyse&title=Estrogen+and+progesterone+regulate+secretion+of+insulin-like+growth+factor+binding+proteins+by+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DP.%2BC.%26aulast%3DGill%26aufirst%3DP.%2BG.%26aulast%3DDe%2BYoung%26aufirst%3DN.%2BJ.%26aulast%3DWeger%26aufirst%3DM.%2BA.%26aulast%3DKnowles%26aufirst%3DS.%2BE.%26aulast%3DMoyse%26aufirst%3DK.%2BJ.%26atitle%3DEstrogen%2520and%2520progesterone%2520regulate%2520secretion%2520of%2520insulin-like%2520growth%2520factor%2520binding%2520proteins%2520by%2520human%2520breast%2520cancer%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1993%26volume%3D193%26issue%3D2%26spage%3D467%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sutherland, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddel, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I. W.</span><span> </span><span class="NLM_article-title">Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle</span> <span class="citation_source-journal">Eur. J. Cancer Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1016%2F0277-5379%2883%2990177-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=6683633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADyaL3sXktlart74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1983&pages=615-621&issue=5&author=R.+L.+Sutherlandauthor=M.+D.+Greenauthor=R.+E.+Hallauthor=R.+R.+Reddelauthor=I.+W.+Taylor&title=Tamoxifen+induces+accumulation+of+MCF+7+human+mammary+carcinoma+cells+in+the+G0%2FG1+phase+of+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle</span></div><div class="casAuthors">Sutherland, Robert L.; Green, Michael D.; Hall, Rosemary E.; Reddel, Roger R.; Taylor, Ian W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer & Clinical Oncology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">615-21</span>CODEN:
                <span class="NLM_cas:coden">EJCODS</span>;
        ISSN:<span class="NLM_cas:issn">0277-5379</span>.
    </div><div class="casAbstract">When MCF 7 human mammary carcinoma cells in exponential growth phase were treated with tamoxifen (I)  [10540-29-1], a dose-dependent inhibition of cell growth was obsd.  This inhibition was accompanied by a dose-dependent decrease in the percentage of S phase cells and a concomitant increase in the percentage of cells in the G0/G1 phase of the cell cycle.  Simultaneous treatment of cultures with a 10-fold lower concn. of estradiol  [50-28-2] completely reversed the growth inhibitory and cell cycle effects of tamoxifen at doses < 5 μM but only partially reversed the effects of higher doses of this drug.  Thus, tamoxifen is a cell cycle phase-specific growth inhibitory agent.  In addn. to having effects on cell proliferation that are reversed by estrogens and are likely to be estrogen receptor-mediated, tamoxifen has antitumor activity in vitro that involves biochem. mechanisms independent of the estrogen receptor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcY6107cWVU7Vg90H21EOLACvtfcHk0liJKPPCQvfvMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXktlart74%253D&md5=c3165258377ee45cd0eb2ac0e36fc3aa</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0277-5379%2883%2990177-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0277-5379%252883%252990177-3%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DGreen%26aufirst%3DM.%2BD.%26aulast%3DHall%26aufirst%3DR.%2BE.%26aulast%3DReddel%26aufirst%3DR.%2BR.%26aulast%3DTaylor%26aufirst%3DI.%2BW.%26atitle%3DTamoxifen%2520induces%2520accumulation%2520of%2520MCF%25207%2520human%2520mammary%2520carcinoma%2520cells%2520in%2520the%2520G0%252FG1%2520phase%2520of%2520the%2520cell%2520cycle%26jtitle%3DEur.%2520J.%2520Cancer%2520Clin.%2520Oncol.%26date%3D1983%26volume%3D19%26issue%3D5%26spage%3D615%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, B. G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2069</span><span class="NLM_x">–</span> <span class="NLM_lpage">2083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1091%2Fmbc.11.6.2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=10848630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=2069-2083&issue=6&author=L.+Qiuauthor=A.+Burgessauthor=D.+P.+Fairlieauthor=H.+Leonardauthor=P.+G.+Parsonsauthor=B.+G.+Gabrielli&title=Histone+deacetylase+inhibitors+trigger+a+G2+checkpoint+in+normal+cells+that+is+defective+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells</span></div><div class="casAuthors">Qiu, Ling; Burgess, Andrew; Fairlie, David P.; Leonard, Helen; Parsons, Peter G.; Gabrielli, Brian G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2069-2083</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Important aspects of cell cycle regulation are the checkpoints, which respond to a variety of cellular stresses to inhibit cell cycle progression and act as protective mechanisms to ensure genomic integrity.  An increasing no. of tumor suppressors are being demonstrated to have roles in checkpoint mechanisms, implying that checkpoint dysfunction is likely to be a common feature of cancers.  Here we report that histone deacetylase inhibitors, in particular azelaic bishydroxamic acid, triggers a G2 phase cell cycle checkpoint response in normal human cells, and this checkpoint is defective in a range of tumor cell lines.  Loss of this G2 checkpoint results in the tumor cells undergoing an aberrant mitosis resulting in fractured multinuclei and micronuclei and eventually cell death.  This histone deacetylase inhibitor-sensitive checkpoint appears to be distinct from G2/M checkpoints activated by genotoxins and microtubule poisons and may be the human homolog of a yeast G2 checkpoint, which responds to aberrant histone acetylation states.  Azelaic bishydroxamic acid may represent a new class of anticancer drugs with selective toxicity based on its ability to target a dysfunctional checkpoint mechanism in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnlqZq6d7QILVg90H21EOLACvtfcHk0liJKPPCQvfvMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1Sisbc%253D&md5=b53ae6e6752acfd61069314aeebe7850</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1091%2Fmbc.11.6.2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.11.6.2069%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DBurgess%26aufirst%3DA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DP.%2BG.%26aulast%3DGabrielli%26aufirst%3DB.%2BG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520trigger%2520a%2520G2%2520checkpoint%2520in%2520normal%2520cells%2520that%2520is%2520defective%2520in%2520tumor%2520cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2000%26volume%3D11%26issue%3D6%26spage%3D2069%26epage%3D2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span> </span><span class="NLM_article-title">p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">49</span><span class="NLM_x">) </span> <span class="NLM_fpage">7762</span><span class="NLM_x">–</span> <span class="NLM_lpage">7773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7762-7773&issue=49&author=T.+Hiroseauthor=Y.+Sowaauthor=S.+Takahashiauthor=S.+Saitoauthor=C.+Yasudaauthor=N.+Shindoauthor=K.+Furuichiauthor=T.+Sakai&title=p53-independent+induction+of+Gadd45+by+histone+deacetylase+inhibitor%3A+coordinate+regulation+by+transcription+factors+Oct-1+and+NF-Y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DSowa%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DYasuda%26aufirst%3DC.%26aulast%3DShindo%26aufirst%3DN.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3Dp53-independent%2520induction%2520of%2520Gadd45%2520by%2520histone%2520deacetylase%2520inhibitor%253A%2520coordinate%2520regulation%2520by%2520transcription%2520factors%2520Oct-1%2520and%2520NF-Y%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26issue%3D49%26spage%3D7762%26epage%3D7773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Warrener, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beamish, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, B.</span><span> </span><span class="NLM_article-title">Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=1550-1552&issue=11&author=R.+Warrenerauthor=H.+Beamishauthor=A.+Burgessauthor=N.+J.+Waterhouseauthor=N.+Gilesauthor=D.+Fairlieauthor=B.+Gabrielli&title=Tumor+cell-selective+cytotoxicity+by+targeting+cell+cycle+checkpoints"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWarrener%26aufirst%3DR.%26aulast%3DBeamish%26aufirst%3DH.%26aulast%3DBurgess%26aufirst%3DA.%26aulast%3DWaterhouse%26aufirst%3DN.%2BJ.%26aulast%3DGiles%26aufirst%3DN.%26aulast%3DFairlie%26aufirst%3DD.%26aulast%3DGabrielli%26aufirst%3DB.%26atitle%3DTumor%2520cell-selective%2520cytotoxicity%2520by%2520targeting%2520cell%2520cycle%2520checkpoints%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26issue%3D11%26spage%3D1550%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Pujol, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Pawel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hearn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G.</span><span> </span><span class="NLM_article-title">Preliminary results of combined therapy with topotecan and carboplatin in advanced non-small-cell lung cancer</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=47-54&issue=Suppl+1&author=J.+L.+Pujolauthor=J.+von+Pawelauthor=S.+Tumoloauthor=A.+Martoniauthor=S.+Hearnauthor=S.+Z.+Fieldsauthor=G.+Ross&title=Preliminary+results+of+combined+therapy+with+topotecan+and+carboplatin+in+advanced+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPujol%26aufirst%3DJ.%2BL.%26aulast%3Dvon%2BPawel%26aufirst%3DJ.%26aulast%3DTumolo%26aufirst%3DS.%26aulast%3DMartoni%26aufirst%3DA.%26aulast%3DHearn%26aufirst%3DS.%26aulast%3DFields%26aufirst%3DS.%2BZ.%26aulast%3DRoss%26aufirst%3DG.%26atitle%3DPreliminary%2520results%2520of%2520combined%2520therapy%2520with%2520topotecan%2520and%2520carboplatin%2520in%2520advanced%2520non-small-cell%2520lung%2520cancer%26jtitle%3DOncology%26date%3D2001%26volume%3D61%26issue%3DSuppl%25201%26spage%3D47%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&issue=1%E2%80%933&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lgZyKjcCJI0jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26issue%3D1%25E2%2580%25933%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Dreaden, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodji, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Sayed, M. A.</span><span> </span><span class="NLM_article-title">Tamoxifen–Poly(ethylene glycol)-thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2253</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9002212" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=2247-2253&issue=12&author=E.+C.+Dreadenauthor=S.+C.+Mwakwariauthor=Q.+H.+Sodjiauthor=A.+K.+Oyelereauthor=M.+A.+El-Sayed&title=Tamoxifen%E2%80%93Poly%28ethylene+glycol%29-thiol+Gold+Nanoparticle+Conjugates%3A+Enhanced+Potency+and+Selective+Delivery+for+Breast+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tamoxifen-Poly(ethylene glycol)-Thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment</span></div><div class="casAuthors">Dreaden, Erik C.; Mwakwari, Sandra C.; Sodji, Quaovi H.; Oyelere, Adegboyega K.; El-Sayed, Mostafa A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2253</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The breast cancer treatment drug tamoxifen has been widely administered for more than three decades.  This small mol. competes with 17β-estradiol for binding to estrogen receptor, a hormone receptor upregulated in a majority of breast cancers, subsequently initiating programmed cell death.  We have synthesized a thiol-PEGylated tamoxifen deriv. that can be used to selectively target and deliver plasmonic gold nanoparticles to estrogen receptor pos. breast cancer cells with up to 2.7-fold enhanced drug potency in vitro.  Optical microscopy/spectroscopy, time-dependent dose-response data, and estrogen competition studies indicate that augmented activity is due to increased rates of intracellular tamoxifen transport by nanoparticle endocytosis, rather than by passive diffusion of the free drug.  Both ligand- and receptor-dependent intracellular delivery of gold nanoparticles suggest that plasma membrane localized estrogen receptor alpha may facilitate selective uptake and retention of this and other therapeutic nanoparticle conjugates.  Combined targeting selectivity and enhanced potency provides opportunities for both multimodal endocrine treatment strategies and adjunctive laser photothermal therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Zs2_AAkoO7Vg90H21EOLACvtfcHk0lgUdebGDVRLhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtLfL&md5=a280ed117ce356f75d4de231a6e04ad6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fbc9002212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9002212%26sid%3Dliteratum%253Aachs%26aulast%3DDreaden%26aufirst%3DE.%2BC.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DSodji%26aufirst%3DQ.%2BH.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26aulast%3DEl-Sayed%26aufirst%3DM.%2BA.%26atitle%3DTamoxifen%25E2%2580%2593Poly%2528ethylene%2520glycol%2529-thiol%2520Gold%2520Nanoparticle%2520Conjugates%253A%2520Enhanced%2520Potency%2520and%2520Selective%2520Delivery%2520for%2520Breast%2520Cancer%2520Treatment%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26issue%3D12%26spage%3D2247%26epage%3D2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Pelekanou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kafousi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dambaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darivianaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrekoussis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanidas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiftsis, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathopoulos, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanas, E.</span><span> </span><span class="NLM_article-title">Erythropoietin and Its Receptor in Breast Cancer: Correlation with Steroid Receptors and Outcome</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2016</span><span class="NLM_x">–</span> <span class="NLM_lpage">2023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=2016-2023&issue=10&author=V.+Pelekanouauthor=M.+Kampaauthor=M.+Kafousiauthor=K.+Dambakiauthor=K.+Darivianakiauthor=T.+Vrekoussisauthor=E.+Sanidasauthor=D.+D.+Tsiftsisauthor=E.+N.+Stathopoulosauthor=E.+Castanas&title=Erythropoietin+and+Its+Receptor+in+Breast+Cancer%3A+Correlation+with+Steroid+Receptors+and+Outcome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPelekanou%26aufirst%3DV.%26aulast%3DKampa%26aufirst%3DM.%26aulast%3DKafousi%26aufirst%3DM.%26aulast%3DDambaki%26aufirst%3DK.%26aulast%3DDarivianaki%26aufirst%3DK.%26aulast%3DVrekoussis%26aufirst%3DT.%26aulast%3DSanidas%26aufirst%3DE.%26aulast%3DTsiftsis%26aufirst%3DD.%2BD.%26aulast%3DStathopoulos%26aufirst%3DE.%2BN.%26aulast%3DCastanas%26aufirst%3DE.%26atitle%3DErythropoietin%2520and%2520Its%2520Receptor%2520in%2520Breast%2520Cancer%253A%2520Correlation%2520with%2520Steroid%2520Receptors%2520and%2520Outcome%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2007%26volume%3D16%26issue%3D10%26spage%3D2016%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohatgi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azizi, B.</span><span> </span><span class="NLM_article-title">Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule</span> <span class="citation_source-journal">BMC Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1186%2F1472-6750-10-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=20167077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ltFOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=15&issue=1&author=J.+Taylorauthor=P.+Rohatgiauthor=H.+T.+Spencerauthor=D.+Doyleauthor=B.+Azizi&title=Characterization+of+a+molecular+switch+system+that+regulates+gene+expression+in+mammalian+cells+through+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule</span></div><div class="casAuthors">Taylor Jennifer L; Rohatgi Priyanka; Spencer H Trent; Doyle Donald F; Azizi Bahareh</div><div class="citationInfo"><span class="NLM_cas:title">BMC biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Molecular switch systems that activate gene expression by a small molecule are effective technologies that are widely used in applied biological research.  Nuclear receptors are valuable candidates for these regulation systems due to their functional role as ligand activated transcription factors.  Previously, our group engineered a variant of the retinoid x receptor to be responsive to the synthetic compound, LG335, but not responsive to its natural ligand, 9-cis-retinoic acid.  RESULTS:  This work focuses on characterizing a molecular switch system that quantitatively controls transgene expression.  This system is composed of an orthogonal ligand/nuclear receptor pair, LG335 and GRQCIMFI, along with an artificial promoter controlling expression of a target transgene.  GRQCIMFI is composed of the fusion of the DNA binding domain of the yeast transcription factor, Gal4, and a retinoid x receptor variant.  The variant consists of the following mutations: Q275C, I310M, and F313I in the ligand binding domain.  When introduced into mammalian cell culture, the switch shows luciferase activity at concentrations as low as 100 nM of LG335 with a 6.3 +/- 1.7-fold induction ratio.  The developed one-component system activates transgene expression when introduced transiently or virally.  CONCLUSIONS:  We have successfully shown that this system can induce tightly controlled transgene expression and can be used for transient transfections or retroviral transductions in mammalian cell culture.  Further characterization is needed for gene therapy applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFv_UyM0JWlnp3bfzSLaX5fW6udTcc2eZEsLzNDT5cRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ltFOmuw%253D%253D&md5=e2b1df9993ab616edb6191813b138440</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1186%2F1472-6750-10-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6750-10-15%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DRohatgi%26aufirst%3DP.%26aulast%3DSpencer%26aufirst%3DH.%2BT.%26aulast%3DDoyle%26aufirst%3DD.%26aulast%3DAzizi%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520a%2520molecular%2520switch%2520system%2520that%2520regulates%2520gene%2520expression%2520in%2520mammalian%2520cells%2520through%2520a%2520small%2520molecule%26jtitle%3DBMC%2520Biotechnol.%26date%3D2010%26volume%3D10%26issue%3D1%26spage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&issue=2&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0ljy3gjG-Q8FEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26issue%3D2%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Hooft, R. W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vriend, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abola, E. E.</span><span> </span><span class="NLM_article-title">Errors in protein structures</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">381</span><span class="NLM_x"> (</span><span class="NLM_issue">6580</span><span class="NLM_x">) </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=272-272&issue=6580&author=R.+W.+W.+Hooftauthor=G.+Vriendauthor=C.+Sanderauthor=E.+E.+Abola&title=Errors+in+protein+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHooft%26aufirst%3DR.%2BW.%2BW.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DAbola%26aufirst%3DE.%2BE.%26atitle%3DErrors%2520in%2520protein%2520structures%26jtitle%3DNature%26date%3D1996%26volume%3D381%26issue%3D6580%26spage%3D272%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Arnold, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwede, T.</span><span> </span><span class="NLM_article-title">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=195-201&issue=2&author=K.+Arnoldauthor=L.+Bordoliauthor=J.+Koppauthor=T.+Schwede&title=The+SWISS-MODEL+workspace%3A+a+web-based+environment+for+protein+structure+homology+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520workspace%253A%2520a%2520web-based%2520environment%2520for%2520protein%2520structure%2520homology%2520modelling%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26issue%3D2%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kuiper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchenthaler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, J. A.</span><span> </span><span class="NLM_article-title">The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems</span> <span class="citation_source-journal">Front. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400467w&amp;key=10.1006%2Ffrne.1998.0170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400467w&amp;key=9799586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400467w&amp;key=1%3ACAS%3A528%3ADyaK1cXntl2iur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=253-286&issue=4&author=G.+Kuiperauthor=P.+J.+Shughrueauthor=I.+Merchenthalerauthor=J.+A.+Gustafsson&title=The+estrogen+receptor+beta+subtype%3A+a+novel+mediator+of+estrogen+action+in+neuroendocrine+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The estrogen receptor β subtype: a novel mediator of estrogen action in neuroendocrine systems</span></div><div class="casAuthors">Kuiper, George G. J. M.; Shughrue, Paul J.; Merchenthaler, Istvan; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Neuroendocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-286</span>CODEN:
                <span class="NLM_cas:coden">FNEDA7</span>;
        ISSN:<span class="NLM_cas:issn">0091-3022</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 170 refs.  The recent discovery that an addnl. estrogen receptor (ERβ) subtype is present in many rat, mouse, and human tissues has advanced the authors' understanding of the mechanisms underlying estrogen signaling.  Ligand-binding expts. have shown specific binding of 17β-estradiol by ERβ with an affinity similar to that of ERα.  The rat tissue distribution and/or the relative level of ERα and ERβ expression seems to be quite different, i.e., moderate to high expression in uterus, testis, pituitary, ovary, kidney, epididymis, and adrenal for ERα and prostate, ovary, lung, bladder, brain, bone, uterus, and testis for ERβ.  Within the same organ it often appears that the ER subtypes are expressed in different cell types, supporting the hypothesis that the ER's may have different biol. functions.  The cell type-specific expression of ERα and ERβ in rat prostate, testis, uterus, ovary, and brain and the distribution of ERβ mRNA in the ERα knock-out mouse brain are discussed.  The discovery of ERβ suggests the existence of two previously unrecognized pathways of estrogen signaling; via the ERβ subtype in tissues exclusively expressing this subtype and via the formation of heterodimers in tissues expressing both ER subtypes.  The existence of two ER subtypes, their differential expression pattern, and different actions on certain response elements could provide explanations for the striking species-, cell-, and promoter-specific actions of estrogens and antiestrogens.  The challenge for the future is to unravel the detailed physiol. role of each subtype and to use this knowledge to develop the next generation of ER-targeted drugs with improved therapeutic profiles in the treatment or prevention of osteoporosis, cardiovascular system disorders, Alzheimer's disease, breast cancer, and disorders of the urogenital tract.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF_BbY8aCugrVg90H21EOLACvtfcHk0ljy3gjG-Q8FEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntl2iur8%253D&md5=5778675c3ad5cd44092f361d7d895706</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1006%2Ffrne.1998.0170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ffrne.1998.0170%26sid%3Dliteratum%253Aachs%26aulast%3DKuiper%26aufirst%3DG.%26aulast%3DShughrue%26aufirst%3DP.%2BJ.%26aulast%3DMerchenthaler%26aufirst%3DI.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520estrogen%2520receptor%2520beta%2520subtype%253A%2520a%2520novel%2520mediator%2520of%2520estrogen%2520action%2520in%2520neuroendocrine%2520systems%26jtitle%3DFront.%2520Neuroendocrinol.%26date%3D1998%26volume%3D19%26issue%3D4%26spage%3D253%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ERT','PDB','3ERT'); return false;">PDB: 3ERT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P15','PDB','2P15'); return false;">PDB: 2P15</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZZ1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZZ1','PDB','1ZZ1'); return false;">PDB: 1ZZ1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YAT','PDB','2YAT'); return false;">PDB: 2YAT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OLS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OLS','PDB','3OLS'); return false;">PDB: 3OLS</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a href="/doi/suppl/10.1021/jm400467w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34455"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectral information, general methods, predicted pharmacokinetic properties, and molecular modeling outputs.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400467w/suppl_file/jm400467w_si_001.pdf">jm400467w_si_001.pdf (5.56 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400467w&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-14%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400467w%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400467w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992f29ede823e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
